BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 1998;95:322-327. [PMID: 9419374 DOI: 10.1073/pnas.95.1.322] [Cited by in Crossref: 2587] [Cited by in F6Publishing: 2432] [Article Influence: 107.8] [Reference Citation Analysis]
Number Citing Articles
1 Bergman JM, Roecker AJ, Mercer SP, Bednar RA, Reiss DR, Ransom RW, Meacham Harrell C, Pettibone DJ, Lemaire W, Murphy KL, Li C, Prueksaritanont T, Winrow CJ, Renger JJ, Koblan KS, Hartman GD, Coleman PJ. Proline bis-amides as potent dual orexin receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2008;18:1425-30. [DOI: 10.1016/j.bmcl.2008.01.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
2 Faraco J, Mignot E. Genetics of Narcolepsy. Sleep Medicine Clinics 2011;6:217-28. [DOI: 10.1016/j.jsmc.2011.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Sahu A. Interactions of neuropeptide Y, hypocretin-I (orexin A) and melanin-concentrating hormone on feeding in rats. Brain Research 2002;944:232-8. [DOI: 10.1016/s0006-8993(02)02941-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
4 Rainero I, Ostacoli L, Rubino E, Gallone S, Rocco Picci L, Fenoglio P, Negro E, Rosso C, De Martino P, De Marchi M, Furlan PM, Pinessi L. Association between Major Mood Disorders and the hypocretin receptor 1 gene. Journal of Affective Disorders 2011;130:487-91. [DOI: 10.1016/j.jad.2010.10.033] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
5 Fernø J, Señarís R, Diéguez C, Tena-Sempere M, López M. Orexins (hypocretins) and energy balance: More than feeding. Mol Cell Endocrinol 2015;418 Pt 1:17-26. [PMID: 26213323 DOI: 10.1016/j.mce.2015.07.022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kotz C, Wang C, Teske J, Thorpe A, Novak C, Kiwaki K, Levine J. Orexin A mediation of time spent moving in rats: Neural mechanisms. Neuroscience 2006;142:29-36. [DOI: 10.1016/j.neuroscience.2006.05.028] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 4.9] [Reference Citation Analysis]
7 Watts AG, Sanchez-Watts G. Rapid and preferential activation of Fos protein in hypocretin/orexin neurons following the reversal of dehydration-anorexia. J Comp Neurol 2007;502:768-82. [PMID: 17436292 DOI: 10.1002/cne.21316] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
8 Burdakov D, Liss B, Ashcroft FM. Orexin excites GABAergic neurons of the arcuate nucleus by activating the sodium--calcium exchanger. J Neurosci 2003;23:4951-7. [PMID: 12832517 [PMID: 12832517 DOI: 10.1523/jneurosci.23-12-04951.2003] [Cited by in Crossref: 113] [Article Influence: 5.9] [Reference Citation Analysis]
9 Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511. [PMID: 17292770 DOI: 10.1016/S0140-6736(07)60237-2] [Cited by in Crossref: 471] [Cited by in F6Publishing: 147] [Article Influence: 31.4] [Reference Citation Analysis]
10 Cai J, Cooke FE, Sherborne BS. Antagonists of the orexin receptors. Expert Opinion on Therapeutic Patents 2006;16:631-46. [DOI: 10.1517/13543776.16.5.631] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
11 Hettes SR, Gonzaga J, Heyming TW, Perez S, Wolfsohn S, Stanley B. Dual roles in feeding for AMPA/kainate receptors: receptor activation or inactivation within distinct hypothalamic regions elicits feeding behavior. Brain Research 2003;992:167-78. [DOI: 10.1016/j.brainres.2003.08.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
12 Carter ME, Brill J, Bonnavion P, Huguenard JR, Huerta R, de Lecea L. Mechanism for Hypocretin-mediated sleep-to-wake transitions. Proc Natl Acad Sci U S A 2012;109:E2635-44. [PMID: 22955882 DOI: 10.1073/pnas.1202526109] [Cited by in Crossref: 151] [Cited by in F6Publishing: 140] [Article Influence: 15.1] [Reference Citation Analysis]
13 Winrow CJ, Renger JJ. Discovery and development of orexin receptor antagonists as therapeutics for insomnia. Br J Pharmacol 2014;171:283-93. [PMID: 23731216 DOI: 10.1111/bph.12261] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 10.8] [Reference Citation Analysis]
14 Qi K, Wei C, Li Y, Sui N. Orexin receptors within the nucleus accumbens shell mediate the stress but not drug priming-induced reinstatement of morphine conditioned place preference. Front Behav Neurosci 2013;7:144. [PMID: 24133421 DOI: 10.3389/fnbeh.2013.00144] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
15 Kuwaki T. Thermoregulation under pressure: a role for orexin neurons. Temperature (Austin) 2015;2:379-91. [PMID: 27227052 DOI: 10.1080/23328940.2015.1066921] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
16 Malherbe P, Borroni E, Gobbi L, Knust H, Nettekoven M, Pinard E, Roche O, Rogers-Evans M, Wettstein JG, Moreau JL. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor. Br J Pharmacol 2009;156:1326-41. [PMID: 19751316 DOI: 10.1111/j.1476-5381.2009.00127.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
17 Paul ED, Johnson PL, Shekhar A, Lowry CA. The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic. Neurosci Biobehav Rev. 2014;46 Pt 3:379-396. [PMID: 24661986 DOI: 10.1016/j.neubiorev.2014.03.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 5.5] [Reference Citation Analysis]
18 Elbaz I, Zada D, Tovin A, Braun T, Lerer-Goldshtein T, Wang G, Mourrain P, Appelbaum L. Sleep-Dependent Structural Synaptic Plasticity of Inhibitory Synapses in the Dendrites of Hypocretin/Orexin Neurons. Mol Neurobiol 2017;54:6581-97. [PMID: 27734337 DOI: 10.1007/s12035-016-0175-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
19 Mikrouli E, Wörtwein G, Soylu R, Mathé AA, Petersén Å. Increased numbers of orexin/hypocretin neurons in a genetic rat depression model. Neuropeptides 2011;45:401-6. [PMID: 21871662 DOI: 10.1016/j.npep.2011.07.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
20 Clegg DJ, Air EL, Benoit SC, Sakai RS, Seeley RJ, Woods SC. Intraventricular melanin-concentrating hormone stimulates water intake independent of food intake. Am J Physiol Regul Integr Comp Physiol 2003;284:R494-9. [PMID: 12557891 DOI: 10.1152/ajpregu.00399.2002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
21 Postnova S. Sleep Modelling across Physiological Levels. Clocks Sleep 2019;1:166-84. [PMID: 33089162 DOI: 10.3390/clockssleep1010015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
22 Lamar CR, Gardner W, Brazda A, Kesterson RA. Putative Targets of CNS Melanocortin Receptor Activity. Annals of the New York Academy of Sciences 2003;994:211-7. [DOI: 10.1111/j.1749-6632.2003.tb03182.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Wenger Combremont AL, Bayer L, Dupré A, Mühlethaler M, Serafin M. Slow Bursting Neurons of Mouse Cortical Layer 6b Are Depolarized by Hypocretin/Orexin and Major Transmitters of Arousal. Front Neurol 2016;7:88. [PMID: 27379007 DOI: 10.3389/fneur.2016.00088] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ferdousi M, Finn DP. Stress-induced modulation of pain: Role of the endogenous opioid system. The Opioid System as the Interface between the Brain’s Cognitive and Motivational Systems. Elsevier; 2018. pp. 121-77. [DOI: 10.1016/bs.pbr.2018.07.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
25 Husain AM, Ristanovic RK, Bogan RK. Weight loss in narcolepsy patients treated with sodium oxybate. Sleep Med 2009;10:661-3. [PMID: 19014899 DOI: 10.1016/j.sleep.2008.05.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
26 Singletary KG, Deviche P, Strand C, Delville Y. Distribution of orexin/hypocretin immunoreactivity in the brain of a male songbird, the house finch, Carpodacus mexicanus. J Chem Neuroanat 2006;32:81-9. [PMID: 16806811 DOI: 10.1016/j.jchemneu.2006.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
27 Walterfang M, Upjohn E, Velakoulis D. Is Schizophrenia Associated with Narcolepsy? Cognitive and Behavioral Neurology 2005;18:113-8. [DOI: 10.1097/01.wnn.0000160822.53577.2c] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
28 Barson JR, Leibowitz SF. Hypothalamic neuropeptide signaling in alcohol addiction. Prog Neuropsychopharmacol Biol Psychiatry 2016;65:321-9. [PMID: 25689818 DOI: 10.1016/j.pnpbp.2015.02.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
29 Schöne C, Venner A, Knowles D, Karnani MM, Burdakov D. Dichotomous cellular properties of mouse orexin/hypocretin neurons. J Physiol 2011;589:2767-79. [PMID: 21486780 DOI: 10.1113/jphysiol.2011.208637] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
30 Johnson PL, Truitt W, Fitz SD, Minick PE, Dietrich A, Sanghani S, Träskman-Bendz L, Goddard AW, Brundin L, Shekhar A. A key role for orexin in panic anxiety. Nat Med. 2010;16:111-115. [PMID: 20037593 DOI: 10.1038/nm.2075] [Cited by in Crossref: 247] [Cited by in F6Publishing: 229] [Article Influence: 19.0] [Reference Citation Analysis]
31 Montesano A, Baumgart M, Avallone L, Castaldo L, Lucini C, Tozzini ET, Cellerino A, D'Angelo L, de Girolamo P. Age-related central regulation of orexin and NPY in the short-lived African killifish Nothobranchius furzeri. J Comp Neurol 2019;527:1508-26. [PMID: 30666646 DOI: 10.1002/cne.24638] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
32 Richardson KA, Aston-Jones G. Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference. J Neurosci 2012;32:3809-17. [PMID: 22423101 DOI: 10.1523/JNEUROSCI.3917-11.2012] [Cited by in Crossref: 62] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
33 Satoh S, Matsumura H, Nakajima T, Nakahama K, Kanbayashi T, Nishino S, Yoneda H, Shigeyoshi Y. Inhibition of rostral basal forebrain neurons promotes wakefulness and induces FOS in orexin neurons. Eur J Neurosci 2003;17:1635-45. [PMID: 12752381 DOI: 10.1046/j.1460-9568.2003.02577.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
34 Ono D, Yamanaka A. Hypothalamic regulation of the sleep/wake cycle. Neurosci Res 2017;118:74-81. [PMID: 28526553 DOI: 10.1016/j.neures.2017.03.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
35 Yi CX, la Fleur SE, Fliers E, Kalsbeek A. The role of the autonomic nervous liver innervation in the control of energy metabolism. Biochim Biophys Acta 2010;1802:416-31. [PMID: 20060897 DOI: 10.1016/j.bbadis.2010.01.006] [Cited by in Crossref: 103] [Cited by in F6Publishing: 108] [Article Influence: 8.6] [Reference Citation Analysis]
36 Sunter D, Morgan I, Edwards CM, Dakin CL, Murphy KG, Gardiner J, Taheri S, Rayes E, Bloom SR. Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem. Brain Res 2001;907:27-34. [PMID: 11430882 DOI: 10.1016/s0006-8993(01)02344-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
37 Lassiter K, Greene E, Piekarski A, Faulkner OB, Hargis BM, Bottje W, Dridi S. Orexin system is expressed in avian muscle cells and regulates mitochondrial dynamics. Am J Physiol Regul Integr Comp Physiol 2015;308:R173-87. [PMID: 25502749 DOI: 10.1152/ajpregu.00394.2014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
38 Martin EJ, Hernandez ME, Hayward LF. Blockade of orexin receptors attenuates the cardiovascular response to air-jet stress in spontaneously hypertensive rats. Auton Neurosci 2016;201:8-16. [PMID: 27591948 DOI: 10.1016/j.autneu.2016.08.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
39 Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med (Berl) 2004;82:510-29. [PMID: 15175861 DOI: 10.1007/s00109-004-0552-1] [Cited by in Crossref: 215] [Cited by in F6Publishing: 194] [Article Influence: 11.9] [Reference Citation Analysis]
40 Boss C, Roch C. Orexin research: patent news from 2016. Expert Opinion on Therapeutic Patents 2017;27:1123-33. [DOI: 10.1080/13543776.2017.1344221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
41 Chan A, Li S, Lee AR, Leung J, Yip A, Bird J, Godden KE, Martinez-gonzalez D, Rattenborg NC, Balaban E, Pompeiano M. Activation of state-regulating neurochemical systems in newborn and embryonic chicks. Neuroscience 2016;339:219-34. [DOI: 10.1016/j.neuroscience.2016.09.048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Moriguchi T, Sakurai T, Nambu T, Yanagisawa M, Goto K. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neuroscience Letters 1999;264:101-4. [DOI: 10.1016/s0304-3940(99)00177-9] [Cited by in Crossref: 201] [Cited by in F6Publishing: 54] [Article Influence: 8.7] [Reference Citation Analysis]
43 Veauthier C. Sleep Disorders in Multiple Sclerosis. Review. Curr Neurol Neurosci Rep 2015;15. [DOI: 10.1007/s11910-015-0546-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
44 Cun Y, Tang L, Yan J, He C, Li Y, Hu Z, Xia J. Orexin A attenuates the sleep-promoting effect of adenosine in the lateral hypothalamus of rats. Neurosci Bull 2014;30:877-86. [PMID: 24898402 DOI: 10.1007/s12264-013-1442-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
45 Kobashi M, Furudono Y, Matsuo R, Yamamoto T. Central orexin facilitates gastric relaxation and contractility in rats. Neurosci Lett 2002;332:171-4. [PMID: 12399008 DOI: 10.1016/s0304-3940(02)00958-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
46 Desarnaud F, Murillo-Rodriguez E, Lin L, Xu M, Gerashchenko D, Shiromani SN, Nishino S, Mignot E, Shiromani PJ. The diurnal rhythm of hypocretin in young and old F344 rats. Sleep 2004;27:851-6. [PMID: 15453542 DOI: 10.1093/sleep/27.5.851] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 3.6] [Reference Citation Analysis]
47 Giardino WJ, de Lecea L. Hypocretin (orexin) neuromodulation of stress and reward pathways. Curr Opin Neurobiol 2014;29:103-8. [PMID: 25050887 DOI: 10.1016/j.conb.2014.07.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
48 Büdefeld T, Tobet SA, Majdic G. Steroidogenic factor 1 and the central nervous system. J Neuroendocrinol 2012;24:225-35. [PMID: 21668533 DOI: 10.1111/j.1365-2826.2011.02174.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
49 Di Sebastiano AR, Wilson-pérez HE, Lehman MN, Coolen LM. Lesions of orexin neurons block conditioned place preference for sexual behavior in male rats. Hormones and Behavior 2011;59:1-8. [DOI: 10.1016/j.yhbeh.2010.09.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
50 Leinninger GM. Lateral thinking about leptin: a review of leptin action via the lateral hypothalamus. Physiol Behav 2011;104:572-81. [PMID: 21550356 DOI: 10.1016/j.physbeh.2011.04.060] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
51 Flores Á, Herry C, Maldonado R, Berrendero F. Facilitation of Contextual Fear Extinction by Orexin-1 Receptor Antagonism Is Associated with the Activation of Specific Amygdala Cell Subpopulations. Int J Neuropsychopharmacol 2017;20:654-9. [PMID: 28453642 DOI: 10.1093/ijnp/pyx029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
52 Hoang QV, Zhao P, Nakajima S, Nakajima Y. Orexin (hypocretin) effects on constitutively active inward rectifier K+ channels in cultured nucleus basalis neurons. J Neurophysiol 2004;92:3183-91. [PMID: 15269229 DOI: 10.1152/jn.01222.2003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
53 Kim TK, Han PL. Functional Connectivity of Basolateral Amygdala Neurons Carrying Orexin Receptors and Melanin-concentrating Hormone Receptors in Regulating Sociability and Mood-related Behaviors. Exp Neurobiol 2016;25:307-17. [PMID: 28035181 DOI: 10.5607/en.2016.25.6.307] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
54 Takai T, Takaya T, Nakano M, Akutsu H, Nakagawa A, Aimoto S, Nagai K, Ikegami T. Orexin-A is composed of a highly conservedC-terminal and a specific, hydrophilicN-terminal region, revealing the structural basis of specific recognition by the orexin-1 receptor. J Pept Sci 2006;12:443-54. [DOI: 10.1002/psc.747] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
55 Helwig M, Khorooshi RMH, Tups A, Barrett P, Archer ZA, Exner C, Rozman J, Braulke LJ, Mercer JG, Klingenspor M. PC1/3 and PC2 Gene Expression and Post-Translational Endoproteolytic Pro-Opiomelanocortin Processing is Regulated by Photoperiod in the Seasonal Siberian Hamster (Phodopus sungorus). J Neuroendocrinol 2006;18:413-25. [DOI: 10.1111/j.1365-2826.2006.01431.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
56 Ida T, Nakahara K, Murakami T, Hanada R, Nakazato M, Murakami N. Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 2000;270:318-23. [PMID: 10733946 DOI: 10.1006/bbrc.2000.2412] [Cited by in Crossref: 198] [Cited by in F6Publishing: 191] [Article Influence: 9.0] [Reference Citation Analysis]
57 Perrey DA, Decker AM, Li JX, Gilmour BP, Thomas BF, Harris DL, Runyon SP, Zhang Y. The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. Bioorg Med Chem 2015;23:5709-24. [PMID: 26216017 DOI: 10.1016/j.bmc.2015.07.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
58 Jászberényi M, Bujdosó E, Pataki I, Telegdy G. Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 2000;12:1174-8. [PMID: 11106974 DOI: 10.1046/j.1365-2826.2000.00572.x] [Cited by in Crossref: 127] [Cited by in F6Publishing: 132] [Article Influence: 6.0] [Reference Citation Analysis]
59 Futamura A, Nozawa D, Araki Y, Tamura Y, Tokura S, Kawamoto H, Tokumaru Y, Kakihara S, Aoki T, Ohtake N. Identification of highly selective and potent orexin receptor 1 antagonists derived from a dual orexin receptor 1/2 antagonist based on the structural framework of pyrazoylethylbenzamide. Bioorganic & Medicinal Chemistry 2017;25:5203-15. [DOI: 10.1016/j.bmc.2017.07.051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
60 Nishino S, Okuro M, Kotorii N, Anegawa E, Ishimaru Y, Matsumura M, Kanbayashi T. Hypocretin/orexin and narcolepsy: new basic and clinical insights. Acta Physiol (Oxf) 2010;198:209-22. [PMID: 19555382 DOI: 10.1111/j.1748-1716.2009.02012.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
61 Sears RM, Fink AE, Wigestrand MB, Farb CR, de Lecea L, Ledoux JE. Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus. Proc Natl Acad Sci U S A 2013;110:20260-5. [PMID: 24277819 DOI: 10.1073/pnas.1320325110] [Cited by in Crossref: 110] [Cited by in F6Publishing: 101] [Article Influence: 12.2] [Reference Citation Analysis]
62 Haynes AC, Jackson B, Overend P, Buckingham RE, Wilson S, Tadayyon M, Arch JR. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 1999;20:1099-105. [DOI: 10.1016/s0196-9781(99)00105-9] [Cited by in Crossref: 226] [Cited by in F6Publishing: 54] [Article Influence: 9.8] [Reference Citation Analysis]
63 Dauvilliers Y, Barateau L. Narcolepsy and Other Central Hypersomnias. Continuum (Minneap Minn) 2017;23:989-1004. [PMID: 28777172 DOI: 10.1212/CON.0000000000000492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
64 Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999;98:365-376. [PMID: 10458611 DOI: 10.1016/s0092-8674(00)81965-0] [Cited by in Crossref: 1719] [Cited by in F6Publishing: 581] [Article Influence: 74.7] [Reference Citation Analysis]
65 Yamamoto Y, Ueta Y, Hara Y, Serino R, Nomura M, Shibuya I, Shirahata A, Yamashita H. Postnatal development of orexin/hypocretin in rats. Brain Res Mol Brain Res 2000;78:108-19. [PMID: 10891590 DOI: 10.1016/s0169-328x(00)00080-2] [Cited by in Crossref: 73] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
66 Heiss JE, Yamanaka A, Kilduff TS. Parallel Arousal Pathways in the Lateral Hypothalamus. eNeuro 2018;5:ENEURO. [PMID: 30225361 DOI: 10.1523/ENEURO.0228-18.2018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
67 Taheri S, Gardiner J, Hafizi S, Murphy K, Dakin C, Seal L, Small C, Ghatei M, Bloom S. Orexin A immunoreactivity and prepro-orexin mRNA in the brain of Zucker and WKY rats: . Neuroreport 2001;12:459-64. [DOI: 10.1097/00001756-200103050-00008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
68 Dujardin S, Pijpers A, Pevernagie D. Prescription Drugs Used in Insomnia. Sleep Med Clin 2020;15:133-45. [PMID: 32386689 DOI: 10.1016/j.jsmc.2020.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
69 Kim HC, Lee DA, Lee HJ, Shin KJ, Park KM. Alterations in the structural covariance network of the hypothalamus in patients with narcolepsy. Neuroradiology 2022. [PMID: 35013760 DOI: 10.1007/s00234-021-02878-6] [Reference Citation Analysis]
70 Lu GL, Yau HJ, Chiou LC. Conditioned place preference training prevents hippocampal depotentiation in an orexin-dependent manner. J Biomed Sci 2017;24:69. [PMID: 28877723 DOI: 10.1186/s12929-017-0378-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
71 Roecker AJ, Mercer SP, Schreier JD, Cox CD, Fraley ME, Steen JT, Lemaire W, Bruno JG, Harrell CM, Garson SL, Gotter AL, Fox SV, Stevens J, Tannenbaum PL, Prueksaritanont T, Cabalu TD, Cui D, Stellabott J, Hartman GD, Young SD, Winrow CJ, Renger JJ, Coleman PJ. Discovery of 5''-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2':5',3''-terpyridine-3'-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia. ChemMedChem 2014;9:311-22. [PMID: 24376006 DOI: 10.1002/cmdc.201300447] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
72 Dugovic C, Shelton JE, Yun S, Bonaventure P, Shireman BT, Lovenberg TW. Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism. Front Neurosci 2014;8:28. [PMID: 24592208 DOI: 10.3389/fnins.2014.00028] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
73 Dingemanse J, Cruz HG, Gehin M, Hoever P. Pharmacokinetic interactions between the orexin receptor antagonist almorexant and the CYP3A4 inhibitors ketoconazole and diltiazem. J Pharm Sci 2014;103:1548-56. [PMID: 24604243 DOI: 10.1002/jps.23916] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
74 Singletary KG, Deviche P, Strand C, Delville Y. Distribution of orexin/hypocretin immunoreactivity in the brain of a male songbird, the house finch, Carpodacus mexicanus. Journal of Chemical Neuroanatomy 2007;33:101-9. [DOI: 10.1016/j.jchemneu.2006.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
75 Anaclet C, Parmentier R, Ouk K, Guidon G, Buda C, Sastre JP, Akaoka H, Sergeeva OA, Yanagisawa M, Ohtsu H, Franco P, Haas HL, Lin JS. Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci 2009;29:14423-38. [PMID: 19923277 DOI: 10.1523/JNEUROSCI.2604-09.2009] [Cited by in Crossref: 131] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]
76 Fakhari M, Azizi H, Semnanian S. Central antagonism of orexin type-1 receptors attenuates the development of morphine dependence in rat locus coeruleus neurons. Neuroscience 2017;363:1-10. [DOI: 10.1016/j.neuroscience.2017.08.054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
77 Krasnova IN, Justinova Z, Cadet JL. Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways. Psychopharmacology (Berl) 2016;233:1945-62. [PMID: 26873080 DOI: 10.1007/s00213-016-4235-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 8.5] [Reference Citation Analysis]
78 Imperatore R, D'Angelo L, Safari O, Motlagh HA, Piscitelli F, de Girolamo P, Cristino L, Varricchio E, di Marzo V, Paolucci M. Overlapping Distribution of Orexin and Endocannabinoid Receptors and Their Functional Interaction in the Brain of Adult Zebrafish. Front Neuroanat 2018;12:62. [PMID: 30104964 DOI: 10.3389/fnana.2018.00062] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
79 Macedo GC, Kawakami SE, Vignoli T, Sinigaglia-Coimbra R, Suchecki D. The influence of orexins on ethanol-induced behavioral sensitization in male mice. Neurosci Lett 2013;551:84-8. [PMID: 23880022 DOI: 10.1016/j.neulet.2013.07.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
80 Szabadi E. Functional neuroanatomy of the central noradrenergic system. J Psychopharmacol. 2013;27:659-693. [PMID: 23761387 DOI: 10.1177/0269881113490326] [Cited by in Crossref: 167] [Cited by in F6Publishing: 152] [Article Influence: 18.6] [Reference Citation Analysis]
81 Bray GA, Greenway FL. Current and potential drugs for treatment of obesity. Endocr Rev 1999;20:805-75. [PMID: 10605627 DOI: 10.1210/edrv.20.6.0383] [Cited by in Crossref: 123] [Cited by in F6Publishing: 111] [Article Influence: 5.6] [Reference Citation Analysis]
82 Postnova S, Voigt K, Braun HA. A mathematical model of homeostatic regulation of sleep-wake cycles by hypocretin/orexin. J Biol Rhythms 2009;24:523-35. [PMID: 19926811 DOI: 10.1177/0748730409346655] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
83 Oikonomou G, Prober DA. Attacking sleep from a new angle: contributions from zebrafish. Curr Opin Neurobiol 2017;44:80-8. [PMID: 28391131 DOI: 10.1016/j.conb.2017.03.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
84 Thompson MD, Sakurai T, Rainero I, Maj MC, Kukkonen JP. Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics. Pharmaceuticals (Basel) 2017;10:E79. [PMID: 28991183 DOI: 10.3390/ph10040079] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
85 Aissaoui H, Koberstein R, Zumbrunn C, Gatfield J, Brisbare-roch C, Jenck F, Treiber A, Boss C. N-Glycine-sulfonamides as potent dual orexin 1/orexin 2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2008;18:5729-33. [DOI: 10.1016/j.bmcl.2008.09.079] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
86 Salgado-Delgado R, Nadia S, Angeles-Castellanos M, Buijs RM, Escobar C. In a rat model of night work, activity during the normal resting phase produces desynchrony in the hypothalamus. J Biol Rhythms 2010;25:421-31. [PMID: 21135158 DOI: 10.1177/0748730410383403] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
87 Vazquez-DeRose J, Schwartz MD, Nguyen AT, Warrier DR, Gulati S, Mathew TK, Neylan TC, Kilduff TS. Hypocretin/orexin antagonism enhances sleep-related adenosine and GABA neurotransmission in rat basal forebrain. Brain Struct Funct 2016;221:923-40. [PMID: 25431268 DOI: 10.1007/s00429-014-0946-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
88 Zhang S, Blache D, Vercoe PE, Adam CL, Blackberry MA, Findlay PA, Eidne KA, Martin GB. Expression of orexin receptors in the brain and peripheral tissues of the male sheep. Regulatory Peptides 2005;124:81-7. [DOI: 10.1016/j.regpep.2004.07.010] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
89 Herring WJ, Connor KM, Snyder E, Snavely DB, Zhang Y, Hutzelmann J, Matzura-Wolfe D, Benca RM, Krystal AD, Walsh JK, Lines C, Roth T, Michelson D. Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials. J Clin Sleep Med 2016;12:1215-25. [PMID: 27397664 DOI: 10.5664/jcsm.6116] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
90 Perrey DA, German NA, Gilmour BP, Li JX, Harris DL, Thomas BF, Zhang Y. Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. J Med Chem 2013;56:6901-16. [PMID: 23941044 DOI: 10.1021/jm400720h] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
91 Williams KS, Diniz Behn CG. Dynamic Interactions between Orexin and Dynorphin May Delay Onset of Functional Orexin Effects: A Modeling Study. J Biol Rhythms 2011;26:171-81. [DOI: 10.1177/0748730410395471] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
92 Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ. Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A 2008;105:19480-5. [PMID: 19033203 DOI: 10.1073/pnas.0808023105] [Cited by in Crossref: 196] [Cited by in F6Publishing: 195] [Article Influence: 14.0] [Reference Citation Analysis]
93 Calva CB, Fadel JR. Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction. Brain Res 2020;1731:145921. [PMID: 30148983 DOI: 10.1016/j.brainres.2018.08.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
94 Srinivasan S, Shariff M, Bartlett SE. The role of the glucocorticoids in developing resilience to stress and addiction. Front Psychiatry 2013;4:68. [PMID: 23914175 DOI: 10.3389/fpsyt.2013.00068] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
95 Levy KA, Brodnik ZD, Shaw JK, Perrey DA, Zhang Y, España RA. Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling. Psychopharmacology (Berl) 2017;234:2761-76. [PMID: 28667509 DOI: 10.1007/s00213-017-4673-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
96 Bode FJ, Stephan M, Wiehager S, Nguyen HP, Björkqvist M, von Hörsten S, Bauer A, Petersén A. Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model. Behav Brain Res 2009;205:175-82. [PMID: 19573560 DOI: 10.1016/j.bbr.2009.06.031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
97 Guilleminault C, Cao MT. Narcolepsy. Principles and Practice of Sleep Medicine. Elsevier; 2011. pp. 957-68. [DOI: 10.1016/b978-1-4160-6645-3.00085-2] [Cited by in Crossref: 9] [Article Influence: 0.8] [Reference Citation Analysis]
98 Zeitzer JM, Buckmaster CL, Parker KJ, Hauck CM, Lyons DM, Mignot E. Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J Neurosci 2003;23:3555-60. [PMID: 12716965 [PMID: 12716965 DOI: 10.1523/jneurosci.23-08-03555.2003] [Cited by in Crossref: 188] [Article Influence: 9.9] [Reference Citation Analysis]
99 Khoo SY, McNally GP, Clemens KJ. The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking. PLoS One 2017;12:e0173967. [PMID: 28296947 DOI: 10.1371/journal.pone.0173967] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
100 Downs JL, Dunn MR, Borok E, Shanabrough M, Horvath TL, Kohama SG, Urbanski HF. Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque. Neurobiol Aging 2007;28:1286-95. [PMID: 16870307 DOI: 10.1016/j.neurobiolaging.2006.05.025] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
101 Akbari E, Naghdi N, Motamedi F. The selective orexin 1 receptor antagonist SB-334867-A impairs acquisition and consolidation but not retrieval of spatial memory in Morris water maze. Peptides 2007;28:650-6. [PMID: 17161886 DOI: 10.1016/j.peptides.2006.11.002] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 4.2] [Reference Citation Analysis]
102 Han F. Narcolepsy, orexins and respiratory regulation: Respiratory regulation in narcolepsy. Sleep and Biological Rhythms 2011;9:44-51. [DOI: 10.1111/j.1479-8425.2010.00467.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
103 Ouyang M, Hellman K, Abel T, Thomas SA. Adrenergic signaling plays a critical role in the maintenance of waking and in the regulation of REM sleep. J Neurophysiol 2004;92:2071-82. [PMID: 15190089 DOI: 10.1152/jn.00226.2004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 3.7] [Reference Citation Analysis]
104 Oh DY, Kim K, Kwon HB, Seong JY. Cellular and molecular biology of orphan G protein-coupled receptors. Int Rev Cytol 2006;252:163-218. [PMID: 16984818 DOI: 10.1016/S0074-7696(06)52003-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
105 Lewis SL. Whatcha Talkin' 'Bout, Willis-Ekbom? Continuum (Minneap Minn) 2017;23:953-4. [PMID: 28777169 DOI: 10.1212/01.CON.0000522242.68042.65] [Reference Citation Analysis]
106 Tyree SM, Borniger JC, de Lecea L. Hypocretin as a Hub for Arousal and Motivation. Front Neurol 2018;9:413. [PMID: 29928253 DOI: 10.3389/fneur.2018.00413] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
107 Dyer C, Touchette K, Carroll J, Allee G, Matteri R. Cloning of Porcine Prepro-Orexin cDNA and Effects of an Intramuscular Injection of Synthetic Porcine Orexin-B on Feed Intake in Young Pigs. Domestic Animal Endocrinology 1999;16:145-8. [DOI: 10.1016/s0739-7240(99)00011-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
108 Horvath TL, Diano S, van den Pol AN. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci 1999;19:1072-87. [PMID: 9920670 [PMID: 9920670 DOI: 10.1523/jneurosci.19-03-01072.1999] [Cited by in Crossref: 383] [Article Influence: 16.7] [Reference Citation Analysis]
109 Liguori G, Paino S, Mirabella N, Squillacioti C, De Luca A, Vittoria A. Expression of Orexin A and its Receptor 1 in the Epididymis of the South American Camelid Alpaca ( Vicugna pacos ). Anat Histol Embryol 2014;43:42-7. [DOI: 10.1111/ahe.12046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
110 Schwartz MW, Baskin DG, Kaiyala KJ, Woods SC. Model for the regulation of energy balance and adiposity by the central nervous system. The American Journal of Clinical Nutrition 1999;69:584-96. [DOI: 10.1093/ajcn/69.4.584] [Cited by in Crossref: 161] [Cited by in F6Publishing: 152] [Article Influence: 7.0] [Reference Citation Analysis]
111 Smart D, Jerman JC, Brough SJ, Neville WA, Jewitt F, Porter RA. The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors. Br J Pharmacol 2000;129:1289-91. [PMID: 10742282 DOI: 10.1038/sj.bjp.0703257] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
112 Boss C. Orexin receptor antagonists--a patent review (2010 to August 2014). Expert Opin Ther Pat 2014;24:1367-81. [PMID: 25407283 DOI: 10.1517/13543776.2014.978859] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
113 Guerreiro S, Florence C, Rousseau E, Hamadat S, Hirsch EC, Michel PP. The Sleep-Modulating Peptide Orexin-B Protects Midbrain Dopamine Neurons from Degeneration, Alone or in Cooperation with Nicotine. Mol Pharmacol 2015;87:525-32. [DOI: 10.1124/mol.114.095703] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
114 Marchant NJ, Millan EZ, McNally GP. The hypothalamus and the neurobiology of drug seeking. Cell Mol Life Sci 2012;69:581-97. [PMID: 21947443 DOI: 10.1007/s00018-011-0817-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
115 Sakurai S, Nishijima T, Takahashi S, Yamauchi K, Arihara Z, Takahashi K. Low Plasma Orexin-A Levels Were Improved by Continuous Positive Airway Pressure Treatment in Patients With Severe Obstructive Sleep Apnea-Hypopnea Syndrome. Chest 2005;127:731-7. [DOI: 10.1378/chest.127.3.731] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
116 Morrison SF, Madden CJ, Tupone D. Central control of brown adipose tissue thermogenesis. Front Endocrinol (Lausanne) 2012;3:00005. [PMID: 22389645 DOI: 10.3389/fendo.2012.00005] [Cited by in Crossref: 97] [Cited by in F6Publishing: 114] [Article Influence: 9.7] [Reference Citation Analysis]
117 Martínez-Orozco FJ, Vicario JL, Villalibre-Valderrey I, De Andrés C, Fernández-Arquero M, Peraita-Adrados R. Narcolepsy with cataplexy and comorbid immunopathological diseases. J Sleep Res 2014;23:414-9. [PMID: 24645699 DOI: 10.1111/jsr.12143] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
118 Björnström K, Turina D, Strid T, Sundqvist T, Eintrei C. Orexin A inhibits propofol-induced neurite retraction by a phospholipase D/protein kinase Cε-dependent mechanism in neurons. PLoS One 2014;9:e97129. [PMID: 24828410 DOI: 10.1371/journal.pone.0097129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
119 Ono K, Kai A, Honda E, Inenaga K. Hypocretin-1/orexin-A activates subfornical organ neurons of rats. Neuroreport 2008;19:69-73. [PMID: 18281895 DOI: 10.1097/WNR.0b013e3282f32d64] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
120 Fadel J, Burk JA. Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention. Brain Res 2010;1314:112-23. [PMID: 19699722 DOI: 10.1016/j.brainres.2009.08.046] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
121 Faesel N, Kolodziejczyk MH, Koch M, Fendt M. Orexin deficiency affects sociability and the acquisition, expression, and extinction of conditioned social fear. Brain Res 2021;1751:147199. [PMID: 33160959 DOI: 10.1016/j.brainres.2020.147199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Alvarez-Bolado G, Celio MR. The ventrolateral hypothalamic area and the parvafox nucleus: Role in the expression of (positive) emotions? J Comp Neurol 2016;524:1616-23. [PMID: 26179507 DOI: 10.1002/cne.23853] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
123 Cole S, Mayer HS, Petrovich GD. Orexin/Hypocretin-1 Receptor Antagonism Selectively Reduces Cue-Induced Feeding in Sated Rats and Recruits Medial Prefrontal Cortex and Thalamus. Sci Rep 2015;5:16143. [PMID: 26536818 DOI: 10.1038/srep16143] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
124 Williams RH, Burdakov D. Hypothalamic orexins/hypocretins as regulators of breathing. Expert Rev Mol Med 2008;10:e28. [PMID: 18828950 DOI: 10.1017/S1462399408000823] [Cited by in Crossref: 59] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
125 Brogan RS, Grove KL, Smith MS. Differential regulation of leptin receptor but not orexin in the hypothalamus of the lactating rat. J Neuroendocrinol 2000;12:1077-86. [PMID: 11069123 DOI: 10.1046/j.1365-2826.2000.00559.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
126 Stricker-Krongrad A, Richy S, Beck B. Orexins/hypocretins in the ob/ob mouse: hypothalamic gene expression, peptide content and metabolic effects. Regul Pept 2002;104:11-20. [PMID: 11830271 DOI: 10.1016/s0167-0115(01)00344-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
127 Feillet CA. Food for Thoughts: Feeding Time and Hormonal Secretion: Influence of feeding on hormone secretion profiles. Journal of Neuroendocrinology 2010;22:620-8. [DOI: 10.1111/j.1365-2826.2010.01998.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
128 Cohen S, Matar MA, Vainer E, Zohar J, Kaplan Z, Cohen H. Significance of the orexinergic system in modulating stress-related responses in an animal model of post-traumatic stress disorder. Transl Psychiatry 2020;10:10. [PMID: 32066707 DOI: 10.1038/s41398-020-0698-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
129 Kenny PJ. Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci. 2011;12:638-651. [PMID: 22011680 DOI: 10.1038/nrn3105] [Cited by in Crossref: 237] [Cited by in F6Publishing: 227] [Article Influence: 21.5] [Reference Citation Analysis]
130 Liu J, Han J, Izawa K, Sato T, White S, Meanwell NA, Soloshonok VA. Cyclic tailor-made amino acids in the design of modern pharmaceuticals. Eur J Med Chem 2020;208:112736. [PMID: 32966895 DOI: 10.1016/j.ejmech.2020.112736] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
131 Orlowska-Feuer P, Smyk MK, Palus-Chramiec K, Dyl K, Lewandowski MH. Orexin A as a modulator of dorsal lateral geniculate neuronal activity: a comprehensive electrophysiological study on adult rats. Sci Rep 2019;9:16729. [PMID: 31723155 DOI: 10.1038/s41598-019-53012-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
132 Bell BJ, Wang AA, Kim DW, Xiong J, Blackshaw S, Wu MN. Characterization of mWake expression in the murine brain. J Comp Neurol 2021;529:1954-87. [PMID: 33140455 DOI: 10.1002/cne.25066] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Wang CM, Yang CQ, Cheng BH, Chen J, Bai B. Orexin-A protects SH-SY5Y cells against H2O2-induced oxidative damage via the PI3K/MEK1/2/ERK1/2 signaling pathway. Int J Immunopathol Pharmacol 2018;32:2058738418785739. [PMID: 29983082 DOI: 10.1177/2058738418785739] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
134 Kalló I, Omrani A, Meye FJ, de Jong H, Liposits Z, Adan RAH. Characterization of orexin input to dopamine neurons of the ventral tegmental area projecting to the medial prefrontal cortex and shell of nucleus accumbens. Brain Struct Funct 2022. [PMID: 35029758 DOI: 10.1007/s00429-021-02449-8] [Reference Citation Analysis]
135 Askari K, Oryan S, Eidi A, Zaringhalam J, Haghparast A. Modulatory role of the orexin system in stress-induced analgesia: Involvement of the ventral tegmental area. Eur J Pain 2021. [PMID: 34288265 DOI: 10.1002/ejp.1840] [Reference Citation Analysis]
136 Liu Z, Jiang L, Zhu F, Fu C, Lu S, Zhou J, Wu X, Bai C, Li S. Chronic intermittent hypoxia and the expression of orexin and its receptors in the brains of rats: Intermittent hypoxia and orexin. Sleep and Biological Rhythms 2014;12:22-9. [DOI: 10.1111/sbr.12043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
137 Soffin EM, Evans ML, Gill CH, Harries MH, Benham CD, Davies CH. SB-334867-A antagonises orexin mediated excitation in the locus coeruleus. Neuropharmacology 2002;42:127-33. [PMID: 11750922 DOI: 10.1016/s0028-3908(01)00156-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
138 Nitkiewicz A, Smolinska N, Przala J, Kaminski T. Expression of orexin receptors 1 (OX1R) and 2 (OX2R) in the porcine ovary during the oestrous cycle. Regulatory Peptides 2010;165:186-90. [DOI: 10.1016/j.regpep.2010.07.166] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
139 Dunn KE, Huhn AS, Bergeria CL, Gipson CD, Weerts EM. Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence. J Pharmacol Exp Ther 2019;371:422-52. [PMID: 31391211 DOI: 10.1124/jpet.119.258004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
140 Deporter DP, Coborn JE, Teske JA. Partial Sleep Deprivation Reduces the Efficacy of Orexin-A to Stimulate Physical Activity and Energy Expenditure: Sleep Deprivation Dampens EE During Physical Activity. Obesity 2017;25:1716-22. [DOI: 10.1002/oby.21944] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
141 Guan JL, Suzuki R, Funahashi H, Wang QP, Kageyama H, Uehara K, Yamada S, Tsurugano S, Shioda S. Ultrastructural localization of orexin-1 receptor in pre- and post-synaptic neurons in the rat arcuate nucleus. Neurosci Lett 2002;329:209-12. [PMID: 12165414 DOI: 10.1016/s0304-3940(02)00660-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
142 Stojakovic A, Espinosa EP, Farhad OT, Lutfy K. Effects of nicotine on homeostatic and hedonic components of food intake. J Endocrinol 2017;235:R13-31. [PMID: 28814527 DOI: 10.1530/JOE-17-0166] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 4.4] [Reference Citation Analysis]
143 Yaeger JD, Krupp KT, Gale JJ, Summers CH. Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity. Medicine in Drug Discovery 2020;8:100059. [DOI: 10.1016/j.medidd.2020.100059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
144 Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev. 2007;56:27-78. [PMID: 17574681 DOI: 10.1016/j.brainresrev.2007.05.004] [Cited by in Crossref: 885] [Cited by in F6Publishing: 894] [Article Influence: 59.0] [Reference Citation Analysis]
145 Equihua AC, De La Herrán-Arita AK, Drucker-Colin R. Orexin receptor antagonists as therapeutic agents for insomnia. Front Pharmacol 2013;4:163. [PMID: 24416019 DOI: 10.3389/fphar.2013.00163] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
146 Tomasik PJ, Sztefko K. The effect of enteral and parenteral feeding on secretion of orexigenic peptides in infants. BMC Gastroenterol 2009;9:92. [PMID: 20003268 DOI: 10.1186/1471-230X-9-92] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
147 Hollander JA, Pham D, Fowler CD, Kenny PJ. Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence. Front Behav Neurosci 2012;6:47. [PMID: 22837742 DOI: 10.3389/fnbeh.2012.00047] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
148 Wang H, Li S, Kirouac GJ. Role of the orexin (hypocretin) system in contextual fear conditioning in rats. Behavioural Brain Research 2017;316:47-53. [DOI: 10.1016/j.bbr.2016.08.052] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
149 Kumar A, Chanana P, Choudhary S. Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs. Pharmacological Reports 2016;68:231-42. [DOI: 10.1016/j.pharep.2015.09.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
150 Carvajal F, Alcaraz-iborra M, Lerma-cabrera JM, Valor LM, de la Fuente L, Sanchez-amate MDC, Cubero I. Orexin receptor 1 signaling contributes to ethanol binge-like drinking: Pharmacological and molecular evidence. Behavioural Brain Research 2015;287:230-7. [DOI: 10.1016/j.bbr.2015.03.046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
151 Wigglesworth MJ, Wolfe LA, Wise A. Orphan seven transmembrane receptor screening. Ernst Schering Found Symp Proc 2006;:105-43. [PMID: 17703580 DOI: 10.1007/2789_2006_006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
152 Costa A, Antonaci F, Ramusino MC, Nappi G. The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias. Curr Neuropharmacol 2015;13:304-23. [PMID: 26411963 DOI: 10.2174/1570159x13666150309233556] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
153 Chang X, Zhao Y, Guo L. Effect of Orexin-A on Cortisol Secretion in H295R Cells via p70S6K/4EBP1 Signaling Pathway. Int J Endocrinol 2015;2015:405157. [PMID: 26064108 DOI: 10.1155/2015/405157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
154 Ferreira JGP, Bittencourt JC, Adamantidis A. Melanin-concentrating hormone and sleep. Current Opinion in Neurobiology 2017;44:152-8. [DOI: 10.1016/j.conb.2017.04.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
155 Wise MS. Narcolepsy and other disorders of excessive sleepiness. Medical Clinics of North America 2004;88:597-610. [DOI: 10.1016/j.mcna.2004.02.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
156 Christopher JA, Aves SJ, Brown J, Errey JC, Klair SS, Langmead CJ, Mace OJ, Mould R, Patel JC, Tehan BG, Zhukov A, Marshall FH, Congreve M. Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties. Med Chem Commun 2015;6:947-55. [DOI: 10.1039/c5md00027k] [Cited by in Crossref: 11] [Article Influence: 1.6] [Reference Citation Analysis]
157 Baimel C, Bartlett SE, Chiou LC, Lawrence AJ, Muschamp JW, Patkar O, Tung LW, Borgland SL. Orexin/hypocretin role in reward: implications for opioid and other addictions. Br J Pharmacol 2015;172:334-48. [PMID: 24641197 DOI: 10.1111/bph.12639] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 12.1] [Reference Citation Analysis]
158 Li Z, Liu X, Zhang P, Han R, Sun G, Jiang R, Wang Y, Liu X, Li W, Kang X, Tian Y. Comparative transcriptome analysis of hypothalamus-regulated feed intake induced by exogenous visfatin in chicks. BMC Genomics 2018;19:249. [PMID: 29642854 DOI: 10.1186/s12864-018-4644-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
159 Näslund E, Ehrström M, Ma J, Hellström PM, Kirchgessner AL. Localization and effects of orexin on fasting motility in the rat duodenum. Am J Physiol Gastrointest Liver Physiol 2002;282:G470-9. [PMID: 11841997 DOI: 10.1152/ajpgi.00219.2001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
160 Mahler SV, Smith RJ, Moorman DE, Sartor GC, Aston-Jones G. Multiple roles for orexin/hypocretin in addiction. Prog Brain Res 2012;198:79-121. [PMID: 22813971 DOI: 10.1016/B978-0-444-59489-1.00007-0] [Cited by in Crossref: 140] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]
161 Gao XB, Wang AH. Experience-dependent plasticity in hypocretin/orexin neurones: re-setting arousal threshold. Acta Physiol (Oxf) 2010;198:251-62. [PMID: 19785627 DOI: 10.1111/j.1748-1716.2009.02047.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
162 Mediavilla C, Cabello V, Risco S. SB-334867-A, a selective orexin-1 receptor antagonist, enhances taste aversion learning and blocks taste preference learning in rats. Pharmacol Biochem Behav 2011;98:385-91. [PMID: 21295056 DOI: 10.1016/j.pbb.2011.01.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
163 Boutrel B, Cannella N, de Lecea L. The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res 2010;1314:103-11. [PMID: 19948148 DOI: 10.1016/j.brainres.2009.11.054] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 6.5] [Reference Citation Analysis]
164 Welch MG, Keune JD, Welch-Horan TB, Anwar N, Anwar M, Ludwig RJ, Ruggiero DA. Secretin: hypothalamic distribution and hypothesized neuroregulatory role in autism. Cell Mol Neurobiol 2004;24:219-41. [PMID: 15176437 DOI: 10.1023/b:cemn.0000018618.59015.a2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
165 Okumura T, Nozu T. Role of brain orexin in the pathophysiology of functional gastrointestinal disorders. J Gastroenterol Hepatol. 2011;26 Suppl 3:61-66. [PMID: 21443712 DOI: 10.1111/j.1440-1746.2011.06626.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
166 Arima Y, Yokota S, Fujitani M. Lateral parabrachial neurons innervate orexin neurons projecting to brainstem arousal areas in the rat. Sci Rep 2019;9:2830. [PMID: 30808976 DOI: 10.1038/s41598-019-39063-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
167 Kotz CM. Integration of feeding and spontaneous physical activity: role for orexin. Physiol Behav 2006;88:294-301. [PMID: 16787655 DOI: 10.1016/j.physbeh.2006.05.031] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
168 Grafe LA, Eacret D, Dobkin J, Bhatnagar S. Reduced Orexin System Function Contributes to Resilience to Repeated Social Stress. eNeuro 2018;5:ENEURO. [PMID: 29662948 DOI: 10.1523/ENEURO.0273-17.2018] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 8.3] [Reference Citation Analysis]
169 Wheeler DS, Wan S, Miller A, Angeli N, Adileh B, Hu W, Holland PC. Role of lateral hypothalamus in two aspects of attention in associative learning. Eur J Neurosci 2014;40:2359-77. [PMID: 24750426 DOI: 10.1111/ejn.12592] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
170 Justinussen J, Holm A, Kornum B. An optimized method for measuring hypocretin-1 peptide in the mouse brain reveals differential circadian regulation of hypocretin-1 levels rostral and caudal to the hypothalamus. Neuroscience 2015;310:354-61. [DOI: 10.1016/j.neuroscience.2015.09.050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
171 Gundlach AL. Galanin/GALP and galanin receptors: role in central control of feeding, body weight/obesity and reproduction? Eur J Pharmacol 2002;440:255-68. [PMID: 12007540 DOI: 10.1016/s0014-2999(02)01433-4] [Cited by in Crossref: 98] [Cited by in F6Publishing: 20] [Article Influence: 4.9] [Reference Citation Analysis]
172 Morales A, Bonnet C, Bourgoin N, Touvier T, Nadam J, Laglaine A, Navarro F, Moulin C, Georges B, Pequignot JM, Bezin L. Unexpected expression of orexin-B in basal conditions and increased levels in the adult rat hippocampus during pilocarpine-induced epileptogenesis. Brain Res 2006;1109:164-75. [PMID: 16904080 DOI: 10.1016/j.brainres.2006.06.075] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
173 Hoyer D, Bartfai T. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach. Chem Biodivers 2012;9:2367-87. [PMID: 23161624 DOI: 10.1002/cbdv.201200288] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
174 Del Cid-Pellitero E, Garzón M. Medial prefrontal cortex receives input from dorsal raphe nucleus neurons targeted by hypocretin1/orexinA-containing axons. Neuroscience 2011;172:30-43. [PMID: 21036204 DOI: 10.1016/j.neuroscience.2010.10.058] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
175 Sun Y, Tisdale RK, Kilduff TS. Hypocretin/Orexin Receptor Pharmacology and Sleep Phases. Front Neurol Neurosci 2021;45:22-37. [PMID: 34052813 DOI: 10.1159/000514963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
176 Ida T, Nakahara K, Kuroiwa T, Fukui K, Nakazato M, Murakami T, Murakami N. Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats. Neuroscience Letters 2000;293:119-22. [DOI: 10.1016/s0304-3940(00)01498-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
177 Urade Y. Neurobiological Basis of Hypersomnia. Sleep Medicine Clinics 2017;12:265-77. [DOI: 10.1016/j.jsmc.2017.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
178 Mousavi Y, Azizi H, Mirnajafi-zadeh J, Javan M, Semnanian S. Blockade of orexin type-1 receptors in locus coeruleus nucleus attenuates the development of morphine dependency in rats. Neuroscience Letters 2014;578:90-4. [DOI: 10.1016/j.neulet.2014.06.038] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
179 Kohlmeier KA, Watanabe S, Tyler CJ, Burlet S, Leonard CS. Dual orexin actions on dorsal raphe and laterodorsal tegmentum neurons: noisy cation current activation and selective enhancement of Ca2+ transients mediated by L-type calcium channels. J Neurophysiol 2008;100:2265-81. [PMID: 18667550 DOI: 10.1152/jn.01388.2007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
180 Stettner GM, Kubin L. Antagonism of orexin receptors in the posterior hypothalamus reduces hypoglossal and cardiorespiratory excitation from the perifornical hypothalamus. J Appl Physiol (1985) 2013;114:119-30. [PMID: 23104701 DOI: 10.1152/japplphysiol.00965.2012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
181 Wiskerke J, James MH, Aston-Jones G. The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task. Brain Res 2020;1731:146222. [PMID: 31002819 DOI: 10.1016/j.brainres.2019.04.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
182 Chokroverty S, Avidan AY. Sleep and Its Disorders. Neurology in Clinical Practice. Elsevier; 2012. pp. 1634-702. [DOI: 10.1016/b978-1-4377-0434-1.00093-1] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
183 Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, Bonci A, Bartlett SE. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 2008;199:109-17. [PMID: 18470506 DOI: 10.1007/s00213-008-1136-5] [Cited by in Crossref: 166] [Cited by in F6Publishing: 178] [Article Influence: 11.9] [Reference Citation Analysis]
184 Beck B, Richy S. Hypothalamic Hypocretin/Orexin and Neuropeptide Y: Divergent Interaction with Energy Depletion and Leptin. Biochemical and Biophysical Research Communications 1999;258:119-22. [DOI: 10.1006/bbrc.1999.0605] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 3.0] [Reference Citation Analysis]
185 Zhu J, Tang S, Zhao D, Zeng Z, Mo H, Hu K. Orexin A improves the cognitive impairment induced by chronic intermittent hypoxia in mice. Brain Res Bull 2021;173:203-10. [PMID: 34051297 DOI: 10.1016/j.brainresbull.2021.05.022] [Reference Citation Analysis]
186 Muehlan C, Fischer H, Zimmer D, Aissaoui H, Grimont J, Boss C, Croft M, van Gerven J, Krähenbühl S, Dingemanse J. Metabolism of the Dual Orexin Receptor Antagonist ACT-541468, Based on Microtracer/ Accelerator Mass Spectrometry. CDM 2019;20:254-65. [DOI: 10.2174/1389200220666190206141814] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
187 Lai F, Cucca F, Frau R, Corrias F, Schlich M, Caboni P, Fadda AM, Bassareo V. Systemic Administration of Orexin a Loaded Liposomes Potentiates Nucleus Accumbens Shell Dopamine Release by Sucrose Feeding. Front Psychiatry 2018;9:640. [PMID: 30559683 DOI: 10.3389/fpsyt.2018.00640] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
188 Wang JJ, Chen YH, Li KY, Sun FY. Differential sensitivity of GABAergic and glycinergic inputs to orexin-A in preganglionic cardiac vagal neurons of newborn rats. Acta Pharmacol Sin 2005;26:1442-7. [PMID: 16297341 DOI: 10.1111/j.1745-7254.2005.00231.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
189 Reinscheid RK, Civelli O. The History of N/OFQ and the NOP Receptor. Handb Exp Pharmacol 2019;254:3-16. [PMID: 30689090 DOI: 10.1007/164_2018_195] [Reference Citation Analysis]
190 Selbach O, Doreulee N, Bohla C, Eriksson KS, Sergeeva OA, Poelchen W, Brown RE, Haas HL. Orexins/hypocretins cause sharp wave- and theta-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling. Neuroscience 2004;127:519-28. [PMID: 15262340 DOI: 10.1016/j.neuroscience.2004.05.012] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 4.7] [Reference Citation Analysis]
191 Griffond B, Risold P, Jacquemard C, Colard C, Fellmann D. Insulin-induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area. Neuroscience Letters 1999;262:77-80. [DOI: 10.1016/s0304-3940(98)00976-8] [Cited by in Crossref: 150] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
192 Leone M, Proietti Cecchini A, Franzini A, Messina G, Bussone G. From neuroimaging to patients’ bench: what we have learnt from trigemino-autonomic pain syndromes. Neurol Sci 2012;33:99-102. [DOI: 10.1007/s10072-012-1051-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
193 Acuna-Goycolea C, van den Pol AN. Neuroendocrine proopiomelanocortin neurons are excited by hypocretin/orexin. J Neurosci 2009;29:1503-13. [PMID: 19193897 DOI: 10.1523/JNEUROSCI.5147-08.2009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
194 Yamashita T, Yamanaka A. Lateral hypothalamic circuits for sleep-wake control. Curr Opin Neurobiol 2017;44:94-100. [PMID: 28427008 DOI: 10.1016/j.conb.2017.03.020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
195 Liu Y, Zhao Y, Guo L. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism. Molecular and Cellular Endocrinology 2016;420:208-16. [DOI: 10.1016/j.mce.2015.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
196 Hoffmann J, Supronsinchai W, Akerman S, Andreou AP, Winrow CJ, Renger J, Hargreaves R, Goadsby PJ. Evidence for orexinergic mechanisms in migraine. Neurobiology of Disease 2015;74:137-43. [DOI: 10.1016/j.nbd.2014.10.022] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 7.1] [Reference Citation Analysis]
197 Jacobson LH, Chen S, Mir S, Hoyer D. Orexin OX2 Receptor Antagonists as Sleep Aids. In: Lawrence AJ, de Lecea L, editors. Behavioral Neuroscience of Orexin/Hypocretin. Cham: Springer International Publishing; 2017. pp. 105-36. [DOI: 10.1007/7854_2016_47] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
198 Mertens IL, Van Gaal LF. Promising New Approaches to the Management of Obesity: . Drugs 2000;60:1-9. [DOI: 10.2165/00003495-200060010-00001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
199 Abrahamson EE, Moore RY. Lesions of suprachiasmatic nucleus efferents selectively affect rest-activity rhythm. Mol Cell Endocrinol 2006;252:46-56. [PMID: 16793198 DOI: 10.1016/j.mce.2006.03.036] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
200 Kotz CM, Perez-Leighton CE, Teske JA, Billington CJ. Spontaneous Physical Activity Defends Against Obesity. Curr Obes Rep 2017;6:362-70. [PMID: 29101738 DOI: 10.1007/s13679-017-0288-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
201 Cason AM, Smith RJ, Tahsili-Fahadan P, Moorman DE, Sartor GC, Aston-Jones G. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav 2010;100:419-28. [PMID: 20338186 DOI: 10.1016/j.physbeh.2010.03.009] [Cited by in Crossref: 155] [Cited by in F6Publishing: 150] [Article Influence: 12.9] [Reference Citation Analysis]
202 Smolinska N, Nitkiewicz A, Maleszka A, Kiezun M, Dobrzyn K, Czerwinska J, Chojnowska K, Kaminski T. The effect of the estrous cycle on the expression of prepro-orexin gene and protein and the levels of orexin A and B in the porcine pituitary. Animal 2014;8:300-7. [DOI: 10.1017/s1751731113002152] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
203 Liu ZW, Gan G, Suyama S, Gao XB. Intracellular energy status regulates activity in hypocretin/orexin neurones: a link between energy and behavioural states. J Physiol 2011;589:4157-66. [PMID: 21727218 DOI: 10.1113/jphysiol.2011.212514] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
204 Lopez MF, Moorman DE, Aston-Jones G, Becker HC. The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice. Brain Res 2016;1636:74-80. [PMID: 26851547 DOI: 10.1016/j.brainres.2016.01.049] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
205 Leonard CS, Ishibashi M. Orexin Receptor Functions in the Ascending Arousal System. In: Sakurai T, Pandi-perumal S, Monti JM, editors. Orexin and Sleep. Cham: Springer International Publishing; 2015. pp. 67-80. [DOI: 10.1007/978-3-319-23078-8_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
206 Vogel V, Sanchez C, Jennum P. EEG measurements by means of radiotelemetry after intracerebroventricular (ICV) cannulation in rodents. Journal of Neuroscience Methods 2002;118:89-96. [DOI: 10.1016/s0165-0270(02)00148-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
207 Flores Á, Julià-Hernández M, Maldonado R, Berrendero F. Involvement of the orexin/hypocretin system in the pharmacological effects induced by Δ(9) -tetrahydrocannabinol. Br J Pharmacol 2016;173:1381-92. [PMID: 26799708 DOI: 10.1111/bph.13440] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
208 Liguori G, Pelagalli A, Assisi L, Squillacioti C, Costagliola A, Mirabella N. Effects of orexins on 17β-estradiol synthesis and P450 aromatase modulation in the testis of alpaca (Vicugna pacos). Anim Reprod Sci 2018;192:313-20. [PMID: 29622348 DOI: 10.1016/j.anireprosci.2018.03.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
209 Aluisio L, Fraser I, Berdyyeva T, Tryputsen V, Shireman BT, Shoblock J, Lovenberg T, Dugovic C, Bonaventure P. Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortex. Front Neurosci 2014;8:107. [PMID: 24904253 DOI: 10.3389/fnins.2014.00107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
210 Alzugaray ME, Adami ML, Diambra LA, Hernandez-Martinez S, Damborenea C, Noriega FG, Ronderos JR. Allatotropin: an ancestral myotropic neuropeptide involved in feeding. PLoS One 2013;8:e77520. [PMID: 24143240 DOI: 10.1371/journal.pone.0077520] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
211 Latifi B, Adamantidis A, Bassetti C, Schmidt MH. Sleep-Wake Cycling and Energy Conservation: Role of Hypocretin and the Lateral Hypothalamus in Dynamic State-Dependent Resource Optimization. Front Neurol 2018;9:790. [PMID: 30344503 DOI: 10.3389/fneur.2018.00790] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
212 Hunt NJ, Rodriguez ML, Waters KA, Machaalani R. Changes in orexin (hypocretin) neuronal expression with normal aging in the human hypothalamus. Neurobiology of Aging 2015;36:292-300. [DOI: 10.1016/j.neurobiolaging.2014.08.010] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
213 Kanenishi K, Ueno M, Momose S, Kuwabara H, Tanaka H, Sato C, Kobayashi T, Hino O, Sakamoto H, Hata T. Prepro-orexin mRNA expression in the rat brain is increased during pregnancy. Neuroscience Letters 2004;368:73-7. [DOI: 10.1016/j.neulet.2004.06.068] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
214 Christensen J, Yamakawa GR, Shultz SR, Mychasiuk R. Is the glymphatic system the missing link between sleep impairments and neurological disorders? Examining the implications and uncertainties. Prog Neurobiol 2021;198:101917. [PMID: 32991958 DOI: 10.1016/j.pneurobio.2020.101917] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
215 Hellmann J, Drabek M, Yin J, Gunera J, Pröll T, Kraus F, Langmead CJ, Hübner H, Weikert D, Kolb P, Rosenbaum DM, Gmeiner P. Structure-based development of a subtype-selective orexin 1 receptor antagonist. Proc Natl Acad Sci U S A 2020;117:18059-67. [PMID: 32669442 DOI: 10.1073/pnas.2002704117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
216 Dhillo WS. Appetite Regulation: An Overview. Thyroid 2007;17:433-45. [DOI: 10.1089/thy.2007.0018] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 5.1] [Reference Citation Analysis]
217 Saitoh T, Seki K, Nakajima R, Yamamoto N, Kutsumura N, Nagumo Y, Irukayama-Tomobe Y, Ogawa Y, Ishikawa Y, Yanagisawa M, Nagase H. Essential structure of orexin 1 receptor antagonist YNT-707, part V: Structure-activity relationship study of the substituents on the 17-amino group. Bioorg Med Chem Lett 2020;30:126893. [PMID: 31879208 DOI: 10.1016/j.bmcl.2019.126893] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
218 Li P, Li SB, Wang X, Phillips CD, Schwarz LA, Luo L, de Lecea L, Krasnow MA. Brain Circuit of Claustrophobia-like Behavior in Mice Identified by Upstream Tracing of Sighing. Cell Rep 2020;31:107779. [PMID: 32553161 DOI: 10.1016/j.celrep.2020.107779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
219 Papolos D, Mattis S, Golshan S, Molay F. Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes. J Affect Disord 2009;118:28-38. [PMID: 19631388 DOI: 10.1016/j.jad.2009.06.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
220 García-Brito S, Aldavert-Vera L, Huguet G, Álvarez A, Kádár E, Segura-Torres P. Increased training compensates for OX1R blockage-impairment of spatial memory and c-Fos expression in different cortical and subcortical areas. Behav Brain Res 2018;353:21-31. [PMID: 29953904 DOI: 10.1016/j.bbr.2018.05.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
221 Malherbe P, Roche O, Marcuz A, Kratzeisen C, Wettstein JG, Bissantz C. Mapping the Binding Pocket of Dual Antagonist Almorexant to Human Orexin 1 and Orexin 2 Receptors: Comparison with the Selective OX 1 Antagonist SB-674042 and the Selective OX 2 Antagonist N -Ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]- N -pyridin-3-ylmethyl-acetamide (EMPA). Mol Pharmacol 2010;78:81-93. [DOI: 10.1124/mol.110.064584] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
222 Zhou JJ, Ma HJ, Shao J, Wei Y, Zhang X, Zhang Y, Li DP. Downregulation of Orexin Receptor in Hypothalamic Paraventricular Nucleus Decreases Blood Pressure in Obese Zucker Rats. J Am Heart Assoc 2019;8:e011434. [PMID: 31213116 DOI: 10.1161/JAHA.118.011434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
223 Suzuki H, Yamamoto T. Orexin-B-like immunoreactivity in pituitary αMSH-producing cells and median eminence GnRH-containing fibres of the flat-tailed house gecko. Anat Histol Embryol 2019;48:415-20. [PMID: 31241795 DOI: 10.1111/ahe.12461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
224 Arrigoni E, Chee MJS, Fuller PM. To eat or to sleep: That is a lateral hypothalamic question. Neuropharmacology 2019;154:34-49. [PMID: 30503993 DOI: 10.1016/j.neuropharm.2018.11.017] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
225 Brojeni MS, Rashvand M, Haghparast A. Role of orexin receptors within the dentate gyrus of the hippocampus in antinociception induced by chemical stimulation of the lateral hypothalamus in the tail-flick test as a model of acute pain in rats. Physiology & Behavior 2019;209:112595. [DOI: 10.1016/j.physbeh.2019.112595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
226 Wollmann G, Acuna-goycolea C, van den Pol AN. Direct Excitation of Hypocretin/Orexin Cells by Extracellular ATP at P2X Receptors. Journal of Neurophysiology 2005;94:2195-206. [DOI: 10.1152/jn.00035.2005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
227 Milagro FI, Martínez JA. Orexin A and B are Involved in the Regulation of Body Temperature and Glucose Homeostasis in Rats. Nutritional Neuroscience 2016;3:443-7. [DOI: 10.1080/1028415x.2000.11747344] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
228 Berner LA, Brown TA, Lavender JM, Lopez E, Wierenga CE, Kaye WH. Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin. Mol Cell Endocrinol 2019;497:110320. [PMID: 30395874 DOI: 10.1016/j.mce.2018.10.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
229 Mohammadkhani A, Fragale JE, Pantazis CB, Bowrey HE, James MH, Aston-Jones G. Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil. J Neurosci 2019;39:9831-40. [PMID: 31641055 DOI: 10.1523/JNEUROSCI.0255-19.2019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
230 Furutani N, Hondo M, Kageyama H, Tsujino N, Mieda M, Yanagisawa M, Shioda S, Sakurai T. Neurotensin co-expressed in orexin-producing neurons in the lateral hypothalamus plays an important role in regulation of sleep/wakefulness states. PLoS One 2013;8:e62391. [PMID: 23620827 DOI: 10.1371/journal.pone.0062391] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
231 Abdollahi H, Ghaemi-jandabi M, Azizi H, Semnanian S. The role of orexin type-1 receptors in the development of morphine tolerance in locus coeruleus neurons: An electrophysiological perspective. Brain Research 2016;1646:91-7. [DOI: 10.1016/j.brainres.2016.05.043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
232 Feng P, Hu Y, Vurbic D, Akladious A, Strohl KP. Chromosome 1 replacement increases brain orexins and antidepressive measures without increasing locomotor activity. J Psychiatr Res 2014;59:140-7. [PMID: 25190041 DOI: 10.1016/j.jpsychires.2014.08.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
233 Carter ME, Adamantidis A, Ohtsu H, Deisseroth K, de Lecea L. Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions. J Neurosci 2009;29:10939-49. [PMID: 19726652 DOI: 10.1523/JNEUROSCI.1205-09.2009] [Cited by in Crossref: 155] [Cited by in F6Publishing: 89] [Article Influence: 11.9] [Reference Citation Analysis]
234 Morganstern I, Chang GQ, Barson JR, Ye Z, Karatayev O, Leibowitz SF. Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus. Alcohol Clin Exp Res 2010;34:886-96. [PMID: 20331576 DOI: 10.1111/j.1530-0277.2010.01161.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
235 Schöne C, Apergis-Schoute J, Sakurai T, Adamantidis A, Burdakov D. Coreleased orexin and glutamate evoke nonredundant spike outputs and computations in histamine neurons. Cell Rep 2014;7:697-704. [PMID: 24767990 DOI: 10.1016/j.celrep.2014.03.055] [Cited by in Crossref: 103] [Cited by in F6Publishing: 98] [Article Influence: 12.9] [Reference Citation Analysis]
236 Heier MS, Jansson TS, Gautvik KM. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy. J Clin Sleep Med 2011;7:653-8. [PMID: 22171205 DOI: 10.5664/jcsm.1474] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
237 He C, Chen QH, Ye JN, Li C, Yang L, Zhang J, Xia JX, Hu ZA. Functional inactivation of hypocretin 1 receptors in the medial prefrontal cortex affects the pyramidal neuron activity and gamma oscillations: An in vivo multiple-channel single-unit recording study. Neuroscience 2015;297:1-10. [PMID: 25838117 DOI: 10.1016/j.neuroscience.2015.03.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
238 Narita M, Nagumo Y, Miyatake M, Ikegami D, Kurahashi K, Suzuki T. Implication of protein kinase C in the orexin-induced elevation of extracellular dopamine levels and its rewarding effect: Orexin dependence and PKC. European Journal of Neuroscience 2007;25:1537-45. [DOI: 10.1111/j.1460-9568.2007.05403.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
239 Lessig S, Ubhi K, Galasko D, Adame A, Pham E, Remidios K, Chang M, Hansen LA, Masliah E. Reduced hypocretin (orexin) levels in dementia with Lewy bodies. Neuroreport 2010;21:756-60. [PMID: 20531237 DOI: 10.1097/WNR.0b013e32833bfb7c] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
240 Levanti M, Germanà A, Abbate F. Orexin A expression in the ovary of dog and cat. Reprod Domest Anim 2015;50:247-50. [PMID: 25601132 DOI: 10.1111/rda.12478] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
241 Gerashchenko D, Shiromani PJ. Effects of inflammation produced by chronic lipopolysaccharide administration on the survival of hypocretin neurons and sleep. Brain Research 2004;1019:162-9. [DOI: 10.1016/j.brainres.2004.06.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
242 Malter M, Neuneier J, Triller A, Kallweit U. [Narcolepsy in adults: Definition, etiology and treatment]. Fortschr Neurol Psychiatr 2021;89:103-13. [PMID: 33339064 DOI: 10.1055/a-1244-2612] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
243 Stoyanova II, Rutten WL, le Feber J. Orexin a in cortical cultures: expression and effect on synaptogenesis during development. Cell Mol Neurobiol 2012;32:49-57. [PMID: 21739363 DOI: 10.1007/s10571-011-9733-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
244 Kim H, Hong E, Kim J, Lee W. Solution Structure of Human Orexin-A: Regulator of Appetite and Wakefulness. BMB Reports 2004;37:565-73. [DOI: 10.5483/bmbrep.2004.37.5.565] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
245 Huang YS, Liu FY, Lin CY, Hsiao IT, Guilleminault C. Brain imaging and cognition in young narcoleptic patients. Sleep Med 2016;24:137-44. [PMID: 27663355 DOI: 10.1016/j.sleep.2015.11.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
246 Torterolo P, Ramos OV, Sampogna S, Chase MH. Hypocretinergic neurons are activated in conjunction with goal-oriented survival-related motor behaviors. Physiol Behav 2011;104:823-30. [PMID: 21839102 DOI: 10.1016/j.physbeh.2011.07.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
247 Burdakov D. Reactive and predictive homeostasis: Roles of orexin/hypocretin neurons. Neuropharmacology 2019;154:61-7. [PMID: 30347195 DOI: 10.1016/j.neuropharm.2018.10.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
248 Ubaldi M, Cannella N, Ciccocioppo R. Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics. Prog Brain Res 2016;224:251-84. [PMID: 26822362 DOI: 10.1016/bs.pbr.2015.07.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
249 García-garcía B, Reinoso-suárez F, Rodrigo-angulo ML. Hypothalamic Hypocretinergic/Orexinergic Neurons Projecting to the Oral Pontine Rapid Eye Movement Sleep Inducing Site in the Cat: Orexinergic Projection to Rem Induction Site. Anat Rec 2013;296:815-21. [DOI: 10.1002/ar.22690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
250 Zeitzer JM, Joyce DS, McBean A, Quevedo YL, Hernandez B, Holty JE. Effect of Suvorexant vs Placebo on Total Daytime Sleep Hours in Shift Workers: A Randomized Clinical Trial. JAMA Netw Open 2020;3:e206614. [PMID: 32484552 DOI: 10.1001/jamanetworkopen.2020.6614] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
251 Dauvilliers Y, Arnulf I. Narcolepsie avec cataplexie. Revue Neurologique 2008;164:634-45. [DOI: 10.1016/j.neurol.2007.08.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
252 Bernard GM, Miskolzie M, Kotovych G, Wasylishen RE. A solid-state NMR investigation of orexin-B. Can J Chem 2004;82:1554-63. [DOI: 10.1139/v04-131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
253 Uslaner JM, Tye SJ, Eddins DM, Wang X, Fox SV, Savitz AT, Binns J, Cannon CE, Garson SL, Yao L, Hodgson R, Stevens J, Bowlby MR, Tannenbaum PL, Brunner J, Mcdonald TP, Gotter AL, Kuduk SD, Coleman PJ, Winrow CJ, Renger JJ. Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition. Sci Transl Med 2013;5:179ra44. [PMID: 23552372 DOI: 10.1126/scitranslmed.3005213] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
254 Brundin L, Björkqvist M, Träskman-bendz L, Petersén Å. Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt. Journal of Affective Disorders 2009;113:179-82. [DOI: 10.1016/j.jad.2008.04.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
255 Kuwaki T. Orexin links emotional stress to autonomic functions. Autonomic Neuroscience 2011;161:20-7. [DOI: 10.1016/j.autneu.2010.08.004] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 5.4] [Reference Citation Analysis]
256 Xie X, Wisor JP, Hara J, Crowder TL, LeWinter R, Khroyan TV, Yamanaka A, Diano S, Horvath TL, Sakurai T, Toll L, Kilduff TS. Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia. J Clin Invest 2008;118:2471-81. [PMID: 18551194 DOI: 10.1172/JCI35115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 29] [Article Influence: 0.6] [Reference Citation Analysis]
257 Nakamura M, Nishida S, Hayashida K, Ueki Y, Dauvilliers Y, Inoue Y. Differences in brain morphological findings between narcolepsy with and without cataplexy. PLoS One 2013;8:e81059. [PMID: 24312261 DOI: 10.1371/journal.pone.0081059] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
258 Tisdale RK, Yamanaka A, Kilduff TS. Animal models of narcolepsy and the hypocretin/orexin system: Past, present, and future. Sleep 2021;44:zsaa278. [PMID: 33313880 DOI: 10.1093/sleep/zsaa278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
259 Flemström G, Sjöblom M, Jedstedt G, Akerman KE. Short fasting dramatically decreases rat duodenal secretory responsiveness to orexin A but not to VIP or melatonin. Am J Physiol Gastrointest Liver Physiol 2003;285:G1091-6. [PMID: 12869385 DOI: 10.1152/ajpgi.00193.2003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
260 Grone BP, Carpenter RE, Lee M, Maruska KP, Fernald RD. Food deprivation explains effects of mouthbrooding on ovaries and steroid hormones, but not brain neuropeptide and receptor mRNAs, in an African cichlid fish. Horm Behav 2012;62:18-26. [PMID: 22561338 DOI: 10.1016/j.yhbeh.2012.04.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
261 Yeoh JW, Campbell EJ, James MH, Graham BA, Dayas CV. Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls. Front Neurosci 2014;8:36. [PMID: 24616658 DOI: 10.3389/fnins.2014.00036] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
262 Zhang J, Sampogna S, Morales FR, Chase MH. Age-related ultrastructural changes in hypocretinergic terminals in the brainstem and spinal cord of cats. Neuroscience Letters 2005;373:171-4. [DOI: 10.1016/j.neulet.2003.08.085] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
263 Grafe LA, Geng E, Corbett B, Urban K, Bhatnagar S. Sex- and Stress-Dependent Effects on Dendritic Morphology and Spine Densities in Putative Orexin Neurons. Neuroscience 2019;418:266-78. [PMID: 31442567 DOI: 10.1016/j.neuroscience.2019.08.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
264 Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001;18:78-105. [PMID: 11435802 DOI: 10.1097/00004691-200103000-00002] [Cited by in Crossref: 217] [Cited by in F6Publishing: 164] [Article Influence: 10.3] [Reference Citation Analysis]
265 Gan J, Chen Z, Han J, Ma L, Liu S, Wang XD, Ji Y. Orexin-A in Patients With Lewy Body Disease: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2021;12:765701. [PMID: 34867809 DOI: 10.3389/fendo.2021.765701] [Reference Citation Analysis]
266 Jin N, Zhu SY, Yang XY, Zhen C, Li Y, Zhang HH, Xu AP, Wang MY, Zheng C. Orexin-A potentiates glycine currents by activating OX1R and IP3/Ca2+/PKC signaling pathways in spinal cord ventral horn neurons. Brain Res Bull 2021;169:196-204. [PMID: 33515654 DOI: 10.1016/j.brainresbull.2021.01.017] [Reference Citation Analysis]
267 Remmers F, Delemarre-van de Waal HA. Developmental Programming of Energy Balance and Its Hypothalamic Regulation. Endocrine Reviews 2011;32:272-311. [DOI: 10.1210/er.2009-0028] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
268 Cox CD, Breslin MJ, Whitman DB, Schreier JD, McGaughey GB, Bogusky MJ, Roecker AJ, Mercer SP, Bednar RA, Lemaire W, Bruno JG, Reiss DR, Harrell CM, Murphy KL, Garson SL, Doran SM, Prueksaritanont T, Anderson WB, Tang C, Roller S, Cabalu TD, Cui D, Hartman GD, Young SD, Koblan KS, Winrow CJ, Renger JJ, Coleman PJ. Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia. J Med Chem 2010;53:5320-32. [PMID: 20565075 DOI: 10.1021/jm100541c] [Cited by in Crossref: 242] [Cited by in F6Publishing: 217] [Article Influence: 20.2] [Reference Citation Analysis]
269 Yamamoto T, Suzuki H, Uemura H, Yamamoto K, Kikuyama S. Localization of orexin-A-like immunoreactivity in prolactin cells in the bullfrog (Rana catesbeiana) pituitary. General and Comparative Endocrinology 2004;135:186-92. [DOI: 10.1016/j.ygcen.2003.09.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
270 Nishino S. Narcolepsy. Sleep Medicine Clinics 2006;1:47-61. [DOI: 10.1016/j.jsmc.2005.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
271 Devidze N, Zhou Y, Ho A, Zhang Q, Pfaff DW, Kreek MJ. Steady-state methadone effect on generalized arousal in male and female mice. Behav Neurosci 2008;122:1248-56. [PMID: 19045944 DOI: 10.1037/a0013276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
272 van den Pol AN, Acuna-Goycolea C, Clark KR, Ghosh PK. Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection. Neuron 2004;42:635-52. [PMID: 15157424 DOI: 10.1016/s0896-6273(04)00251-x] [Cited by in Crossref: 154] [Cited by in F6Publishing: 86] [Article Influence: 8.6] [Reference Citation Analysis]
273 Wang Y, Chen AQ, Xue Y, Liu MF, Liu C, Liu YH, Pan YP, Diao HL, Chen L. Orexins alleviate motor deficits via increasing firing activity of pallidal neurons in a mouse model of Parkinson's disease. Am J Physiol Cell Physiol 2019;317:C800-12. [PMID: 31365289 DOI: 10.1152/ajpcell.00125.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
274 van den Top M, Nolan MF, Lee K, Richardson PJ, Buijs RM, Davies CH, Spanswick D. Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. J Physiol. 2003;549:809-821. [PMID: 12702746 DOI: 10.1113/jphysiol.2002.033290] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 4.1] [Reference Citation Analysis]
275 Hara J, Yanagisawa M, Sakurai T. Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions. Neuroscience Letters 2005;380:239-42. [DOI: 10.1016/j.neulet.2005.01.046] [Cited by in Crossref: 124] [Cited by in F6Publishing: 115] [Article Influence: 7.3] [Reference Citation Analysis]
276 Nitkiewicz A, Smolinska N, Maleszka A, Chojnowska K, Kaminski T. Expression of orexins and their precursor in the porcine ovary and the influence of orexins on ovarian steroidogenesis in pigs. Anim Reprod Sci 2014;148:53-62. [PMID: 24916957 DOI: 10.1016/j.anireprosci.2014.03.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
277 Chokroverty S. Sleep and Its Disorders. Neurology in Clinical Practice. Elsevier; 2008. pp. 1947-2009. [DOI: 10.1016/b978-0-7506-7525-3.50110-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
278 Rosin DL, Weston MC, Sevigny CP, Stornetta RL, Guyenet PG. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J Comp Neurol 2003;465:593-603. [PMID: 12975818 DOI: 10.1002/cne.10860] [Cited by in Crossref: 166] [Cited by in F6Publishing: 170] [Article Influence: 8.7] [Reference Citation Analysis]
279 Schreyer S, Büttner-Ennever JA, Tang X, Mustari MJ, Horn AK. Orexin-A inputs onto visuomotor cell groups in the monkey brainstem. Neuroscience 2009;164:629-40. [PMID: 19703526 DOI: 10.1016/j.neuroscience.2009.08.039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
280 Arrigoni E, Mochizuki T, Scammell TE. Activation of the basal forebrain by the orexin/hypocretin neurones. Acta Physiol (Oxf) 2010;198:223-35. [PMID: 19723027 DOI: 10.1111/j.1748-1716.2009.02036.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
281 Soares VPMN, de Andrade TGCS, Canteras NS, Coimbra NC, Wotjak CT, Almada RC. Orexin 1 and 2 Receptors in the Prelimbic Cortex Modulate Threat Valuation. Neuroscience 2021;468:158-67. [PMID: 34126185 DOI: 10.1016/j.neuroscience.2021.06.006] [Reference Citation Analysis]
282 Chen C, Hwang L, Chang J, Dun NJ. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2000;278:R692-7. [DOI: 10.1152/ajpregu.2000.278.3.r692] [Cited by in Crossref: 124] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
283 Smith PM, Samson WK, Ferguson AV. Cardiovascular actions of orexin-A in the rat subfornical organ. J Neuroendocrinol 2007;19:7-13. [PMID: 17184481 DOI: 10.1111/j.1365-2826.2006.01497.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
284 Palotai M, Telegdy G, Jászberényi M. Orexin A-induced anxiety-like behavior is mediated through GABA-ergic, α- and β-adrenergic neurotransmissions in mice. Peptides 2014;57:129-34. [DOI: 10.1016/j.peptides.2014.05.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
285 Ehmke H, Just A. The orexins: linking circulatory control with behavior. Am J Physiol Regul Integr Comp Physiol 2003;285:R519-21. [PMID: 12909578 DOI: 10.1152/ajpregu.00311.2003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
286 Han ME, Park SY, Oh SO. Large-scale functional brain networks for consciousness. Anat Cell Biol 2021;54:152-64. [PMID: 33967030 DOI: 10.5115/acb.20.305] [Reference Citation Analysis]
287 Grasselli F, Bussolati S, Grolli S, Di Lecce R, Dall'Aglio C, Basini G. Effects of Orexin B on Swine Granulosa and Endothelial Cells. Animals (Basel) 2021;11:1812. [PMID: 34204547 DOI: 10.3390/ani11061812] [Reference Citation Analysis]
288 Kim M, Park H, Kim S, Choi YK, Shin HK, Jeon J, Jang H, Yun I, Bae S, Bae M. Angiogenic role of orexin-A via the activation of extracellular signal-regulated kinase in endothelial cells. Biochemical and Biophysical Research Communications 2010;403:59-65. [DOI: 10.1016/j.bbrc.2010.10.115] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
289 Jacobson LH, Hoyer D, de Lecea L. Hypocretins (orexins): The ultimate translational neuropeptides. J Intern Med 2022. [PMID: 35043499 DOI: 10.1111/joim.13406] [Reference Citation Analysis]
290 Hunt NJ, Waters KA, Rodriguez ML, Machaalani R. Decreased orexin (hypocretin) immunoreactivity in the hypothalamus and pontine nuclei in sudden infant death syndrome. Acta Neuropathol 2015;130:185-98. [PMID: 25953524 DOI: 10.1007/s00401-015-1437-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
291 Moraes M, Rossini S, Reimão R. Executive attention and working memory in narcoleptic outpatients. Arq Neuro-Psiquiatr 2012;70:335-40. [DOI: 10.1590/s0004-282x2012005000007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
292 Sargin D. The role of the orexin system in stress response. Neuropharmacology 2019;154:68-78. [PMID: 30266600 DOI: 10.1016/j.neuropharm.2018.09.034] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
293 Boss C, Roch-brisbare C, Steiner MA, Treiber A, Dietrich H, Jenck F, von Raumer M, Sifferlen T, Brotschi C, Heidmann B, Williams JT, Aissaoui H, Siegrist R, Gatfield J. Structure-Activity Relationship, Biological, and Pharmacological Characterization of the Proline Sulfonamide ACT-462206: a Potent, Brain-Penetrant Dual Orexin 1/Orexin 2 Receptor Antagonist. ChemMedChem 2014;9:2486-96. [DOI: 10.1002/cmdc.201402258] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
294 Chiou LC, Hu SS, Ho YC. Targeting the cannabinoid system for pain relief? Acta Anaesthesiol Taiwan 2013;51:161-70. [PMID: 24529672 DOI: 10.1016/j.aat.2013.10.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
295 Cerdá‐reverter JM, Canosa LF. Chapter 1 Neuroendocrine Systems of the Fish Brain. Fish Neuroendocrinology. Elsevier; 2009. pp. 3-74. [DOI: 10.1016/s1546-5098(09)28001-0] [Cited by in Crossref: 40] [Article Influence: 3.1] [Reference Citation Analysis]
296 Monda M, Viggiano AN, Viggiano A, Viggiano E, Lanza A, De Luca V. Hyperthermic reactions induced by orexin A: role of the ventromedial hypothalamus. Eur J Neurosci 2005;22:1169-75. [PMID: 16176359 DOI: 10.1111/j.1460-9568.2005.04309.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
297 Lee MT, Chiu YT, Chiu YC, Hor CC, Lee HJ, Guerrini R, Calo G, Chiou LC. Neuropeptide S-initiated sequential cascade mediated by OX1, NK1, mGlu5 and CB1 receptors: a pivotal role in stress-induced analgesia. J Biomed Sci 2020;27:7. [PMID: 31915019 DOI: 10.1186/s12929-019-0590-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
298 Matzeu A, Kallupi M, George O, Schweitzer P, Martin-Fardon R. Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence. Neuropsychopharmacology 2018;43:1010-20. [PMID: 29052613 DOI: 10.1038/npp.2017.250] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
299 Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H, Fujino M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998;251:471-6. [PMID: 9792798 DOI: 10.1006/bbrc.1998.9489] [Cited by in Crossref: 1043] [Cited by in F6Publishing: 990] [Article Influence: 43.5] [Reference Citation Analysis]
300 Vanderhaven MW, Cornish JL, Staples LG. The orexin-1 receptor antagonist SB-334867 decreases anxiety-like behavior and c-Fos expression in the hypothalamus of rats exposed to cat odor. Behav Brain Res 2015;278:563-8. [PMID: 25447305 DOI: 10.1016/j.bbr.2014.10.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
301 Mieda M, Williams SC, Sinton CM, Richardson JA, Sakurai T, Yanagisawa M. Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness. J Neurosci 2004;24:10493-501. [PMID: 15548664 DOI: 10.1523/JNEUROSCI.3171-04.2004] [Cited by in Crossref: 151] [Cited by in F6Publishing: 63] [Article Influence: 8.9] [Reference Citation Analysis]
302 Nakajo H, Chou MY, Kinoshita M, Appelbaum L, Shimazaki H, Tsuboi T, Okamoto H. Hunger Potentiates the Habenular Winner Pathway for Social Conflict by Orexin-Promoted Biased Alternative Splicing of the AMPA Receptor Gene. Cell Rep 2020;31:107790. [PMID: 32579920 DOI: 10.1016/j.celrep.2020.107790] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
303 Winsky-Sommerer R, Boutrel B, de Lecea L. Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. Mol Neurobiol 2005;32:285-94. [PMID: 16385142 DOI: 10.1385/MN:32:3:285] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
304 Burlet S, Tyler CJ, Leonard CS. Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 2002;22:2862-72. [PMID: 11923451 DOI: 20026234] [Cited by in Crossref: 184] [Article Influence: 9.2] [Reference Citation Analysis]
305 Panula P, Nuutinen S. The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci 2013;14:472-87. [DOI: 10.1038/nrn3526] [Cited by in Crossref: 179] [Cited by in F6Publishing: 168] [Article Influence: 19.9] [Reference Citation Analysis]
306 Samson WK, Resch ZT. The hypocretin/orexin story. Trends Endocrinol Metab 2000;11:257-62. [PMID: 10920381 DOI: 10.1016/s1043-2760(00)00273-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
307 Melén K, Jalkanen P, Kukkonen JP, Partinen M, Nohynek H, Vuorela A, Vaarala O, Freitag TL, Meri S, Julkunen I. No evidence of autoimmunity to human OX1 or OX2 orexin receptors in Pandemrix-vaccinated narcoleptic children. J Transl Autoimmun 2020;3:100055. [PMID: 32743535 DOI: 10.1016/j.jtauto.2020.100055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
308 Nair SG, Golden SA, Shaham Y. Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats. Br J Pharmacol 2008;154:406-16. [PMID: 18223663 DOI: 10.1038/bjp.2008.3] [Cited by in Crossref: 101] [Cited by in F6Publishing: 105] [Article Influence: 7.2] [Reference Citation Analysis]
309 Wacker D, Roth BL. An alerting structure: human orexin receptor 1. Nat Struct Mol Biol 2016;23:265-6. [PMID: 27045444 DOI: 10.1038/nsmb.3198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
310 Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005;437:1257-63. [DOI: 10.1038/nature04284] [Cited by in Crossref: 1577] [Cited by in F6Publishing: 1306] [Article Influence: 92.8] [Reference Citation Analysis]
311 Monda M, Viggiano A, Viggiano A, Mondola R, Viggiano E, Messina G, Tafuri D, De Luca V. Olanzapine blocks the sympathetic and hyperthermic reactions due to cerebral injection of orexin A. Peptides 2008;29:120-6. [PMID: 18053616 DOI: 10.1016/j.peptides.2007.10.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
312 Gotter AL, Winrow CJ, Brunner J, Garson SL, Fox SV, Binns J, Harrell CM, Cui D, Yee KL, Stiteler M, Stevens J, Savitz A, Tannenbaum PL, Tye SJ, McDonald T, Yao L, Kuduk SD, Uslaner J, Coleman PJ, Renger JJ. The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold. BMC Neurosci 2013;14:90. [PMID: 23981345 DOI: 10.1186/1471-2202-14-90] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
313 Aracri P, Banfi D, Pasini ME, Amadeo A, Becchetti A. Hypocretin (orexin) regulates glutamate input to fast-spiking interneurons in layer V of the Fr2 region of the murine prefrontal cortex. Cereb Cortex 2015;25:1330-47. [PMID: 24297328 DOI: 10.1093/cercor/bht326] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
314 Aou S, Li XL, Li AJ, Oomura Y, Shiraishi T, Sasaki K, Imamura T, Wayner MJ. Orexin-A (hypocretin-1) impairs Morris water maze performance and CA1-Schaffer collateral long-term potentiation in rats. Neuroscience 2003;119:1221-8. [PMID: 12831875 DOI: 10.1016/s0306-4522(02)00745-5] [Cited by in Crossref: 62] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
315 Gerashchenko D, Blanco-Centurion C, Greco MA, Shiromani PJ. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats. Neuroscience 2003;116:223-35. [PMID: 12535955 DOI: 10.1016/s0306-4522(02)00575-4] [Cited by in Crossref: 75] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
316 Semmens DC, Mirabeau O, Moghul I, Pancholi MR, Wurm Y, Elphick MR. Transcriptomic identification of starfish neuropeptide precursors yields new insights into neuropeptide evolution. Open Biol 2016;6:150224. [PMID: 26865025 DOI: 10.1098/rsob.150224] [Cited by in Crossref: 82] [Cited by in F6Publishing: 64] [Article Influence: 13.7] [Reference Citation Analysis]
317 Erami E, Azhdari-zarmehri H, Rahmani A, Ghasemi-dashkhasan E, Semnanian S, Haghparast A. Blockade of orexin receptor 1 attenuates the development of morphine tolerance and physical dependence in rats. Pharmacology Biochemistry and Behavior 2012;103:212-9. [DOI: 10.1016/j.pbb.2012.08.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
318 Kotz CM, Billington CJ, Levine AS. Obesity and Aging. Clinics in Geriatric Medicine 1999;15:391-412. [DOI: 10.1016/s0749-0690(18)30066-1] [Cited by in Crossref: 26] [Article Influence: 1.1] [Reference Citation Analysis]
319 Dall'aglio C, Zannoni A, Mercati F, Forni M, Bacci ML, Boiti C. Differential gene expression and immune localization of the orexin system in the major salivary glands of pigs. Regulatory Peptides 2011;172:51-7. [DOI: 10.1016/j.regpep.2011.08.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
320 Iqbal J, Henry B, Pompolo S, Rao A, Clarke I. Long-term alteration in bodyweight and food restriction does not affect the gene expression of either preproorexin or prodynorphin in the sheep. Neuroscience 2003;118:217-26. [DOI: 10.1016/s0306-4522(02)00815-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
321 Jaeger LB, Farr SA, Banks WA, Morley JE. Effects of orexin-A on memory processing. Peptides 2002;23:1683-8. [PMID: 12217429 DOI: 10.1016/s0196-9781(02)00110-9] [Cited by in Crossref: 89] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
322 Grafe LA, Eacret D, Luz S, Gotter AL, Renger JJ, Winrow CJ, Bhatnagar S. Orexin 2 receptor regulation of the hypothalamic-pituitary-adrenal (HPA) response to acute and repeated stress. Neuroscience 2017;348:313-23. [PMID: 28257896 DOI: 10.1016/j.neuroscience.2017.02.038] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
323 Roth T, Black J, Cluydts R, Charef P, Cavallaro M, Kramer F, Zammit G, Walsh J. Dual Orexin Receptor Antagonist, Almorexant, in Elderly Patients With Primary Insomnia: A Randomized, Controlled Study. Sleep 2017;40. [PMID: 28364509 DOI: 10.1093/sleep/zsw034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
324 Sanchez-Alavez M, Benedict J, Wills DN, Ehlers CL. Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal. Sleep 2019;42:zsz020. [PMID: 30715515 DOI: 10.1093/sleep/zsz020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
325 Silveyra P, Cataldi NI, Lux-Lantos VA, Libertun C. Role of orexins in the hypothalamic-pituitary-ovarian relationships. Acta Physiol (Oxf) 2010;198:355-60. [PMID: 19796256 DOI: 10.1111/j.1748-1716.2009.02049.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
326 Boutrel B. Hypocrétines : entre l’envie et le besoin… ou l’émergence d’une nouvelle voie d’origine hypothalamique impliquée dans la motivation et l’addiction. Med Sci (Paris) 2006;22:573-5. [DOI: 10.1051/medsci/20062267573] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
327 Couvineau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 2021; 27(44): 7582-7596 [PMID: 34908800 DOI: 10.3748/wjg.v27.i44.7582] [Reference Citation Analysis]
328 Nishino S, Deguzman C, Yamadera W, Chiba S, Kanbayashi T. Neurochemistry and Biomarkers of Narcolepsy and Other Primary and Secondary Hypersomnias. Sleep Medicine Clinics 2012;7:233-48. [DOI: 10.1016/j.jsmc.2012.03.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
329 Li B, Chang L, Peng X. Orexin 2 receptor in the nucleus accumbens is critical for the modulation of acute stress-induced anxiety. Psychoneuroendocrinology 2021;131:105317. [PMID: 34111776 DOI: 10.1016/j.psyneuen.2021.105317] [Reference Citation Analysis]
330 Jalewa J, Wong-lin K, Mcginnity TM, Prasad G, Hölscher C. Increased number of orexin/hypocretin neurons with high and prolonged external stress-induced depression. Behavioural Brain Research 2014;272:196-204. [DOI: 10.1016/j.bbr.2014.05.030] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
331 McGaughey G, Bayly CI, Cox CD, Schreier JD, Breslin MJ, Bogusky M, Pitzenberger S, Ball R, Coleman PJ. Shaping suvorexant: application of experimental and theoretical methods for driving synthetic designs. J Comput Aided Mol Des 2014;28:5-12. [PMID: 24488306 DOI: 10.1007/s10822-014-9710-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
332 Chicurel M. The sandman's secrets. Nature 2000;407:554-6. [DOI: 10.1038/35036738] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
333 Wang P, Wang M, Zhang L, Zhong S, Jiang W, Wang Z, Sun C, Zhang S, Liu Z. Functional characterization of an orexin neuropeptide in amphioxus reveals an ancient origin of orexin/orexin receptor system in chordate. Sci China Life Sci 2019;62:1655-69. [PMID: 30945108 DOI: 10.1007/s11427-018-9421-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
334 Tupone D, Madden CJ, Morrison SF. Autonomic regulation of brown adipose tissue thermogenesis in health and disease: potential clinical applications for altering BAT thermogenesis. Front Neurosci 2014;8:14. [PMID: 24570653 DOI: 10.3389/fnins.2014.00014] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 6.6] [Reference Citation Analysis]
335 Monda M, Viggiano A, Viggiano A, Viggiano E, Messina G, Tafuri D, De Luca V. Quetiapine lowers sympathetic and hyperthermic reactions due to cerebral injection of orexin A. Neuropeptides 2006;40:357-63. [PMID: 17010428 DOI: 10.1016/j.npep.2006.07.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
336 Li A, Nattie E. Orexin, cardio-respiratory function, and hypertension. Front Neurosci 2014;8:22. [PMID: 24574958 DOI: 10.3389/fnins.2014.00022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
337 Kirsz K, Szczesna M, Molik E, Misztal T, Wojtowicz AK, Zieba DA. Seasonal changes in the interactions among leptin, ghrelin, and orexin in sheep1. Journal of Animal Science 2012;90:2524-31. [DOI: 10.2527/jas.2011-4463] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
338 Madaan P, Behl T, Sehgal A, Singh S, Sharma N, Yadav S, Kaur S, Bhatia S, Al-harrasi A, Abdellatif AAH, Ashraf GM, Abdel-daim MM, Dailah HG, Anwer MK, Bungau S. Exploring the Therapeutic Potential of Targeting Purinergic and Orexinergic Receptors in Alcoholic Neuropathy. Neurotox Res. [DOI: 10.1007/s12640-022-00477-8] [Reference Citation Analysis]
339 Gillette MU, Abbott SM. BIOLOGICAL TIMEKEEPING. Sleep Med Clin 2009;4:99-110. [PMID: 21052483 DOI: 10.1016/j.jsmc.2009.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
340 Urstadt KR, Coop SH, Banuelos BD, Stanley BG. Behaviorally specific versus non-specific suppression of accumbens shell-mediated feeding by ipsilateral versus bilateral inhibition of the lateral hypothalamus. Behav Brain Res 2013;257:230-41. [PMID: 24100119 DOI: 10.1016/j.bbr.2013.09.048] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
341 Pavone LM, Tafuri S, Avallone L, Staiano N, Vittoria A. Expression of orexin A and its receptor 1 in the vestibular glands of the cattle genital tract. Anat Rec (Hoboken) 2009;292:202-6. [PMID: 19089887 DOI: 10.1002/ar.20833] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
342 Posar A, Pizza F, Parmeggiani A, Plazzi G. Neuropsychological findings in childhood narcolepsy. J Child Neurol 2014;29:1370-6. [PMID: 24293310 DOI: 10.1177/0883073813508315] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
343 Kirchgessner AL, Liu M. Orexin Synthesis and Response in the Gut. Neuron 1999;24:941-51. [DOI: 10.1016/s0896-6273(00)81041-7] [Cited by in Crossref: 232] [Cited by in F6Publishing: 42] [Article Influence: 10.1] [Reference Citation Analysis]
344 Taheri S, Bloom S. Orexins/hypocretins: waking up the scientific world: Orexins and hypocretins. Clinical Endocrinology 2001;54:421-9. [DOI: 10.1046/j.1365-2265.2001.01247.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
345 Wayner M, Armstrong D, Phelix C, Oomura Y. Orexin-A (Hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo. Peptides 2004;25:991-6. [DOI: 10.1016/j.peptides.2004.03.018] [Cited by in Crossref: 127] [Cited by in F6Publishing: 124] [Article Influence: 7.1] [Reference Citation Analysis]
346 Ahmadi-soleimani SM, Ghaemi-jandabi M, Azizi H, Semnanian S. Orexin type 1 receptor antagonism in Lateral Paragigantocellularis nucleus attenuates naloxone precipitated morphine withdrawal symptoms in rats. Neuroscience Letters 2014;558:62-6. [DOI: 10.1016/j.neulet.2013.10.064] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
347 Holmqvist T, Akerman KE, Kukkonen JP. Orexin signaling in recombinant neuron-like cells. FEBS Lett 2002;526:11-4. [PMID: 12208495 DOI: 10.1016/s0014-5793(02)03101-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
348 Sokołowska P, Urbańska A, Biegańska K, Wagner W, Ciszewski W, Namiecińska M, Zawilska JB. Orexins protect neuronal cell cultures against hypoxic stress: an involvement of Akt signaling. J Mol Neurosci 2014;52:48-55. [PMID: 24243084 DOI: 10.1007/s12031-013-0165-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
349 Edalat P, Kavianpour M, Zarrabian S, Haghparast A. Role of orexin-1 and orexin-2 receptors in the CA1 region of hippocampus in the forced swim stress- and food deprivation-induced reinstatement of morphine seeking behaviors in rats. Brain Research Bulletin 2018;142:25-32. [DOI: 10.1016/j.brainresbull.2018.06.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
350 Gupta A, Miegueu P, Lapointe M, Poirier P, Martin J, Bastien M, Tiwari S, Cianflone K. Acute post-bariatric surgery increase in orexin levels associates with preferential lipid profile improvement. PLoS One 2014;9:e84803. [PMID: 24400115 DOI: 10.1371/journal.pone.0084803] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
351 Hervieu G, Cluderay J, Harrison D, Roberts J, Leslie R. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 2001;103:777-97. [DOI: 10.1016/s0306-4522(01)00033-1] [Cited by in Crossref: 340] [Cited by in F6Publishing: 109] [Article Influence: 16.2] [Reference Citation Analysis]
352 López M, de Lecea L, Diéguez C. Editorial: Hypocretins/Orexins. Front Endocrinol (Lausanne) 2020;11:357. [PMID: 32582031 DOI: 10.3389/fendo.2020.00357] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
353 Domínguez L, Morona R, Joven A, González A, López JM. Immunohistochemical localization of orexins (hypocretins) in the brain of reptiles and its relation to monoaminergic systems. Journal of Chemical Neuroanatomy 2010;39:20-34. [DOI: 10.1016/j.jchemneu.2009.07.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
354 Konadhode RR, Pelluru D, Shiromani PJ. Neurons containing orexin or melanin concentrating hormone reciprocally regulate wake and sleep. Front Syst Neurosci 2014;8:244. [PMID: 25620917 DOI: 10.3389/fnsys.2014.00244] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
355 Shaw PJ, Franken P. Perchance to dream: solving the mystery of sleep through genetic analysis. J Neurobiol 2003;54:179-202. [PMID: 12486704 DOI: 10.1002/neu.10167] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
356 Borgland SL, Storm E, Bonci A. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons. Eur J Neurosci 2008;28:1545-56. [PMID: 18793323 DOI: 10.1111/j.1460-9568.2008.06397.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 6.9] [Reference Citation Analysis]
357 Voisin T, Firar AE, Avondo V, Laburthe M. Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor. Endocrinology 2006;147:4977-84. [PMID: 16857748 DOI: 10.1210/en.2006-0201] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
358 Kordik CP, Reitz AB. Pharmacological Treatment of Obesity:  Therapeutic Strategies. J Med Chem 1999;42:181-201. [DOI: 10.1021/jm980521l] [Cited by in Crossref: 119] [Cited by in F6Publishing: 99] [Article Influence: 5.2] [Reference Citation Analysis]
359 S�ll R, Beck-sickinger AG. On the synthesis of orexin A: a novel one-step procedure to obtain peptides with two intramolecular disulphide bonds. J Peptide Sci 2000;6:387-97. [DOI: 10.1002/1099-1387(200008)6:8<387::aid-psc267>3.0.co;2-m] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
360 Muroya S, Funahashi H, Yamanaka A, Kohno D, Uramura K, Nambu T, Shibahara M, Kuramochi M, Takigawa M, Yanagisawa M. Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus. Eur J Neurosci. 2004;19:1524-1534. [PMID: 15066149 DOI: 10.1111/j.1460-9568.2004.03255.x] [Cited by in Crossref: 177] [Cited by in F6Publishing: 168] [Article Influence: 9.8] [Reference Citation Analysis]
361 Fujita S, Hasegawa T, Nishiyama Y, Fujisawa S, Nakano Y, Nada T, Iwata N, Kamada Y, Masuyama H, Otsuka F. Interaction between orexin A and bone morphogenetic protein system on progesterone biosynthesis by rat granulosa cells. J Steroid Biochem Mol Biol 2018;181:73-9. [PMID: 29545164 DOI: 10.1016/j.jsbmb.2018.03.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
362 Jacobson LH, Callander GE, Hoyer D. Suvorexant for the treatment of insomnia. Expert Rev Clin Pharmacol 2014;7:711-30. [PMID: 25318834 DOI: 10.1586/17512433.2014.966813] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
363 Burdakov D, Alexopoulos H. Metabolic state signalling through central hypocretin/orexin neurons. J Cell Mol Med 2005;9:795-803. [PMID: 16364191 DOI: 10.1111/j.1582-4934.2005.tb00380.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
364 Smart D, Haynes AC, Williams G, Arch JR. Orexins and the treatment of obesity. Eur J Pharmacol 2002;440:199-212. [PMID: 12007536 DOI: 10.1016/s0014-2999(02)01429-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
365 Czerwinska J, Chojnowska K, Kaminski T, Bogacka I, Smolinska N, Kaminska B. Orexin receptor expression in the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes of free-living European beavers (Castor fiber L.) in different periods of the reproductive cycle. Gen Comp Endocrinol 2017;240:103-13. [PMID: 27664717 DOI: 10.1016/j.ygcen.2016.09.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
366 Strawn JR, Pyne-geithman GJ, Ekhator NN, Horn PS, Uhde TW, Shutter LA, Baker DG, Geracioti TD. Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder. Psychoneuroendocrinology 2010;35:1001-7. [DOI: 10.1016/j.psyneuen.2010.01.001] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 5.2] [Reference Citation Analysis]
367 Öz P, Gökalp HK, Göver T, Uzbay T. Dose-dependent and opposite effects of orexin A on prepulse inhibition response in sleep-deprived and non-sleep-deprived rats. Behav Brain Res 2018;346:73-9. [PMID: 29237551 DOI: 10.1016/j.bbr.2017.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
368 Gatfield J, Brisbare-Roch C, Jenck F, Boss C. Orexin receptor antagonists: a new concept in CNS disorders? ChemMedChem 2010;5:1197-214. [PMID: 20544785 DOI: 10.1002/cmdc.201000132] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
369 Sotelo MI, Tyan J, Markunas C, Sulaman BA, Horwitz L, Lee H, Morrow JG, Rothschild G, Duan B, Eban-Rothschild A. Lateral hypothalamic neuronal ensembles regulate pre-sleep nest-building behavior. Curr Biol 2022:S0960-9822(21)01740-1. [PMID: 35051354 DOI: 10.1016/j.cub.2021.12.053] [Reference Citation Analysis]
370 Robaire B, Hinton BT. The Epididymis. Knobil and Neill's Physiology of Reproduction. Elsevier; 2015. pp. 691-771. [DOI: 10.1016/b978-0-12-397175-3.00017-x] [Cited by in Crossref: 33] [Article Influence: 4.7] [Reference Citation Analysis]
371 Arias-Carrión O, Murillo-Rodriguez E, Xu M, Blanco-Centurion C, Drucker-Colín R, Shiromani PJ. Transplantation of hypocretin neurons into the pontine reticular formation: preliminary results. Sleep 2004;27:1465-70. [PMID: 15683135 DOI: 10.1093/sleep/27.8.1465] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
372 Gerashchenko D, Horvath TL, Xie XS. Direct inhibition of hypocretin/orexin neurons in the lateral hypothalamus by nociceptin/orphanin FQ blocks stress-induced analgesia in rats. Neuropharmacology 2011;60:543-9. [PMID: 21195099 DOI: 10.1016/j.neuropharm.2010.12.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
373 Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2014;137:232-241. [PMID: 24277718 DOI: 10.1093/brain/awt320] [Cited by in Crossref: 259] [Cited by in F6Publishing: 216] [Article Influence: 28.8] [Reference Citation Analysis]
374 Galas L, Vaudry H, Braun B, Van Den Pol AN, De Lecea L, Sutcliffe JG, Chartrel N. Immunohistochemical localization and biochemical characterization of hypocretin/orexin-related peptides in the central nervous system of the frogRana ridibunda. J Comp Neurol 2001;429:242-52. [DOI: 10.1002/1096-9861(20000108)429:2<242::aid-cne5>3.0.co;2-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
375 Teske J, Billington C, Kotz C. Neuropeptidergic Mediators of Spontaneous Physical Activity and Non-Exercise Activity Thermogenesis. Neuroendocrinology 2008;87:71-90. [DOI: 10.1159/000110802] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
376 Okumura T, Nozu T, Kumei S, Takakusaki K, Miyagishi S, Ohhira M. Adenosine A1 receptors mediate the intracisternal injection of orexin-induced antinociceptive action against colonic distension in conscious rats. Journal of the Neurological Sciences 2016;362:106-10. [DOI: 10.1016/j.jns.2016.01.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
377 Majid H, Hirshkowitz M. Therapeutics of Narcolepsy. Sleep Medicine Clinics 2010;5:659-73. [DOI: 10.1016/j.jsmc.2010.08.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
378 Tanaka S. Transcriptional regulation of the hypocretin/orexin gene. Vitam Horm 2012;89:75-90. [PMID: 22640609 DOI: 10.1016/B978-0-12-394623-2.00005-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
379 Vecsey CG, Pírez N, Griffith LC. The Drosophila neuropeptides PDF and sNPF have opposing electrophysiological and molecular effects on central neurons. J Neurophysiol 2014;111:1033-45. [PMID: 24353297 DOI: 10.1152/jn.00712.2013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
380 Putula J, Turunen PM, Johansson L, Näsman J, Ra R, Korhonen L, Kukkonen JP. Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction. FEBS Letters 2011;585:1368-74. [DOI: 10.1016/j.febslet.2011.04.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
381 Steininger TL, Kilduff TS, Behan M, Benca RM, Landry CF. Comparison of hypocretin/orexin and melanin-concentrating hormone neurons and axonal projections in the embryonic and postnatal rat brain. Journal of Chemical Neuroanatomy 2004;27:165-81. [DOI: 10.1016/j.jchemneu.2004.02.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
382 Wojciechowicz T, Skrzypski M, Szczepankiewicz D, Hertig I, Kołodziejski PA, Billert M, Strowski MZ, Nowak KW. Original Research: Orexins A and B stimulate proliferation and differentiation of porcine preadipocytes. Exp Biol Med (Maywood) 2016;241:1786-95. [PMID: 27190275 DOI: 10.1177/1535370216649261] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
383 Brown RM, Kim AK, Khoo SY, Kim JH, Jupp B, Lawrence AJ. Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats: Orexin and alcohol-seeking. Addiction Biology 2016;21:603-12. [DOI: 10.1111/adb.12251] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
384 López M, Nogueiras R, Tena-Sempere M, Diéguez C. Orexins (hypocretins) actions on the GHRH/somatostatin-GH axis. Acta Physiol (Oxf) 2010;198:325-34. [PMID: 19769635 DOI: 10.1111/j.1748-1716.2009.02042.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
385 James MH, Campbell EJ, Dayas CV. Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders. Curr Top Behav Neurosci 2017;33:197-219. [PMID: 28083790 DOI: 10.1007/7854_2016_56] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 11.0] [Reference Citation Analysis]
386 Kaminski T, Smolinska N, Kiezun M, Dobrzyn K, Szeszko K, Maleszka A. Effect of orexin B on CYP17A1 and CYP19A3 expression and oestradiol, oestrone and testosterone secretion in the porcine uterus during early pregnancy and the oestrous cycle. Animal 2018;12:1921-32. [PMID: 29366436 DOI: 10.1017/S1751731117003779] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
387 Dun NJ, Le Dun, S, Chen C, Hwang LL, Kwok EH, Chang J. Orexins: a role in medullary sympathetic outflow. Regulatory Peptides 2000;96:65-70. [DOI: 10.1016/s0167-0115(00)00202-0] [Cited by in Crossref: 70] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
388 Murai Y, Akaike T. Orexins cause depolarization via nonselective cationic and K+ channels in isolated locus coeruleus neurons. Neuroscience Research 2005;51:55-65. [DOI: 10.1016/j.neures.2004.09.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
389 Nishino S, Yoshida Y. History and perspectives of hypocretin/orexin research in sleep medicine. Sleep and Biological Rhythms 2003;1:43-54. [DOI: 10.1046/j.1446-9235.2003.00001.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
390 Howard AD, Mcallister G, Feighner SD, Liu Q, Nargund RP, Van der Ploeg LH, Patchett AA. Orphan G-protein-coupled receptors and natural ligand discovery. Trends in Pharmacological Sciences 2001;22:132-40. [DOI: 10.1016/s0165-6147(00)01636-9] [Cited by in Crossref: 188] [Cited by in F6Publishing: 59] [Article Influence: 9.0] [Reference Citation Analysis]
391 Han D, Shi Y, Han F. The effects of orexin-A and orexin receptors on anxiety- and depression-related behaviors in a male rat model of post-traumatic stress disorder. J Comp Neurol 2022;530:592-606. [PMID: 34387361 DOI: 10.1002/cne.25231] [Reference Citation Analysis]
392 Pedrazzoli M, D'almeida V, Martins PJ, Machado RB, Ling L, Nishino S, Tufik S, Mignot E. Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation. Brain Research 2004;995:1-6. [DOI: 10.1016/j.brainres.2003.09.032] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
393 Harro J, Laas K, Eensoo D, Kurrikoff T, Sakala K, Vaht M, Parik J, Mäestu J, Veidebaum T. Orexin/hypocretin receptor gene (HCRTR1) variation is associated with aggressive behaviour. Neuropharmacology 2019;156:107527. [DOI: 10.1016/j.neuropharm.2019.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
394 Burgess CR, Scammell TE. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci 2012;32:12305-11. [PMID: 22956821 DOI: 10.1523/JNEUROSCI.2630-12.2012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
395 Bårdsen K, Gjerstad MD, Partinen M, Kvivik I, Tjensvoll AB, Ruoff P, Omdal R, Brede C. Considerably Lower Levels of Hypocretin-1 in Cerebrospinal Fluid Is Revealed by a Novel Mass Spectrometry Method Compared with Standard Radioimmunoassay. Anal Chem 2019;91:9323-9. [DOI: 10.1021/acs.analchem.9b02710] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
396 Boychuk CR, Fuller DD, Hayward LF. Sex differences in heart rate variability during sleep following prenatal nicotine exposure in rat pups. Behav Brain Res 2011;219:82-91. [PMID: 21163307 DOI: 10.1016/j.bbr.2010.12.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
397 Kummer M, Neidert SJ, Jöhren O, Dominiak P. Orexin (hypocretin) gene expression in rat ependymal cells: . Neuroreport 2001;12:2117-20. [DOI: 10.1097/00001756-200107200-00015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
398 Ichinose M, Asai M, Sawada M, Sasaki K, Oomura Y. Induction of outward current by orexin-B in mouse peritoneal macrophages. FEBS Letters 1998;440:51-4. [DOI: 10.1016/s0014-5793(98)01432-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
399 Teske JA, Billington CJ, Kotz CM. Mechanisms underlying obesity resistance associated with high spontaneous physical activity. Neuroscience 2014;256:91-100. [PMID: 24161277 DOI: 10.1016/j.neuroscience.2013.10.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
400 Smith MS, Grove KL. Integration of the regulation of reproductive function and energy balance: lactation as a model. Front Neuroendocrinol 2002;23:225-56. [PMID: 12127305 DOI: 10.1016/s0091-3022(02)00002-x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
401 Tandon S, Keefe KA, Taha SA, Roeper J. Mu opioid receptor signaling in the nucleus accumbens shell increases responsiveness of satiety-modulated lateral hypothalamus neurons. Eur J Neurosci 2017;45:1418-30. [DOI: 10.1111/ejn.13579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
402 Cannella N, Ubaldi M, Masi A, Bramucci M, Roberto M, Bifone A, Ciccocioppo R. Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future. Neurosci Biobehav Rev 2019;103:384-98. [PMID: 31112713 DOI: 10.1016/j.neubiorev.2019.05.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
403 Carr JA, Brown CL, Mansouri R, Venkatesan S. Neuropeptides and amphibian prey-catching behavior. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 2002;132:151-62. [DOI: 10.1016/s1096-4959(01)00545-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
404 Ahima RS, Saper CB, Flier JS, Elmquist JK. Leptin regulation of neuroendocrine systems. Front Neuroendocrinol. 2000;21:263-307. [PMID: 10882542 DOI: 10.1006/frne.2000.0197] [Cited by in Crossref: 519] [Cited by in F6Publishing: 447] [Article Influence: 23.6] [Reference Citation Analysis]
405 Hsueh YC, Cheng SM, Pan JT. Fasting stimulates tuberoinfundibular dopaminergic neuronal activity and inhibits prolactin secretion in oestrogen-primed ovariectomized rats: involvement of orexin A and neuropeptide Y. J Neuroendocrinol 2002;14:745-52. [PMID: 12213136 DOI: 10.1046/j.1365-2826.2002.00835.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
406 Zigman JM, Elmquist JK. Minireview: From Anorexia to Obesity—The Yin and Yang of Body Weight Control. Endocrinology 2003;144:3749-56. [DOI: 10.1210/en.2003-0241] [Cited by in Crossref: 276] [Cited by in F6Publishing: 245] [Article Influence: 14.5] [Reference Citation Analysis]
407 Lin L, Wisor J, Shiba T, Taheri S, Yanai K, Wurts S, Lin X, Vitaterna M, Takahashi J, Lovenberg T, Koehl M, Uhl G, Nishino S, Mignot E. Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background. Peptides 2002;23:2203-11. [DOI: 10.1016/s0196-9781(02)00251-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
408 Lu BS, Zee PC. Neurobiology of Sleep. Clinics in Chest Medicine 2010;31:309-18. [DOI: 10.1016/j.ccm.2010.02.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
409 Graebner AK, Iyer M, Carter ME. Understanding how discrete populations of hypothalamic neurons orchestrate complicated behavioral states. Front Syst Neurosci 2015;9:111. [PMID: 26300745 DOI: 10.3389/fnsys.2015.00111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
410 España RA, Scammell TE. Sleep neurobiology from a clinical perspective. Sleep 2011;34:845-58. [PMID: 21731134 DOI: 10.5665/SLEEP.1112] [Cited by in Crossref: 81] [Cited by in F6Publishing: 63] [Article Influence: 7.4] [Reference Citation Analysis]
411 Jaiswal SJ, Owens RL, Malhotra A. Raising awareness about sleep disorders. Lung India 2017;34:262-8. [PMID: 28474653 DOI: 10.4103/0970-2113.205331] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
412 Bayer L, Mairet-coello G, Risold P, Griffond B. Orexin/hypocretin neurons: chemical phenotype and possible interactions with melanin-concentrating hormone neurons. Regulatory Peptides 2002;104:33-9. [DOI: 10.1016/s0167-0115(01)00320-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
413 Ramsey JJ, Kemnitz JW, Newton W, Hagopian K, Patterson TA, Swick AG. Food intake in rhesus monkeys following central administration of orexins. Regul Pept 2005;124:209-14. [PMID: 15544861 DOI: 10.1016/j.regpep.2004.07.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
414 Hoever P, Hay J, Rad M, Cavallaro M, van Gerven JM, Dingemanse J. Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Dose Almorexant, an Orexin Receptor Antagonist, in Healthy Elderly Subjects. Journal of Clinical Psychopharmacology 2013;33:363-70. [DOI: 10.1097/jcp.0b013e31828f5a7a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
415 Nixon JP, Kotz CM, Novak CM, Billington CJ, Teske JA. Neuropeptides controlling energy balance: orexins and neuromedins. Handb Exp Pharmacol 2012;:77-109. [PMID: 22249811 DOI: 10.1007/978-3-642-24716-3_4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
416 Bell MR, De Lorme KC, Figueira RJ, Kashy DA, Sisk CL. Adolescent gain in positive valence of a socially relevant stimulus: engagement of the mesocorticolimbic reward circuitry. Eur J Neurosci 2013;37:457-68. [PMID: 23173754 DOI: 10.1111/ejn.12058] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
417 Muehlan C, Heuberger J, Juif P, Croft M, van Gerven J, Dingemanse J. Accelerated Development of the Dual Orexin Receptor Antagonist ACT-541468: Integration of a Microtracer in a First-in-Human Study. Clin Pharmacol Ther 2018;104:1022-9. [DOI: 10.1002/cpt.1046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
418 Muehlan C, Vaillant C, Zenklusen I, Kraehenbuehl S, Dingemanse J. Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders. Expert Opinion on Drug Metabolism & Toxicology 2020;16:1063-78. [DOI: 10.1080/17425255.2020.1817380] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
419 Williams VM, Bhagwandin A, Swiegers J, Bertelsen MF, Hård T, Thannickal TC, Siegel JM, Sherwood CC, Manger PR. Nuclear organization of orexinergic neurons in the hypothalamus of a lar gibbon and a chimpanzee. Anat Rec (Hoboken) 2021. [PMID: 34535040 DOI: 10.1002/ar.24775] [Reference Citation Analysis]
420 Stump CA, Cooke AJ, Bruno J, Cabalu TD, Gotter AL, Harell CM, Kuduk SD, Mcdonald TP, O’brien J, Renger JJ, Williams PD, Winrow CJ, Coleman PJ. Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacology. Bioorganic & Medicinal Chemistry Letters 2016;26:5809-14. [DOI: 10.1016/j.bmcl.2016.10.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
421 Arias-Carrión O, Drucker-Colín R, Murillo-Rodríguez E. Survival rates through time of hypocretin grafted neurons within their projection site. Neurosci Lett 2006;404:93-7. [PMID: 16762505 DOI: 10.1016/j.neulet.2006.05.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
422 Stamatakis AM, Sparta DR, Jennings JH, McElligott ZA, Decot H, Stuber GD. Amygdala and bed nucleus of the stria terminalis circuitry: Implications for addiction-related behaviors. Neuropharmacology 2014;76 Pt B:320-8. [PMID: 23752096 DOI: 10.1016/j.neuropharm.2013.05.046] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 9.2] [Reference Citation Analysis]
423 Ueno T, Ishida T, Aluri J, Suzuki M, Beuckmann CT, Kameyama T, Asakura S, Kusano K. Disposition and Metabolism of [ 14 C]Lemborexant in Healthy Human Subjects and Characterization of Its Circulating Metabolites. Drug Metab Dispos 2020;49:31-8. [DOI: 10.1124/dmd.120.000229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
424 Bruijnzeel AW. Tobacco addiction and the dysregulation of brain stress systems. Neurosci Biobehav Rev 2012;36:1418-41. [PMID: 22405889 DOI: 10.1016/j.neubiorev.2012.02.015] [Cited by in Crossref: 100] [Cited by in F6Publishing: 92] [Article Influence: 10.0] [Reference Citation Analysis]
425 Olarte-Sánchez CM, Valencia Torres L, Body S, Cassaday HJ, Bradshaw CM, Szabadi E. Effect of orexin-B-saporin-induced lesions of the lateral hypothalamus on performance on a progressive ratio schedule. J Psychopharmacol 2012;26:871-86. [PMID: 21926428 DOI: 10.1177/0269881111409607] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
426 Ishibashi M, Gumenchuk I, Miyazaki K, Inoue T, Ross WN, Leonard CS. Hypocretin/Orexin Peptides Alter Spike Encoding by Serotonergic Dorsal Raphe Neurons through Two Distinct Mechanisms That Increase the Late Afterhyperpolarization. J Neurosci 2016;36:10097-115. [PMID: 27683906 DOI: 10.1523/JNEUROSCI.0635-16.2016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
427 Yamada H, Takahashi N, Tanno S, Nagamine M, Takakusaki K, Okumura T. A selective orexin-1 receptor antagonist, SB334867, blocks 2-DG-induced gastric acid secretion in rats. Neurosci Lett. 2005;376:137-142. [PMID: 15698936 DOI: 10.1016/j.neulet.2004.11.043] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
428 Campbell EJ, Norman A, Bonomo Y, Lawrence AJ. Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial. Brain Res 2020;1728:146597. [PMID: 31837287 DOI: 10.1016/j.brainres.2019.146597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
429 Soffin EM, Gill CH, Brough SJ, Jerman JC, Davies CH. Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus. Neuropharmacology. 2004;46:1168-1176. [PMID: 15111023 DOI: 10.1016/j.neuropharm.2004.02.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
430 Puskás N, Papp RS, Gallatz K, Palkovits M. Interactions between orexin-immunoreactive fibers and adrenaline or noradrenaline-expressing neurons of the lower brainstem in rats and mice. Peptides 2010;31:1589-97. [PMID: 20434498 DOI: 10.1016/j.peptides.2010.04.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
431 Yamuy J, Fung SJ, Xi M, Chase MH. Hypocretinergic control of spinal cord motoneurons. J Neurosci 2004;24:5336-45. [PMID: 15190106 DOI: 10.1523/JNEUROSCI.4812-03.2004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
432 Darlison MG, Richter D. Multiple genes for neuropeptides and their receptors: co-evolution and physiology. Trends in Neurosciences 1999;22:81-8. [DOI: 10.1016/s0166-2236(98)01333-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
433 Janockova J, Dolezal R, Nepovimova E, Kobrlova T, Benkova M, Kuca K, Konecny J, Mezeiova E, Melikova M, Hepnarova V, Ring A, Soukup O, Korabecny J. Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods. Molecules 2018;23:E2926. [PMID: 30423961 DOI: 10.3390/molecules23112926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
434 Nisimaru N, Mittal C, Shirai Y, Sooksawate T, Anandaraj P, Hashikawa T, Nagao S, Arata A, Sakurai T, Yamamoto M, Ito M. Orexin-neuromodulated cerebellar circuit controls redistribution of arterial blood flows for defense behavior in rabbits. Proc Natl Acad Sci U S A 2013;110:14124-31. [PMID: 23912185 DOI: 10.1073/pnas.1312804110] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
435 Fadel J, Bubser M, Deutch AY. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J Neurosci 2002;22:6742-6. [PMID: 12151553 DOI: 20026632] [Cited by in Crossref: 147] [Article Influence: 7.4] [Reference Citation Analysis]
436 Medrano M, Aguinaga D, Reyes-resina I, Canela EI, Mallol J, Navarro G, Franco R. Orexin A/Hypocretin Modulates Leptin Receptor-Mediated Signaling by Allosteric Modulations Mediated by the Ghrelin GHS-R1A Receptor in Hypothalamic Neurons. Mol Neurobiol 2018;55:4718-30. [DOI: 10.1007/s12035-017-0670-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
437 Lyons DJ, Hellysaz A, Ammari R, Broberger C. Hypocretin/Orexin Peptides Excite Rat Neuroendocrine Dopamine Neurons through Orexin 2 Receptor-Mediated Activation of a Mixed Cation Current. Sci Rep 2017;7:41535. [PMID: 28145492 DOI: 10.1038/srep41535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
438 Yu L, Zhang XY, Chen ZP, Zhuang QX, Zhu JN, Wang JJ. Orexin excites rat inferior vestibular nuclear neurons via co-activation of OX1 and OX 2 receptors. J Neural Transm (Vienna) 2015;122:747-55. [PMID: 25371350 DOI: 10.1007/s00702-014-1330-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
439 Hong C, Byrne NJ, Zamlynny B, Tummala S, Xiao L, Shipman JM, Partridge AT, Minnick C, Breslin MJ, Rudd MT, Stachel SJ, Rada VL, Kern JC, Armacost KA, Hollingsworth SA, O'Brien JA, Hall DL, McDonald TP, Strickland C, Brooun A, Soisson SM, Hollenstein K. Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation. Nat Commun 2021;12:815. [PMID: 33547286 DOI: 10.1038/s41467-021-21087-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
440 Parks GS, Warrier DR, Dittrich L, Schwartz MD, Palmerston JB, Neylan TC, Morairty SR, Kilduff TS. The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems. Neuropsychopharmacology 2016;41:1144-55. [PMID: 26289145 DOI: 10.1038/npp.2015.256] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
441 Oken BS, Salinsky MC, Elsas SM. Vigilance, alertness, or sustained attention: physiological basis and measurement. Clin Neurophysiol. 2006;117:1885-1901. [PMID: 16581292 DOI: 10.1016/j.clinph.2006.01.017] [Cited by in Crossref: 377] [Cited by in F6Publishing: 269] [Article Influence: 23.6] [Reference Citation Analysis]
442 García MC, López M, Gualillo O, Seoane LM, Diéguez C, Señarís RM. Hypothalamic levels of NPY, MCH, and prepro‐orexin mRNA during pregnancy and lactation in the rat: role of prolactin. FASEB j 2003;17:1392-400. [DOI: 10.1096/fj.02-0933com] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 4.3] [Reference Citation Analysis]
443 Revell VL, Della Monica C, Mendis J, Hassanin H, Halter RJ, Chaplan SR, Dijk DJ. Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial. Neuropsychopharmacology 2021. [PMID: 34628482 DOI: 10.1038/s41386-021-01175-3] [Reference Citation Analysis]
444 Pinos H, Pérez-Izquierdo MA, Carrillo B, Collado P. Effects of undernourishment on the hypothalamic orexinergic system. Physiol Behav 2011;102:17-21. [PMID: 20932853 DOI: 10.1016/j.physbeh.2010.09.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
445 Mahlios J, De la Herrán-Arita AK, Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol 2013;23:767-73. [PMID: 23725858 DOI: 10.1016/j.conb.2013.04.013] [Cited by in Crossref: 110] [Cited by in F6Publishing: 84] [Article Influence: 12.2] [Reference Citation Analysis]
446 Tafti M, Franken P. Invited Review: Genetic dissection of sleep. Journal of Applied Physiology 2002;92:1339-47. [DOI: 10.1152/japplphysiol.00834.2001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
447 Schlicker E, Kathmann M. Presynaptic Neuropeptide Receptors. In: Südhof TC, Starke K, editors. Pharmacology of Neurotransmitter Release. Berlin: Springer Berlin Heidelberg; 2008. pp. 409-34. [DOI: 10.1007/978-3-540-74805-2_13] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
448 George CF, Singh SM. Hypocretin (orexin) pathway to sleep. The Lancet 2000;355:6. [DOI: 10.1016/s0140-6736(99)90468-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
449 Hoch M, van Gorsel H, van Gerven J, Dingemanse J. Entry-into-humans study with ACT-462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant: The Journal of Clinical Pharmacology. The Journal of Clinical Pharmacology 2014;54:979-86. [DOI: 10.1002/jcph.297] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
450 Smolinska N, Kiezun M, Dobrzyn K, Szeszko K, Maleszka A, Kaminski T. Expression of the orexin system in the porcine uterus, conceptus and trophoblast during early pregnancy. Animal 2015;9:1820-31. [DOI: 10.1017/s1751731115001020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
451 Holland P, Goadsby PJ. The Hypothalamic Orexinergic System: Pain and Primary Headaches. Headache: The Journal of Head and Face Pain 2007;47:951-62. [DOI: 10.1111/j.1526-4610.2007.00842.x] [Cited by in Crossref: 128] [Cited by in F6Publishing: 105] [Article Influence: 8.5] [Reference Citation Analysis]
452 Håkansson M, de Lecea L, Sutcliffe JG, Yanagisawa M, Meister B. Leptin receptor- and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus. J Neuroendocrinol 1999;11:653-63. [PMID: 10447804 DOI: 10.1046/j.1365-2826.1999.00378.x] [Cited by in Crossref: 170] [Cited by in F6Publishing: 159] [Article Influence: 7.4] [Reference Citation Analysis]
453 Alóe F, Alves RC, Araújo JF, Azevedo A, Bacelar A, Bezerra M, Bittencourt LR, Bustamante G, Cardoso TA, Eckeli AL, Fernandes RM, Goulart L, Pradella-Hallinan M, Hasan R, Sander HH, Pinto LR Jr, Lopes MC, Minhoto GR, Moraes W, Moreira GA, Pachito D, Pedrazolli M, Poyares D, Prado L, Rizzo G, Rodrigues RN, Roitman I, Silva AB, Tavares SM. [Brazilian guidelines for the diagnosis of narcolepsy]. Braz J Psychiatry 2010;32:294-304. [PMID: 20585744 DOI: 10.1590/s1516-44462010005000014] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
454 Kaufmann P, Ort M, Golor G, Kornberger R, Dingemanse J. First-in-human study with ACT-539313, a novel selective orexin-1 receptor antagonist. Br J Clin Pharmacol 2020;86:1377-86. [PMID: 32067262 DOI: 10.1111/bcp.14251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
455 Tsuneki H, Sugihara Y, Honda R, Wada T, Sasaoka T, Kimura I. Reduction of blood glucose level by orexins in fasting normal and streptozotocin-diabetic mice. European Journal of Pharmacology 2002;448:245-52. [DOI: 10.1016/s0014-2999(02)01936-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
456 Badami VM, Rice CD, Lois JH, Madrecha J, Yates BJ. Distribution of hypothalamic neurons with orexin (hypocretin) or melanin concentrating hormone (MCH) immunoreactivity and multisynaptic connections with diaphragm motoneurons. Brain Res 2010;1323:119-26. [PMID: 20144885 DOI: 10.1016/j.brainres.2010.02.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
457 Nakamura K. Neural circuit for psychological stress-induced hyperthermia. Temperature (Austin) 2015;2:352-61. [PMID: 27227049 DOI: 10.1080/23328940.2015.1070944] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
458 Kane JK, Tanaka H, Parker SL, Yanagisawa M, Li MD. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin. Biochem Biophys Res Commun 2000;272:959-65. [PMID: 10860858 DOI: 10.1006/bbrc.2000.2880] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
459 Dingemanse J, Hoever P, Hoch M, Treiber A, Wagner-redeker W, Miraval T, Hopfgartner G, Shakeri-nejad K. Elucidation of the Metabolic Pathways and the Resulting Multiple Metabolites of Almorexant, a Dual Orexin Receptor Antagonist, in Humans. Drug Metab Dispos 2013;41:1046-59. [DOI: 10.1124/dmd.112.050120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
460 Li Y, van den Pol AN. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides. J Neurosci 2006;26:13037-47. [PMID: 17167093 DOI: 10.1523/JNEUROSCI.3380-06.2006] [Cited by in Crossref: 86] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
461 Bigalke JA, Gao H, Chen QH, Shan Z. Activation of Orexin 1 Receptors in the Paraventricular Nucleus Contributes to the Development of Deoxycorticosterone Acetate-Salt Hypertension Through Regulation of Vasopressin. Front Physiol 2021;12:641331. [PMID: 33633591 DOI: 10.3389/fphys.2021.641331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
462 Ulrich-Lai YM, Fulton S, Wilson M, Petrovich G, Rinaman L. Stress exposure, food intake and emotional state. Stress 2015;18:381-99. [PMID: 26303312 DOI: 10.3109/10253890.2015.1062981] [Cited by in F6Publishing: 40] [Reference Citation Analysis]
463 Nahon J. The melanocortins and melanin-concentrating hormone in the central regulation of feeding behavior and energy homeostasis. Comptes Rendus Biologies 2006;329:623-38. [DOI: 10.1016/j.crvi.2006.03.021] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 5.6] [Reference Citation Analysis]
464 Ito M. Functional roles of neuropeptides in cerebellar circuits. Neuroscience 2009;162:666-72. [PMID: 19361475 DOI: 10.1016/j.neuroscience.2009.01.019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
465 Kiyashchenko LI, Mileykovskiy BY, Lai YY, Siegel JM. Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area. J Neurophysiol 2001;85:2008-16. [PMID: 11353017 DOI: 10.1152/jn.2001.85.5.2008] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 3.1] [Reference Citation Analysis]
466 Jöhren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P. Prepro-Orexin and Orexin Receptor mRNAs Are Differentially Expressed in Peripheral Tissues of Male and Female Rats. Endocrinology 2001;142:3324-31. [DOI: 10.1210/endo.142.8.8299] [Cited by in Crossref: 133] [Cited by in F6Publishing: 144] [Article Influence: 6.3] [Reference Citation Analysis]
467 Varricchio E, Russo F, Coccia E, Turchini GM, Francis DS, Paolucci M. The orexinergic system in rainbow trout Oncorhynchus mykiss and its regulation by dietary lipids. Microsc Res Tech 2015;78:707-14. [PMID: 26096763 DOI: 10.1002/jemt.22528] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
468 Thompson MD, Xhaard H, Sakurai T, Rainero I, Kukkonen JP. OX1 and OX2 orexin/hypocretin receptor pharmacogenetics. Front Neurosci 2014;8:57. [PMID: 24834023 DOI: 10.3389/fnins.2014.00057] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
469 Reynolds GP, Hill MJ, Kirk SL. The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics. J Psychopharmacol 2006;20:15-8. [PMID: 16785265 DOI: 10.1177/1359786806066040] [Cited by in Crossref: 105] [Cited by in F6Publishing: 102] [Article Influence: 7.5] [Reference Citation Analysis]
470 Chase MH. Motor control during sleep and wakefulness: Clarifying controversies and resolving paradoxes. Sleep Medicine Reviews 2013;17:299-312. [DOI: 10.1016/j.smrv.2012.09.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
471 Abizaid A, Gao Q, Horvath TL. Thoughts for food: brain mechanisms and peripheral energy balance. Neuron 2006;51:691-702. [PMID: 16982416 DOI: 10.1016/j.neuron.2006.08.025] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 4.8] [Reference Citation Analysis]
472 Shu Q, Hu ZL, Huang C, Yu XW, Fan H, Yang JW, Fang P, Ni L, Chen JG, Wang F. Orexin-A promotes cell migration in cultured rat astrocytes via Ca2+-dependent PKCα and ERK1/2 signals. PLoS One 2014;9:e95259. [PMID: 24748172 DOI: 10.1371/journal.pone.0095259] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
473 Christopher JA. Small-molecule antagonists of the orexin receptors. Pharm Pat Anal 2014;3:625-38. [PMID: 25489915 DOI: 10.4155/ppa.14.46] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
474 Kitka T, Adori C, Katai Z, Vas S, Molnar E, Papp RS, Toth ZE, Bagdy G. Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivation. Neurochem Int 2011;59:686-94. [PMID: 21740944 DOI: 10.1016/j.neuint.2011.06.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
475 Guo ZZ, Jiang SM, Zeng LP, Tang L, Li N, Xu ZP, Wei X. ipRGCs: possible causation accounts for the higher prevalence of sleep disorders in glaucoma patients. Int J Ophthalmol 2017;10:1163-7. [PMID: 28730123 DOI: 10.18240/ijo.2017.07.22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
476 Arcamone N, D’angelo L, de Girolamo P, Lucini C, Pelagalli A, Castaldo L. Orexin and orexin receptor like peptides in the gastroenteric tract of Gallus domesticus: An immunohistochemical survey on presence and distribution. Research in Veterinary Science 2014;96:234-40. [DOI: 10.1016/j.rvsc.2014.02.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
477 Cason AM, Aston-Jones G. Role of orexin/hypocretin in conditioned sucrose-seeking in rats. Psychopharmacology (Berl) 2013;226:155-65. [PMID: 23096770 DOI: 10.1007/s00213-012-2902-y] [Cited by in Crossref: 73] [Cited by in F6Publishing: 64] [Article Influence: 7.3] [Reference Citation Analysis]
478 Johnson PL, Federici LM, Fitz SD, Renger JJ, Shireman B, Winrow CJ, Bonaventure P, Shekhar A. OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES. Depress Anxiety 2015;32:671-83. [PMID: 26332431 DOI: 10.1002/da.22403] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 6.4] [Reference Citation Analysis]
479 Assisi L, Tafuri S, Liguori G, Paino S, Pavone LM, Staiano N, Vittoria A. Expression and role of receptor 1 for orexins in seminiferous tubules of rat testis. Cell Tissue Res 2012;348:601-7. [DOI: 10.1007/s00441-012-1394-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
480 Sakurai T, Mieda M. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol Sci 2011;32:451-62. [PMID: 21565412 DOI: 10.1016/j.tips.2011.03.007] [Cited by in Crossref: 139] [Cited by in F6Publishing: 136] [Article Influence: 12.6] [Reference Citation Analysis]
481 Stern AL, Naidoo N. Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease. Springerplus 2015;4:25. [PMID: 25635245 DOI: 10.1186/s40064-014-0777-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
482 Chen J, Randeva H. Genomic organization and regulation of the human orexin (hypocretin) receptor 2 gene: identification of alternative promoters. Biochemical Journal 2010;427:377-90. [DOI: 10.1042/bj20091755] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
483 Berthoud HR, Münzberg H. The lateral hypothalamus as integrator of metabolic and environmental needs: from electrical self-stimulation to opto-genetics. Physiol Behav. 2011;104:29-39. [PMID: 21549732 DOI: 10.1016/j.physbeh.2011.04.051] [Cited by in Crossref: 136] [Cited by in F6Publishing: 131] [Article Influence: 12.4] [Reference Citation Analysis]
484 Zhang J, Li B, Yu L, He YC, Li HZ, Zhu JN, Wang JJ. A role for orexin in central vestibular motor control. Neuron 2011;69:793-804. [PMID: 21338887 DOI: 10.1016/j.neuron.2011.01.026] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 6.3] [Reference Citation Analysis]
485 Louhivuori LM, Jansson L, Nordström T, Bart G, Näsman J, Åkerman KE. Selective interference with TRPC3/6 channels disrupts OX1 receptor signalling via NCX and reveals a distinct calcium influx pathway. Cell Calcium 2010;48:114-23. [DOI: 10.1016/j.ceca.2010.07.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
486 Luppi AI, Spindler LRB, Menon DK, Stamatakis EA. The Inert Brain: Explaining Neural Inertia as Post-anaesthetic Sleep Inertia. Front Neurosci 2021;15:643871. [PMID: 33737863 DOI: 10.3389/fnins.2021.643871] [Reference Citation Analysis]
487 Mohammad Ahmadi Soleimani S, Azizi H, Pachenari N, Mirnajafi-zadeh J, Semnanian S. Enhancement of μ-opioid receptor desensitization by orexin-A in rat locus coeruleus neurons. Neuropeptides 2017;63:28-36. [DOI: 10.1016/j.npep.2017.03.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
488 Woods SC, Seeley RJ. Adiposity signals and the control of energy homeostasis. Nutrition. 2000;16:894-902. [PMID: 11054594 DOI: 10.1016/s0899-9007(00)00454-8] [Cited by in Crossref: 164] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
489 Flores Á, Saravia R, Maldonado R, Berrendero F. Orexins and fear: implications for the treatment of anxiety disorders. Trends in Neurosciences 2015;38:550-9. [DOI: 10.1016/j.tins.2015.06.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 8.1] [Reference Citation Analysis]
490 Hoyer D, Jacobson LH. Orexin Receptor Antagonists. Curr Sleep Medicine Rep 2017;3:342-53. [DOI: 10.1007/s40675-017-0099-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
491 Dingemanse J, Hoever P. Absence of pharmacokinetic and pharmacodynamic interactions between almorexant and warfarin in healthy subjects. Drugs R D 2013;13:145-51. [PMID: 23737453 DOI: 10.1007/s40268-013-0017-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
492 Matsuki T, Sakurai T. Orexins and Orexin Receptors: From Molecules to Integrative Physiology. In: Civelli O, Zhou Q, editors. Orphan G Protein-Coupled Receptors and Novel Neuropeptides. Berlin: Springer Berlin Heidelberg; 2008. pp. 27-55. [DOI: 10.1007/400_2007_047] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Reference Citation Analysis]
493 Bergman P, Adori C, Vas S, Kai-Larsen Y, Sarkanen T, Cederlund A, Agerberth B, Julkunen I, Horvath B, Kostyalik D, Kalmár L, Bagdy G, Huutoniemi A, Partinen M, Hökfelt T. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc Natl Acad Sci U S A 2014;111:E3735-44. [PMID: 25136085 DOI: 10.1073/pnas.1412189111] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
494 Johnson PL, Molosh A, Fitz SD, Truitt WA, Shekhar A. Orexin, stress, and anxiety/panic states. Prog Brain Res 2012;198:133-61. [PMID: 22813973 DOI: 10.1016/B978-0-444-59489-1.00009-4] [Cited by in Crossref: 125] [Cited by in F6Publishing: 69] [Article Influence: 12.5] [Reference Citation Analysis]
495 Sharf R, Sarhan M, Dileone RJ. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol Psychiatry 2008;64:175-83. [PMID: 18423425 DOI: 10.1016/j.biopsych.2008.03.006] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 7.5] [Reference Citation Analysis]
496 Xiao X, Yeghiazaryan G, Hess S, Klemm P, Sieben A, Kleinridders A, Morgan DA, Wunderlich FT, Rahmouni K, Kong D, Scammell TE, Lowell BB, Kloppenburg P, Brüning JC, Hausen AC. Orexin receptors 1 and 2 in serotonergic neurons differentially regulate peripheral glucose metabolism in obesity. Nat Commun 2021;12:5249. [PMID: 34475397 DOI: 10.1038/s41467-021-25380-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
497 Vécsei L, Lukács M, Tajti J, Fülöp F, Toldi J, Edvinsson L. The Therapeutic Impact of New Migraine Discoveries. Curr Med Chem 2019;26:6261-81. [PMID: 29848264 DOI: 10.2174/0929867325666180530114534] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
498 Wang W, Pan Y, Li Q, Wang L. Orexin: A potential role in the process of obstructive sleep apnea. Peptides 2013;42:48-54. [DOI: 10.1016/j.peptides.2013.01.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
499 Tafuri S, Pavone LM, Muto RL, Basile M, Langella E, Fiorillo E, Avallone L, Staiano N, Vittoria A. Expression of orexin A and its receptor 1 in the rat epididymis. Regulatory Peptides 2009;155:1-5. [DOI: 10.1016/j.regpep.2009.03.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
500 Zagha E, McCormick DA. Neural control of brain state. Curr Opin Neurobiol 2014;29:178-86. [PMID: 25310628 DOI: 10.1016/j.conb.2014.09.010] [Cited by in Crossref: 89] [Cited by in F6Publishing: 72] [Article Influence: 11.1] [Reference Citation Analysis]
501 Mahmoudi M, Maleki-roveshti M, Karimi-haghighi S, Haghparast A. Chemical stimulation of the lateral hypothalamus induced seeking behaviors in rats: Involvement of orexin receptors in the ventral tegmental area. European Journal of Pharmacology 2020;886:173433. [DOI: 10.1016/j.ejphar.2020.173433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
502 Schmeichel BE, Barbier E, Misra KK, Contet C, Schlosburg JE, Grigoriadis D, Williams JP, Karlsson C, Pitcairn C, Heilig M, Koob GF, Vendruscolo LF. Hypocretin receptor 2 antagonism dose-dependently reduces escalated heroin self-administration in rats. Neuropsychopharmacology 2015;40:1123-9. [PMID: 25367502 DOI: 10.1038/npp.2014.293] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
503 Xi M, Chase MH. The injection of hypocretin-1 into the nucleus pontis oralis induces either active sleep or wakefulness depending on the behavioral state when it is administered. Sleep 2010;33:1236-43. [PMID: 20857871 DOI: 10.1093/sleep/33.9.1236] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
504 Swick TJ. The Neurology of Sleep. Sleep Medicine Clinics 2011;6:1-14. [DOI: 10.1016/j.jsmc.2010.12.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
505 Neubauer DN, Pandi-Perumal SR, Spence DW, Buttoo K, Monti JM. Pharmacotherapy of Insomnia. J Cent Nerv Syst Dis 2018;10:1179573518770672. [PMID: 29881321 DOI: 10.1177/1179573518770672] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
506 Kayaba Y, Nakamura A, Kasuya Y, Ohuchi T, Yanagisawa M, Komuro I, Fukuda Y, Kuwaki T. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 2003;285:R581-93. [PMID: 12750151 DOI: 10.1152/ajpregu.00671.2002] [Cited by in Crossref: 210] [Cited by in F6Publishing: 215] [Article Influence: 11.1] [Reference Citation Analysis]
507 Broberger C, De Lecea L, Sutcliffe J, H�kfelt T. Hypocretin/Orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 1998;402:460-74. [DOI: 10.1002/(sici)1096-9861(19981228)402:4<460::aid-cne3>3.0.co;2-s] [Cited by in Crossref: 498] [Article Influence: 20.8] [Reference Citation Analysis]
508 Bai YJ, Li YH, Zheng XG, Han J, Yang XY, Sui N. Orexin A attenuates unconditioned sexual motivation in male rats. Pharmacol Biochem Behav 2009;91:581-9. [PMID: 18952120 DOI: 10.1016/j.pbb.2008.09.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
509 Zeitzer JM, Buckmaster CL, Lyons DM, Mignot E. Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys. J Physiol 2004;557:1045-53. [PMID: 15107479 DOI: 10.1113/jphysiol.2004.061606] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
510 Cole AG, Stroke IL, Qin L, Hussain Z, Simhadri S, Brescia M, Waksmunski FS, Strohl B, Tellew JE, Williams JP, Saunders J, Appell KC, Henderson I, Webb ML. Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2008;18:5420-3. [DOI: 10.1016/j.bmcl.2008.09.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
511 Currie PJ, Khelemsky R, Rigsbee EM, Dono LM, Coiro CD, Chapman CD, Hinchcliff K. Ghrelin is an orexigenic peptide and elicits anxiety-like behaviors following administration into discrete regions of the hypothalamus. Behav Brain Res 2012;226:96-105. [PMID: 21907737 DOI: 10.1016/j.bbr.2011.08.037] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 5.7] [Reference Citation Analysis]
512 Liblau RS. Put to sleep by immune cells. Nature 2018;562:46-8. [PMID: 30275550 DOI: 10.1038/d41586-018-06666-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
513 Novikova NS, Perekrest SV, Shainidze KZ, Korneva EA. Hypothalamic Orexin-Containing Neurons in the Hypothalamus on Exposure to Antigenic and Non-Antigenic Stimuli. Neurosci Behav Physi 2011;41:188-97. [DOI: 10.1007/s11055-011-9399-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
514 Rotter A, Asemann R, Decker A, Kornhuber J, Biermann T. Orexin expression and promoter-methylation in peripheral blood of patients suffering from major depressive disorder. Journal of Affective Disorders 2011;131:186-92. [DOI: 10.1016/j.jad.2010.12.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
515 Risco S, Mediavilla C. Orexin A in the ventral tegmental area enhances saccharin-induced conditioned flavor preference: The role of D1 receptors in central nucleus of amygdala. Behavioural Brain Research 2018;348:192-200. [DOI: 10.1016/j.bbr.2018.04.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
516 Huang ZL, Qu WM, Li WD, Mochizuki T, Eguchi N, Watanabe T, Urade Y, Hayaishi O. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A 2001;98:9965-70. [PMID: 11493714 DOI: 10.1073/pnas.181330998] [Cited by in Crossref: 376] [Cited by in F6Publishing: 336] [Article Influence: 17.9] [Reference Citation Analysis]
517 Thorpe AJ, Kotz CM. Orexin A in the nucleus accumbens stimulates feeding and locomotor activity. Brain Res 2005;1050:156-62. [PMID: 15979595 DOI: 10.1016/j.brainres.2005.05.045] [Cited by in Crossref: 125] [Cited by in F6Publishing: 126] [Article Influence: 7.4] [Reference Citation Analysis]
518 Székely M. Orexins, energy balance, temperature, sleep-wake cycle. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2006;291:R530-2. [DOI: 10.1152/ajpregu.00179.2006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
519 Suno R, Kimura KT, Nakane T, Yamashita K, Wang J, Fujiwara T, Yamanaka Y, Im D, Horita S, Tsujimoto H, Tawaramoto MS, Hirokawa T, Nango E, Tono K, Kameshima T, Hatsui T, Joti Y, Yabashi M, Shimamoto K, Yamamoto M, Rosenbaum DM, Iwata S, Shimamura T, Kobayashi T. Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA. Structure 2018;26:7-19.e5. [DOI: 10.1016/j.str.2017.11.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
520 Gallmann E, Arsenijevic D, Spengler M, Williams G, Langhans W. Effect of CCK-8 on insulin-induced hyperphagia and hypothalamic orexigenic neuropeptide expression in the rat. Peptides 2005;26:437-45. [DOI: 10.1016/j.peptides.2004.10.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
521 Sifferlen T, Boller A, Chardonneau A, Cottreel E, Hoecker J, Aissaoui H, Williams JT, Brotschi C, Heidmann B, Siegrist R, Gatfield J, Treiber A, Brisbare-roch C, Jenck F, Boss C. Discovery of substituted lactams as novel dual orexin receptor antagonists. Synthesis, preliminary structure–activity relationship studies and efforts towards improved metabolic stability and pharmacokinetic properties. Part 1. Bioorganic & Medicinal Chemistry Letters 2014;24:1201-8. [DOI: 10.1016/j.bmcl.2013.12.092] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
522 Prober DA, Rihel J, Onah AA, Sung RJ, Schier AF. Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish. J Neurosci 2006;26:13400-10. [PMID: 17182791 DOI: 10.1523/JNEUROSCI.4332-06.2006] [Cited by in Crossref: 308] [Cited by in F6Publishing: 153] [Article Influence: 20.5] [Reference Citation Analysis]
523 Silverman RB, Holladay MW. Receptors. The Organic Chemistry of Drug Design and Drug Action. Elsevier; 2014. pp. 123-63. [DOI: 10.1016/b978-0-12-382030-3.00003-9] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
524 Nozu T, Kumei S, Takakusaki K, Ataka K, Fujimiya M, Okumura T. Central orexin-A increases colonic motility in conscious rats. Neurosci Lett. 2011;498:143-146. [PMID: 21575675 DOI: 10.1016/j.neulet.2011.04.078] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
525 Vázquez-cuevas F, Aguilar-roblero R, Arellanes-licea E, Macotela Y, Vázquez-martínez O, Villanueva I, Díaz-muñoz M. Food Intake and Its Control by Signaling Molecules. Hormones, Brain and Behavior. Elsevier; 2017. pp. 175-209. [DOI: 10.1016/b978-0-12-803592-4.00006-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
526 Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 1998;438:71-75. [PMID: 9821961 DOI: 10.1016/s0014-5793(98)01266-6] [Cited by in Crossref: 693] [Cited by in F6Publishing: 230] [Article Influence: 28.9] [Reference Citation Analysis]
527 Nishino S, Sagawa Y. The Neurochemistry of Awakening. Science of Awakening. Elsevier; 2010. pp. 229-55. [DOI: 10.1016/s0074-7742(10)93010-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
528 Ubuka T, Mukai M, Wolfe J, Beverly R, Clegg S, Wang A, Hsia S, Li M, Krause JS, Mizuno T, Fukuda Y, Tsutsui K, Bentley GE, Wingfield JC. RNA interference of gonadotropin-inhibitory hormone gene induces arousal in songbirds. PLoS One 2012;7:e30202. [PMID: 22279571 DOI: 10.1371/journal.pone.0030202] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 5.0] [Reference Citation Analysis]
529 Mediavilla C. Bidirectional gut-brain communication: A role for orexin-A. Neurochem Int 2020;141:104882. [PMID: 33068686 DOI: 10.1016/j.neuint.2020.104882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
530 Mileykovskiy BY, Kiyashchenko LI, Siegel JM. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005;46:787-98. [PMID: 15924864 DOI: 10.1016/j.neuron.2005.04.035] [Cited by in Crossref: 579] [Cited by in F6Publishing: 545] [Article Influence: 34.1] [Reference Citation Analysis]
531 Barson JR, Leibowitz SF. Orexin/Hypocretin System: Role in Food and Drug Overconsumption. Int Rev Neurobiol 2017;136:199-237. [PMID: 29056152 DOI: 10.1016/bs.irn.2017.06.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
532 Tarasiuk A, Levi A, Berdugo-Boura N, Yahalom A, Segev Y. Role of orexin in respiratory and sleep homeostasis during upper airway obstruction in rats. Sleep 2014;37:987-98. [PMID: 24790278 DOI: 10.5665/sleep.3676] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
533 Lee DA, Andreev A, Truong TV, Chen A, Hill AJ, Oikonomou G, Pham U, Hong YK, Tran S, Glass L, Sapin V, Engle J, Fraser SE, Prober DA. Genetic and neuronal regulation of sleep by neuropeptide VF. Elife 2017;6:e25727. [PMID: 29106375 DOI: 10.7554/eLife.25727] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 6.2] [Reference Citation Analysis]
534 Cole S, Keefer SE, Anderson LC, Petrovich GD. Medial Prefrontal Cortex Neural Plasticity, Orexin Receptor 1 Signaling, and Connectivity with the Lateral Hypothalamus Are Necessary in Cue-Potentiated Feeding. J Neurosci 2020;40:1744-55. [PMID: 31953368 DOI: 10.1523/JNEUROSCI.1803-19.2020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 7.5] [Reference Citation Analysis]
535 Hisatomi Y, Asakura K, Kugino K, Kurokawa M, Asakura T, Nakata K. Changes in brain tissue and behavior patterns induced by single short-term fasting in mice. PLoS One 2013;8:e80085. [PMID: 24224039 DOI: 10.1371/journal.pone.0080085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
536 Jöhren O, Neidert SJ, Kummer M, Dominiak P. Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus. Peptides 2002;23:1177-80. [DOI: 10.1016/s0196-9781(02)00052-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
537 Dujardin S, Pijpers A, Pevernagie D. Prescription Drugs Used in Insomnia. Sleep Medicine Clinics 2018;13:169-82. [DOI: 10.1016/j.jsmc.2018.03.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
538 Apelbaum A, Perrut A, Chaput M. Orexin A effects on the olfactory bulb spontaneous activity and odor responsiveness in freely breathing rats. Regulatory Peptides 2005;129:49-61. [DOI: 10.1016/j.regpep.2005.01.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
539 Heier MS, Evsiukova T, Vilming S, Gjerstad MD, Schrader H, Gautvik K. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway. Sleep 2007;30:969-73. [PMID: 17702265 DOI: 10.1093/sleep/30.8.969] [Cited by in Crossref: 61] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
540 Burt J, Alberto CO, Parsons MP, Hirasawa M. Local network regulation of orexin neurons in the lateral hypothalamus. Am J Physiol Regul Integr Comp Physiol 2011;301:R572-80. [PMID: 21697524 DOI: 10.1152/ajpregu.00674.2010] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
541 RayatSanati K, Jamali S, Hassanlou AA, Haghparast A. Blockade of orexin receptors in the hippocampal dentate gyrus reduced the extinction latency of morphine-induced place preference in male rats. Neurosci Lett 2021;756:135946. [PMID: 33974952 DOI: 10.1016/j.neulet.2021.135946] [Reference Citation Analysis]
542 Bassetti CLA, Adamantidis A, Burdakov D, Han F, Gay S, Kallweit U, Khatami R, Koning F, Kornum BR, Lammers GJ, Liblau RS, Luppi PH, Mayer G, Pollmächer T, Sakurai T, Sallusto F, Scammell TE, Tafti M, Dauvilliers Y. Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 2019;15:519-39. [DOI: 10.1038/s41582-019-0226-9] [Cited by in Crossref: 113] [Cited by in F6Publishing: 89] [Article Influence: 37.7] [Reference Citation Analysis]
543 Dobrzyn K, Smolinska N, Kiezun M, Szeszko K, Rytelewska E, Kisielewska K, Gudelska M, Kaminski T. The in vitro effect of progesterone on the orexin system in porcine uterine tissues during early pregnancy. Acta Vet Scand 2018;60:76. [PMID: 30477546 DOI: 10.1186/s13028-018-0430-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
544 Umezawa N, Arisaka H, Sakuraba S, Sugita T, Matsumoto A, Kaku Y, Yoshida K, Kuwana S. Orexin-B antagonized respiratory depression induced by sevoflurane, propofol, and remifentanil in isolated brainstem-spinal cords of neonatal rats. Respiratory Physiology & Neurobiology 2015;205:61-5. [DOI: 10.1016/j.resp.2014.10.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
545 Dworak M, Kim T, McCarley RW, Basheer R. Sleep, brain energy levels, and food intake: Relationship between hypothalamic ATP concentrations, food intake, and body weight during sleep-wake and sleep deprivation in rats. Somnologie (Berl) 2011;15:111-7. [PMID: 23585726 DOI: 10.1007/s11818-011-0524-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
546 Saper CB. Restoration: Potential for compensatory changes in numbers of neurons in adult human brain: Restoration. Ann Neurol 2013;74:762-4. [DOI: 10.1002/ana.24039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
547 Li MD, Parker SL, Kane JK. Regulation of feeding-associated peptides and receptors by nicotine. Mol Neurobiol 2000;22:143-65. [PMID: 11414277 DOI: 10.1385/MN:22:1-3:143] [Cited by in Crossref: 44] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
548 Laburthe M, Voisin T. The orexin receptor OX(1)R in colon cancer: a promising therapeutic target and a new paradigm in G protein-coupled receptor signalling through ITIMs. Br J Pharmacol 2012;165:1678-87. [PMID: 21627633 DOI: 10.1111/j.1476-5381.2011.01510.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
549 Harrison T, Chen C, Dun N, Chang J. Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla. Neuroscience Letters 1999;273:17-20. [DOI: 10.1016/s0304-3940(99)00611-4] [Cited by in Crossref: 69] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
550 Vasquez JH, Borniger JC. Neuroendocrine and Behavioral Consequences of Hyperglycemia in Cancer. Endocrinology 2020;161:bqaa047. [PMID: 32193527 DOI: 10.1210/endocr/bqaa047] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
551 Bittencourt JC, Diniz GB. Neuroanatomical Structure of the MCH System. In: Pandi-perumal SR, Torterolo P, Monti JM, editors. Melanin-Concentrating Hormone and Sleep. Cham: Springer International Publishing; 2018. pp. 1-46. [DOI: 10.1007/978-3-319-75765-0_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
552 Datta S, Maclean RR. Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence. Neurosci Biobehav Rev 2007;31:775-824. [PMID: 17445891 DOI: 10.1016/j.neubiorev.2007.02.004] [Cited by in Crossref: 194] [Cited by in F6Publishing: 166] [Article Influence: 12.9] [Reference Citation Analysis]
553 Yazdi F, Jahangirvand M, Ezzatpanah S, Haghparast A. Role of orexin-2 receptors in the nucleus accumbens in antinociception induced by carbachol stimulation of the lateral hypothalamus in formalin test. Behav Pharmacol 2016;27:431-8. [PMID: 26871404 DOI: 10.1097/FBP.0000000000000216] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
554 Barnett S, Li A. Orexin in Respiratory and Autonomic Regulation, Health and Diseases. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 345-63. [DOI: 10.1002/cphy.c190013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
555 Simonneaux V, Ribelayga C. Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev. 2003;55:325-395. [PMID: 12773631 DOI: 10.1124/pr.55.2.2] [Cited by in Crossref: 419] [Cited by in F6Publishing: 385] [Article Influence: 22.1] [Reference Citation Analysis]
556 Kortunay S, Erken HA, Erken G, Genç O, Şahiner M, Turgut S, Turgut G. Orexins increase penicillin-induced epileptic activity. Peptides 2012;34:419-22. [DOI: 10.1016/j.peptides.2012.02.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
557 Riahi E, Arezoomandan R, Fatahi Z, Haghparast A. The electrical activity of hippocampal pyramidal neuron is subjected to descending control by the brain orexin/hypocretin system. Neurobiology of Learning and Memory 2015;119:93-101. [DOI: 10.1016/j.nlm.2015.02.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
558 Yamamoto Y, McKinley MJ, Nakazato M, Yamashita H, Shirahata A, Ueta Y. Postnatal development of orexin-A and orexin-B like immunoreactivities in the Eastern grey kangaroo (Macropus giganteus) hypothalamus. Neurosci Lett. 2006;392:124-128. [PMID: 16188385 DOI: 10.1016/j.neulet.2005.09.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
559 de Lecea L, Sutcliffe JG, Fabre V. Hypocretins/orexins as integrators of physiological information: lessons from mutant animals. Neuropeptides 2002;36:85-95. [PMID: 12359500 DOI: 10.1054/npep.2002.0892] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
560 Cannella N, Economidou D, Kallupi M, Stopponi S, Heilig M, Massi M, Ciccocioppo R. Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology 2009;34:2125-34. [PMID: 19322167 DOI: 10.1038/npp.2009.37] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 5.4] [Reference Citation Analysis]
561 Hoyer D, Allen A, Jacobson LH. Hypnotics with novel modes of action. Br J Clin Pharmacol 2020;86:244-9. [PMID: 31756268 DOI: 10.1111/bcp.14180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
562 Wu W, Wu P, Zhou J, Guan X, Zhang Z, Yang Y, Long L, Xie N, Chen J, Wang F. Orexin-A Activates Hypothalamic AMP-Activated Protein Kinase Signaling through a Ca 2+ -Dependent Mechanism Involving Voltage-Gated L-Type Calcium Channel. Mol Pharmacol 2013;84:876-87. [DOI: 10.1124/mol.113.086744] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
563 Toll L, Khroyan TV, Sonmez K, Ozawa A, Lindberg I, McLaughlin JP, Eans SO, Shahien AA, Kapusta DR. Peptides derived from the prohormone proNPQ/spexin are potent central modulators of cardiovascular and renal function and nociception. FASEB J 2012;26:947-54. [PMID: 22038051 DOI: 10.1096/fj.11-192831] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
564 Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev. 2006;58:46-57. [PMID: 16507882 DOI: 10.1124/pr.58.1.4] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 7.0] [Reference Citation Analysis]
565 Baiardi S, Pizza F, Polischi B, Moresco M, Abu-Rumeileh S, Plazzi G, Parchi P. Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1. Sleep 2020;43:zsz215. [PMID: 31552425 DOI: 10.1093/sleep/zsz215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
566 Laorden ML, Ferenczi S, Pintér-Kübler B, González-Martín LL, Lasheras MC, Kovács KJ, Milanés MV, Núñez C. Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal. PLoS One 2012;7:e36871. [PMID: 22590628 DOI: 10.1371/journal.pone.0036871] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
567 Roth JD, Rowland NE. Interactive Effects of Neurochemicals on Ingestive Behavior. Nutritional Neuroscience 2016;3:161-72. [DOI: 10.1080/1028415x.2000.11747313] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
568 Mieda M, Hasegawa E, Kisanuki YY, Sinton CM, Yanagisawa M, Sakurai T. Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. J Neurosci 2011;31:6518-26. [PMID: 21525292 DOI: 10.1523/JNEUROSCI.6506-10.2011] [Cited by in Crossref: 134] [Cited by in F6Publishing: 78] [Article Influence: 12.2] [Reference Citation Analysis]
569 Prober DA. Discovery of Hypocretin/Orexin Ushers in a New Era of Sleep Research. Trends Neurosci 2018;41:70-2. [PMID: 29405929 DOI: 10.1016/j.tins.2017.11.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
570 Pantazis CB, James MH, Bentzley BS, Aston-Jones G. The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand. Addict Biol 2020;25:e12795. [PMID: 31297913 DOI: 10.1111/adb.12795] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
571 Li J, Hu Z, de Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol 2014;171:332-50. [PMID: 24102345 DOI: 10.1111/bph.12415] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 19.1] [Reference Citation Analysis]
572 Bućan M, Abel T. The mouse: genetics meets behaviour. Nat Rev Genet 2002;3:114-23. [DOI: 10.1038/nrg728] [Cited by in Crossref: 117] [Cited by in F6Publishing: 114] [Article Influence: 5.9] [Reference Citation Analysis]
573 Alcaraz-iborra M, Cubero I. Do Orexins contribute to impulsivity-driven binge consumption of rewarding stimulus and transition to drug/food dependence? Pharmacology Biochemistry and Behavior 2015;134:31-4. [DOI: 10.1016/j.pbb.2015.04.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
574 Plaza-Zabala A, Li X, Milovanovic M, Loweth JA, Maldonado R, Berrendero F, Wolf ME. An investigation of interactions between hypocretin/orexin signaling and glutamate receptor surface expression in the rat nucleus accumbens under basal conditions and after cocaine exposure. Neurosci Lett 2013;557 Pt B:101-6. [PMID: 24262606 DOI: 10.1016/j.neulet.2013.10.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
575 Mahler SV, Aston-Jones GS. Fos activation of selective afferents to ventral tegmental area during cue-induced reinstatement of cocaine seeking in rats. J Neurosci 2012;32:13309-26. [PMID: 22993446 DOI: 10.1523/JNEUROSCI.2277-12.2012] [Cited by in Crossref: 90] [Cited by in F6Publishing: 67] [Article Influence: 9.0] [Reference Citation Analysis]
576 Kenny PJ. Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacol Biochem Behav 2011;97:700-7. [PMID: 20816891 DOI: 10.1016/j.pbb.2010.08.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
577 Sahu A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol. 2003;24:225-253. [PMID: 14726256 DOI: 10.1016/j.yfrne.2003.10.001] [Cited by in Crossref: 206] [Cited by in F6Publishing: 185] [Article Influence: 11.4] [Reference Citation Analysis]
578 Korotkova TM, Eriksson KS, Haas HL, Brown RE. Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept 2002;104:83-9. [PMID: 11830281 DOI: 10.1016/s0167-0115(01)00323-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
579 Suzuki H, Yamamoto T. Orexin-B-like immunoreactivity localizes in both luteinizing-hormone-containing cells and melanin-concentrating hormone-containing fibers in the red-bellied piranha (Pygocentrus nattereri) pituitary. Cell Tissue Res 2013;351:175-82. [PMID: 23161098 DOI: 10.1007/s00441-012-1516-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
580 Katoh K, Kutsumura N, Yamamoto N, Nagumo Y, Saitoh T, Ishikawa Y, Irukayama-Tomobe Y, Tanimura R, Yanagisawa M, Nagase H. Essential structure of orexin 1 receptor antagonist YNT-707: Conversion of the 16-cyclopropylmethyl group to the 16-sulfonamide group in D-nor-nalfurafine derivatives. Bioorg Med Chem Lett 2022;:128550. [PMID: 35041942 DOI: 10.1016/j.bmcl.2022.128550] [Reference Citation Analysis]
581 Shalev U, Erb S, Shaham Y. Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res 2010;1314:15-28. [PMID: 19631614 DOI: 10.1016/j.brainres.2009.07.028] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 7.5] [Reference Citation Analysis]
582 Chen YW, Barson JR, Chen A, Hoebel BG, Leibowitz SF. Glutamatergic input to the lateral hypothalamus stimulates ethanol intake: role of orexin and melanin-concentrating hormone. Alcohol Clin Exp Res 2013;37:123-31. [PMID: 22823322 DOI: 10.1111/j.1530-0277.2012.01854.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
583 Samuels ER, Szabadi E. Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr Neuropharmacol 2008;6:235-53. [PMID: 19506723 DOI: 10.2174/157015908785777229] [Cited by in Crossref: 389] [Cited by in F6Publishing: 362] [Article Influence: 32.4] [Reference Citation Analysis]
584 Rachalski A, Alexandre C, Bernard JF, Saurini F, Lesch KP, Hamon M, Adrien J, Fabre V. Altered sleep homeostasis after restraint stress in 5-HTT knock-out male mice: a role for hypocretins. J Neurosci 2009;29:15575-85. [PMID: 20007481 DOI: 10.1523/JNEUROSCI.3138-09.2009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
585 Singareddy R, Uhde T, Commissaris R. Differential effects of hypocretins on noise-alone versus potentiated startle responses. Physiol Behav 2006;89:650-5. [PMID: 17028045 DOI: 10.1016/j.physbeh.2006.08.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
586 Seifinejad A, Vassalli A, Tafti M. Neurobiology of cataplexy. Sleep Med Rev 2021;60:101546. [PMID: 34607185 DOI: 10.1016/j.smrv.2021.101546] [Reference Citation Analysis]
587 Morairty SR, Wisor J, Silveira K, Sinko W, Kilduff TS. The wake-promoting effects of hypocretin-1 are attenuated in old rats. Neurobiol Aging 2011;32:1514-27. [PMID: 19781813 DOI: 10.1016/j.neurobiolaging.2009.07.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
588 Tsujino N, Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 2009;61:162-76. [PMID: 19549926 DOI: 10.1124/pr.109.001321] [Cited by in Crossref: 314] [Cited by in F6Publishing: 284] [Article Influence: 26.2] [Reference Citation Analysis]
589 de Oliveira CV, Rosas-Arellano MP, Solano-Flores LP, Ciriello J. Cardiovascular effects of hypocretin-1 in nucleus of the solitary tract. Am J Physiol Heart Circ Physiol 2003;284:H1369-77. [PMID: 12531738 DOI: 10.1152/ajpheart.00877.2002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
590 Peters A, Schweiger U, Pellerin L, Hubold C, Oltmanns KM, Conrad M, Schultes B, Born J, Fehm HL. The selfish brain: competition for energy resources. Neurosci Biobehav Rev 2004;28:143-80. [PMID: 15172762 DOI: 10.1016/j.neubiorev.2004.03.002] [Cited by in Crossref: 294] [Cited by in F6Publishing: 233] [Article Influence: 16.3] [Reference Citation Analysis]
591 Stanley S, Wynne K, McGowan B, Bloom S. Hormonal regulation of food intake. Physiol Rev. 2005;85:1131-1158. [PMID: 16183909 DOI: 10.1152/physrev.00015.2004] [Cited by in Crossref: 240] [Cited by in F6Publishing: 215] [Article Influence: 14.1] [Reference Citation Analysis]
592 Cui D, Cabalu T, Yee KL, Small J, Li X, Liu B, Maciolek C, Smith S, Liu W, McCrea JB, Prueksaritanont T. In vitro and in vivo characterisation of the metabolism and disposition of suvorexant in humans. Xenobiotica 2016;46:882-95. [PMID: 26864332 DOI: 10.3109/00498254.2015.1129565] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
593 Chabi A, Zhang Y, Jackson S, Cady R, Lines C, Herring WJ, Connor KM, Michelson D. Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis. Cephalalgia 2015;35:379-88. [PMID: 25106663 DOI: 10.1177/0333102414544979] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 6.8] [Reference Citation Analysis]
594 Kohlmeier KA, Inoue T, Leonard CS. Hypocretin/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum. J Neurophysiol. 2004;92:221-235. [PMID: 14999052 DOI: 10.1152/jn.00076.2004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 3.9] [Reference Citation Analysis]
595 Mendoza-Ruiz LG, Vázquez-León P, Martínez-Mota L, Juan ERS, Miranda-Páez A. Forced ethanol ingestion by Wistar rats from a juvenile age increased voluntary alcohol consumption in adulthood, with the involvement of orexin-A. Alcohol 2018;70:73-80. [PMID: 29803804 DOI: 10.1016/j.alcohol.2018.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
596 Nakamachi T, Shibata H, Sakashita A, Iinuma N, Wada K, Konno N, Matsuda K. Orexin A enhances locomotor activity and induces anxiogenic-like action in the goldfish, Carassius auratus. Hormones and Behavior 2014;66:317-23. [DOI: 10.1016/j.yhbeh.2014.06.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
597 Fonseca EM, Dias MB, Bícego KC, Gargaglioni LH. Orexin in the toad Rhinella schneideri: The location of orexinergic neurons and the role of orexin in ventilatory responses to hypercarbia and hypoxia. Respir Physiol Neurobiol 2016;224:90-9. [PMID: 25434286 DOI: 10.1016/j.resp.2014.11.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
598 Micheli F, Antolini M, Di Fabio R, Pellacani A, Pozzan A. 2-Methyl-3-furanyl-4H-1,2,4-triazol-3-ylthioamides: A new class of selective orexin 2 antagonists. Bioorganic & Medicinal Chemistry Letters 2010;20:6405-7. [DOI: 10.1016/j.bmcl.2010.09.090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
599 Nishino S, Ripley B, Mignot E, Benson KL, Zarcone VP. CSF hypocretin-1 levels in schizophrenics and controls: relationship to sleep architecture. Psychiatry Research 2002;110:1-7. [DOI: 10.1016/s0165-1781(02)00032-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
600 Furuse M. Central regulation of food intake in the neonatal chick. Animal Science Journal 2002;73:83-94. [DOI: 10.1046/j.1344-3941.2002.00014.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
601 Pearl PL. Childhood sleep disorders: Diagnostic and therapeutic approaches. Curr Neurol Neurosci Rep 2002;2:150-7. [DOI: 10.1007/s11910-002-0024-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
602 Arafat AM, Kaczmarek P, Skrzypski M, Pruszyńska-Oszmałek E, Kołodziejski P, Adamidou A, Ruhla S, Szczepankiewicz D, Sassek M, Billert M, Wiedenmann B, Pfeiffer AF, Nowak KW, Strowski MZ. Glucagon regulates orexin A secretion in humans and rodents. Diabetologia 2014;57:2108-16. [PMID: 25063274 DOI: 10.1007/s00125-014-3335-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
603 Patra SK, Arora S. Integrative role of neuropeptides and cytokines in cancer anorexia-cachexia syndrome. Clin Chim Acta 2012;413:1025-34. [PMID: 22251421 DOI: 10.1016/j.cca.2011.12.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
604 Stasi LP, Artusi R, Bovino C, Buzzi B, Canciani L, Caselli G, Colace F, Garofalo P, Giambuzzi S, Larger P, Letari O, Mandelli S, Perugini L, Pucci S, Salvi M, Toro P. Discovery, synthesis, selectivity modulation and DMPK characterization of 5-azaspiro[2.4]heptanes as potent orexin receptor antagonists. Bioorg Med Chem Lett 2013;23:2653-8. [PMID: 23535328 DOI: 10.1016/j.bmcl.2013.02.093] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
605 Ong JJY, Wei DY, Goadsby PJ. Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs. Drugs 2018;78:411-37. [PMID: 29396834 DOI: 10.1007/s40265-018-0865-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 12.3] [Reference Citation Analysis]
606 Dergacheva O, Bateman R, Byrne P, Mendelowitz D. Orexinergic modulation of GABAergic neurotransmission to cardiac vagal neurons in the brain stem nucleus ambiguus changes during development. Neuroscience 2012;209:12-20. [PMID: 22390944 DOI: 10.1016/j.neuroscience.2012.02.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
607 Morairty SR, Revel FG, Malherbe P, Moreau JL, Valladao D, Wettstein JG, Kilduff TS, Borroni E. Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone. PLoS One 2012;7:e39131. [PMID: 22768296 DOI: 10.1371/journal.pone.0039131] [Cited by in Crossref: 79] [Cited by in F6Publishing: 89] [Article Influence: 7.9] [Reference Citation Analysis]
608 Guo S, Cui Y, Huang Z, Liu H, Zhang X, Jiang J, Xin W. Orexin A-mediated AKT signaling in the dentate gyrus contributes to the acquisition, expression and reinstatement of morphine-induced conditioned place preference: Orexin mediate morphine reward. Addiction Biology 2016;21:547-59. [DOI: 10.1111/adb.12236] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
609 Dube MG, Kalra SP, Kalra PS. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action1This study was presented in part at the 28th Annual Meeting of the Society for Neuroscience, Los Angeles, CA, in November 1998.1. Brain Research 1999;842:473-7. [DOI: 10.1016/s0006-8993(99)01824-7] [Cited by in Crossref: 251] [Cited by in F6Publishing: 63] [Article Influence: 10.9] [Reference Citation Analysis]
610 Liguori G, Squillacioti C, Assisi L, Pelagalli A, Vittoria A, Costagliola A, Mirabella N. Potential role of orexin A binding the receptor 1 for orexins in normal and cryptorchid dogs. BMC Vet Res 2018;14:55. [PMID: 29482574 DOI: 10.1186/s12917-018-1375-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
611 Haq IZ, Naidu Y, Reddy P, Chaudhuri KR. Narcolepsy in Parkinson's disease. Expert Rev Neurother 2010;10:879-84. [PMID: 20518604 DOI: 10.1586/ern.10.56] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
612 Blumberg MS. Sleep physiology: setting the right tone. Curr Biol 2013;23:R834-6. [PMID: 24070441 DOI: 10.1016/j.cub.2013.07.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
613 Telegdy G, Adamik A. The action of orexin A on passive avoidance learning. Involvement of transmitters. Regul Pept 2002;104:105-10. [PMID: 11830284 DOI: 10.1016/s0167-0115(01)00341-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
614 Bayer L, Serafin M, Eggermann E, Saint-Mleux B, Machard D, Jones BE, Mühlethaler M. Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J Neurosci 2004;24:6760-4. [PMID: 15282280 DOI: 10.1523/JNEUROSCI.1783-04.2004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
615 Mercer RE, Chee MJ, Colmers WF. The role of NPY in hypothalamic mediated food intake. Front Neuroendocrinol 2011;32:398-415. [PMID: 21726573 DOI: 10.1016/j.yfrne.2011.06.001] [Cited by in Crossref: 111] [Cited by in F6Publishing: 107] [Article Influence: 10.1] [Reference Citation Analysis]
616 Kessler BA, Stanley EM, Frederick-Duus D, Fadel J. Age-related loss of orexin/hypocretin neurons. Neuroscience 2011;178:82-8. [PMID: 21262323 DOI: 10.1016/j.neuroscience.2011.01.031] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 6.6] [Reference Citation Analysis]
617 Nevárez N, de Lecea L. Hypocretin and the Regulation of Sleep-Wake Transitions. Handbook of Sleep Research. Elsevier; 2019. pp. 89-99. [DOI: 10.1016/b978-0-12-813743-7.00006-2] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
618 Sutcliffe JG, de Lecea L. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res 2000;62:161-8. [PMID: 11020209 DOI: 10.1002/1097-4547(20001015)62:2<161::AID-JNR1>3.0.CO;2-1] [Cited by in Crossref: 149] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
619 Barbier M, Risold PY. The claustrum is a target for projections from the supramammillary nucleus in the rat. Neuroscience 2019;409:261-75. [PMID: 30930128 DOI: 10.1016/j.neuroscience.2019.03.045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
620 Alóe F, Azevedo AP, Hasan R. [Sleep-wake cycle mechanisms]. Braz J Psychiatry 2005;27 Suppl 1:33-9. [PMID: 16082453 DOI: 10.1590/s1516-44462005000500007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
621 Farzinpour Z, Taslimi Z, Azizbeigi R, Karimi-haghighi S, Haghparast A. Involvement of orexinergic receptors in the nucleus accumbens, in the effect of forced swim stress on the reinstatement of morphine seeking behaviors. Behavioural Brain Research 2019;356:279-87. [DOI: 10.1016/j.bbr.2018.08.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
622 Akiyama M, Yuasa T, Hayasaka N, Horikawa K, Sakurai T, Shibata S. Reduced food anticipatory activity in genetically orexin (hypocretin) neuron-ablated mice. Eur J Neurosci 2004;20:3054-62. [PMID: 15579160 DOI: 10.1111/j.1460-9568.2004.03749.x] [Cited by in Crossref: 137] [Cited by in F6Publishing: 131] [Article Influence: 8.1] [Reference Citation Analysis]
623 Kask A, Mutulis F, Muceniece R, Pähkla R, Mutule I, Wikberg JE, Rägo L, Schiöth HB. Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo. Endocrinology 1998;139:5006-14. [PMID: 9832440 DOI: 10.1210/endo.139.12.6352] [Cited by in Crossref: 72] [Cited by in F6Publishing: 79] [Article Influence: 3.0] [Reference Citation Analysis]
624 Novak CM, Kotz CM, Levine JA. Central orexin sensitivity, physical activity, and obesity in diet-induced obese and diet-resistant rats. Am J Physiol Endocrinol Metab 2006;290:E396-403. [PMID: 16188908 DOI: 10.1152/ajpendo.00293.2005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 4.5] [Reference Citation Analysis]
625 Horjales-Araujo E, Hellysaz A, Broberger C. Lateral hypothalamic thyrotropin-releasing hormone neurons: distribution and relationship to histochemically defined cell populations in the rat. Neuroscience 2014;277:87-102. [PMID: 24993479 DOI: 10.1016/j.neuroscience.2014.06.043] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
626 Autio J, Stenbäck V, Gagnon DD, Leppäluoto J, Herzig KH. (Neuro) Peptides, Physical Activity, and Cognition. J Clin Med 2020;9:E2592. [PMID: 32785144 DOI: 10.3390/jcm9082592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
627 Martynska L, Wolinska-witort E, Chmielowska M, Kalisz M, Baranowska B, Bik W. Effect of orexin A on the release of GnRH-stimulated gonadotrophins from cultured pituitary cells of immature and mature female rats. Neuropeptides 2014;48:199-205. [DOI: 10.1016/j.npep.2014.05.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
628 Okumura T, Nozu T, Ishioh M, Igarashi S, Kumei S, Ohhira M. Centrally administered butyrate improves gut barrier function, visceral sensation and septic lethality in rats. J Pharmacol Sci 2021;146:183-91. [PMID: 34116731 DOI: 10.1016/j.jphs.2021.04.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
629 Watts AG, Kanoski SE, Sanchez-Watts G, Langhans W. The Physiological Control of Eating: Signals, Neurons, and Networks. Physiol Rev 2021. [PMID: 34486393 DOI: 10.1152/physrev.00028.2020] [Reference Citation Analysis]
630 Zhang J, Sampogna S, Morales FR, Chase MH. Co-localization of hypocretin-1 and hypocretin-2 in the cat hypothalamus and brainstem. Peptides 2002;23:1479-83. [DOI: 10.1016/s0196-9781(02)00084-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
631 Chen XT, Wang XG, Xie LY, Huang JW, Zhao W, Wang Q, Yao LM, Li WR. Effects of Xingnaojing Injection on Adenosinergic Transmission and Orexin Signaling in Lateral Hypothalamus of Ethanol-Induced Coma Rats. Biomed Res Int 2019;2019:2389485. [PMID: 31346513 DOI: 10.1155/2019/2389485] [Reference Citation Analysis]
632 Urbańska A, Sokołowska P, Woldan-Tambor A, Biegańska K, Brix B, Jöhren O, Namiecińska M, Zawilska JB. Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures. J Mol Neurosci 2012;46:10-7. [PMID: 21547533 DOI: 10.1007/s12031-011-9526-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
633 Goadsby P, Charbit A, Andreou A, Akerman S, Holland P. Neurobiology of migraine. Neuroscience 2009;161:327-41. [DOI: 10.1016/j.neuroscience.2009.03.019] [Cited by in Crossref: 260] [Cited by in F6Publishing: 230] [Article Influence: 20.0] [Reference Citation Analysis]
634 Vittoz NM, Berridge CW. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 2006;31:384-95. [PMID: 15988471 DOI: 10.1038/sj.npp.1300807] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 7.7] [Reference Citation Analysis]
635 Waleh N, Apte-deshpande A, Terao A, Ding J, Kilduff T. Modulation of the promoter region of prepro-hypocretin by α-interferon. Gene 2001;262:123-8. [DOI: 10.1016/s0378-1119(00)00544-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
636 Hahn JD, Swanson LW. Distinct patterns of neuronal inputs and outputs of the juxtaparaventricular and suprafornical regions of the lateral hypothalamic area in the male rat. Brain Res Rev 2010;64:14-103. [PMID: 20170674 DOI: 10.1016/j.brainresrev.2010.02.002] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 6.0] [Reference Citation Analysis]
637 Mavanji V, Pomonis B, Kotz CM. Orexin, serotonin, and energy balance. WIREs Mech Dis 2022;14:e1536. [PMID: 35023323 DOI: 10.1002/wsbm.1536] [Reference Citation Analysis]
638 Acuna-Goycolea C, van den Pol AN. Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis. J Neurosci 2005;25:10510-9. [PMID: 16280589 DOI: 10.1523/JNEUROSCI.2552-05.2005] [Cited by in Crossref: 82] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
639 Yamanaka A, Kunii K, Nambu T, Tsujino N, Sakai A, Matsuzaki I, Miwa Y, Katsutoshi Goto, Sakurai T. Orexin-induced food intake involves neuropeptide Y pathway. Brain Research 2000;859:404-9. [DOI: 10.1016/s0006-8993(00)02043-6] [Cited by in Crossref: 192] [Cited by in F6Publishing: 33] [Article Influence: 8.7] [Reference Citation Analysis]
640 Halpern CH, Wolf JA, Bale TL, Stunkard AJ, Danish SF, Grossman M, Jaggi JL, Grady MS, Baltuch GH. Deep brain stimulation in the treatment of obesity: A review. JNS 2008;109:625-34. [DOI: 10.3171/jns/2008/109/10/0625] [Cited by in Crossref: 107] [Cited by in F6Publishing: 30] [Article Influence: 7.6] [Reference Citation Analysis]
641 Kane J, Parker S, Li M. Hypothalamic orexin-A binding sites are downregulated by chronic nicotine treatment in the rat. Neuroscience Letters 2001;298:1-4. [DOI: 10.1016/s0304-3940(00)01730-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
642 Rhyne DN, Anderson SL. Suvorexant in insomnia: efficacy, safety and place in therapy. Ther Adv Drug Saf 2015;6:189-95. [PMID: 26478806 DOI: 10.1177/2042098615595359] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
643 Karnani M, Burdakov D. Multiple hypothalamic circuits sense and regulate glucose levels. Am J Physiol Regul Integr Comp Physiol 2011;300:R47-55. [PMID: 21048078 DOI: 10.1152/ajpregu.00527.2010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 5.6] [Reference Citation Analysis]
644 Singletary KG, Delville Y, Farrell WJ, Wilczynski W. Distribution of orexin/hypocretin immunoreactivity in the nervous system of the green Treefrog, Hyla cinerea. Brain Research 2005;1041:231-6. [DOI: 10.1016/j.brainres.2005.01.095] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
645 Tabikh M, Chahla C, Okdeh N, Kovacic H, Sabatier J, Fajloun Z. Parkinson disease: protective role and function of neuropeptides. Peptides 2021. [DOI: 10.1016/j.peptides.2021.170713] [Reference Citation Analysis]
646 Kaushik MK, Aritake K, Imanishi A, Kanbayashi T, Ichikawa T, Shimizu T, Urade Y, Yanagisawa M. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy. Proc Natl Acad Sci U S A 2018;115:6046-51. [PMID: 29784823 DOI: 10.1073/pnas.1722686115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
647 Satoh S, Matsumura H, Kanbayashi T, Yoshida Y, Urakami T, Nakajima T, Kimura N, Nishino S, Yoneda H. Expression pattern of FOS in orexin neurons during sleep induced by an adenosine A2A receptor agonist. Behavioural Brain Research 2006;170:277-86. [DOI: 10.1016/j.bbr.2006.03.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
648 Messina A, De Fusco C, Monda V, Esposito M, Moscatelli F, Valenzano A, Carotenuto M, Viggiano E, Chieffi S, De Luca V, Cibelli G, Monda M, Messina G. Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis. Front Neural Circuits 2016;10:66. [PMID: 27610076 DOI: 10.3389/fncir.2016.00066] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
649 Coleman PJ, Renger JJ. Orexin receptor antagonists: a review of promising compounds patented since 2006. Expert Opin Ther Pat 2010;20:307-24. [PMID: 20180618 DOI: 10.1517/13543770903567085] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
650 Zhang S, Lin L, Kaur S, Thankachan S, Blanco-Centurion C, Yanagisawa M, Mignot E, Shiromani PJ. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats. Neuroscience 2007;148:34-43. [PMID: 17618058 DOI: 10.1016/j.neuroscience.2007.05.029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
651 van den Pol AN. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 1999;19:3171-82. [PMID: 10191330 [PMID: 10191330 DOI: 10.1523/jneurosci.19-08-03171.1999] [Cited by in Crossref: 377] [Article Influence: 16.4] [Reference Citation Analysis]
652 Lavezzi AM, Ferrero S, Roncati L, Matturri L, Pusiol T. Impaired orexin receptor expression in the Kölliker-Fuse nucleus in sudden infant death syndrome: possible involvement of this nucleus in arousal pathophysiology. Neurol Res 2016;38:706-16. [PMID: 27353953 DOI: 10.1080/01616412.2016.1201632] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
653 Jo YH, Talmage DA, Role LW. Nicotinic receptor-mediated effects on appetite and food intake. J Neurobiol 2002;53:618-32. [PMID: 12436425 DOI: 10.1002/neu.10147] [Cited by in Crossref: 193] [Cited by in F6Publishing: 179] [Article Influence: 10.2] [Reference Citation Analysis]
654 van der Ark PD, Golor G, van Nueten L, Nandy P, de Boer P. Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects. J Psychopharmacol 2018;32:1330-40. [DOI: 10.1177/0269881118791521] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
655 Jiang H, Huang J, Shen Y, Guo S, Wang L, Han C, Liu L, Ma K, Xia Y, Li J, Xu X, Xiong N, Wang T. RBD and Neurodegenerative Diseases. Mol Neurobiol 2017;54:2997-3006. [PMID: 27032389 DOI: 10.1007/s12035-016-9831-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
656 Gallmann E, Arsenijevic D, Williams G, Langhans W, Spengler M. Effect of intraperitoneal CCK-8 on food intake and brain orexin-A after 48 h of fasting in the rat. Regulatory Peptides 2006;133:139-46. [DOI: 10.1016/j.regpep.2005.09.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
657 Hoever P, de Haas SL, Dorffner G, Chiossi E, van Gerven JM, Dingemanse J. Orexin receptor antagonism: an ascending multiple-dose study with almorexant. J Psychopharmacol 2012;26:1071-80. [DOI: 10.1177/0269881112448946] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
658 Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7. [PMID: 10973318 DOI: 10.1038/79690] [Cited by in Crossref: 1341] [Cited by in F6Publishing: 1194] [Article Influence: 61.0] [Reference Citation Analysis]
659 Chien Y, Liu C, Shan J, Lee H, Hsieh MH, Hwu H, Chiou L. Elevated plasma orexin A levels in a subgroup of patients with schizophrenia associated with fewer negative and disorganized symptoms. Psychoneuroendocrinology 2015;53:1-9. [DOI: 10.1016/j.psyneuen.2014.12.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
660 Monda M, Viggiano A, Mondola P, De Luca V. Inhibition of prostaglandin synthesis reduces hyperthermic reactions induced by hypocretin-1/orexin A. Brain Research 2001;909:68-74. [DOI: 10.1016/s0006-8993(01)02606-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
661 Dingemanse J, Gehin M, Cruz HG, Hoever P. Formulation development for the orexin receptor antagonist almorexant: assessment in two clinical studies. Drug Des Devel Ther 2014;8:397-403. [PMID: 24812492 DOI: 10.2147/DDDT.S62118] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
662 Blanco-Centurion C, Gerashchenko D, Shiromani PJ. Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake. J Neurosci 2007;27:14041-8. [PMID: 18094243 DOI: 10.1523/JNEUROSCI.3217-07.2007] [Cited by in Crossref: 90] [Cited by in F6Publishing: 61] [Article Influence: 6.4] [Reference Citation Analysis]
663 Lee HS, Kim MA, Waterhouse BD. Retrograde double-labeling study of common afferent projections to the dorsal raphe and the nuclear core of the locus coeruleus in the rat. J Comp Neurol 2005;481:179-93. [PMID: 15562508 DOI: 10.1002/cne.20365] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
664 Samson WK, Taylor MM, Follwell M, Ferguson AV. Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul Pept 2002;104:97-103. [PMID: 11830283 DOI: 10.1016/s0167-0115(01)00353-6] [Cited by in Crossref: 92] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
665 Narayanaswami V, Dwoskin LP. Obesity: Current and potential pharmacotherapeutics and targets. Pharmacol Ther 2017;170:116-47. [PMID: 27773782 DOI: 10.1016/j.pharmthera.2016.10.015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 11.5] [Reference Citation Analysis]
666 Handwerker G. Narkolepsie. Monatsschr Kinderheilkd 2007;155:624-9. [DOI: 10.1007/s00112-007-1555-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
667 Couvineau A, Voisin T, Nicole P, Gratio V, Abad C, Tan YV. Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases. Front Endocrinol (Lausanne) 2019;10:709. [PMID: 31695678 DOI: 10.3389/fendo.2019.00709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
668 Silver R, Lesauter J. Circadian and homeostatic factors in arousal. Ann N Y Acad Sci 2008;1129:263-74. [PMID: 18591487 DOI: 10.1196/annals.1417.032] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
669 Williams G, Harrold JA, Cutler DJ. The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box. Proc Nutr Soc 2000;59:385-96. [DOI: 10.1017/s0029665100000434] [Cited by in Crossref: 136] [Cited by in F6Publishing: 35] [Article Influence: 9.1] [Reference Citation Analysis]
670 Wilson BD, Bagnol D, Kaelin CB, Ollmann MM, Gantz I, Watson SJ, Barsh GS. Physiological and Anatomical Circuitry between Agouti-Related Protein and Leptin Signaling*. Endocrinology 1999;140:2387-97. [DOI: 10.1210/endo.140.5.6728] [Cited by in Crossref: 103] [Cited by in F6Publishing: 111] [Article Influence: 4.5] [Reference Citation Analysis]
671 Wu S, Sun Y, Hu Y, Zhang H, Hou L, Liu X, Li Y, He H, Luo Z, Chen Y, Wang Y, Shi W, Shen L, Cao C, Liang W, Xu Q, Lv Q, Lan J, Li J, Chen S. Discovery of novel substituted octahydropyrrolo[3,4- c ]pyrroles as dual orexin receptor antagonists for insomnia treatment. Bioorganic & Medicinal Chemistry Letters 2017;27:1458-62. [DOI: 10.1016/j.bmcl.2017.01.075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
672 Boutrel B. A neuropeptide-centric view of psychostimulant addiction. Br J Pharmacol 2008;154:343-57. [PMID: 18414383 DOI: 10.1038/bjp.2008.133] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
673 Mehta R, Singh A, Mallick BN. Disciplined sleep for healthy living: Role of noradrenaline. World J Neurol 2017; 7(1): 6-23 [DOI: 10.5316/wjn.v7.i1.6] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
674 Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA. 1999;96:10911-10916. [PMID: 10485925 DOI: 10.1073/pnas.96.19.10911] [Cited by in Crossref: 834] [Cited by in F6Publishing: 803] [Article Influence: 36.3] [Reference Citation Analysis]
675 Eyigor O, Minbay Z, Kafa IM. Glutamate and Orexin Neurons. Sleep Hormones. Elsevier; 2012. pp. 209-22. [DOI: 10.1016/b978-0-12-394623-2.00011-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
676 Qualls-Creekmore E, Münzberg H. Modulation of Feeding and Associated Behaviors by Lateral Hypothalamic Circuits. Endocrinology 2018;159:3631-42. [PMID: 30215694 DOI: 10.1210/en.2018-00449] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
677 Couvineau A, Dayot S, Nicole P, Gratio V, Rebours V, Couvelard A, Voisin T. The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role. Front Endocrinol (Lausanne) 2018;9:573. [PMID: 30319552 DOI: 10.3389/fendo.2018.00573] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
678 De la Herrán-Arita AK, Guerra-Crespo M, Drucker-Colín R. Narcolepsy and orexins: an example of progress in sleep research. Front Neurol 2011;2:26. [PMID: 21541306 DOI: 10.3389/fneur.2011.00026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
679 Chen W, Zeitzer JM, Mignot E. The Hypocretins and Narcolepsy. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 235-54. [DOI: 10.1007/0-387-25446-3_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
680 Khan Z, Trotti LM. Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia. Chest 2015;148:262-73. [PMID: 26149554 DOI: 10.1378/chest.14-1304] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
681 Haxhiu MA, Rust CF, Brooks C, Kc P. CNS determinants of sleep-related worsening of airway functions: implications for nocturnal asthma. Respir Physiol Neurobiol 2006;151:1-30. [PMID: 16198640 DOI: 10.1016/j.resp.2005.07.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
682 Jørgensen E, Knigge U, Watanabe T, Warberg J, Kjaer A. Histaminergic Neurons Are Involved in the Orexigenic Effect of Orexin-A. Neuroendocrinology 2006;82:70-7. [DOI: 10.1159/000090982] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
683 Hökfelt T, Broberger C, Xu ZQ, Sergeyev V, Ubink R, Diez M. Neuropeptides--an overview. Neuropharmacology 2000;39:1337-56. [PMID: 10818251 DOI: 10.1016/s0028-3908(00)00010-1] [Cited by in Crossref: 383] [Cited by in F6Publishing: 111] [Article Influence: 17.4] [Reference Citation Analysis]
684 Dunietz GL, Vanini G, Shannon C, O'Brien LM, Chervin RD. Associations of plasma hypocretin-1 with metabolic and reproductive health: Two systematic reviews of clinical studies. Sleep Med Rev 2020;52:101307. [PMID: 32259696 DOI: 10.1016/j.smrv.2020.101307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
685 Mohammed M, Yanagisawa M, Blessing W, Ootsuka Y. Attenuated cold defense responses in orexin neuron-ablated rats. Temperature (Austin) 2016;3:465-75. [PMID: 28349086 DOI: 10.1080/23328940.2016.1184366] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
686 Brunetti L, Di Nisio C, Orlando G, Ferrante C, Vacca M. The Regulation of Feeding: A Cross Talk between Peripheral and Central Signalling. Int J Immunopathol Pharmacol 2005;18:201-12. [DOI: 10.1177/039463200501800203] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
687 Fronczek R, Baumann CR, Lammers GJ, Bassetti CL, Overeem S. Hypocretin/orexin disturbances in neurological disorders. Sleep Medicine Reviews 2009;13:9-22. [DOI: 10.1016/j.smrv.2008.05.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
688 Chansard M, Iwahana E, Liang J, Fukuhara C. Regulation of cAMP-induced arylalkylamine N-acetyltransferase, Period1, and MKP-1 gene expression by mitogen-activated protein kinases in the rat pineal gland. Brain Res Mol Brain Res 2005;139:333-40. [PMID: 16024134 DOI: 10.1016/j.molbrainres.2005.06.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
689 Ciriello J, McMurray JC, Babic T, de Oliveira CV. Collateral axonal projections from hypothalamic hypocretin neurons to cardiovascular sites in nucleus ambiguus and nucleus tractus solitarius. Brain Res 2003;991:133-41. [PMID: 14575885 DOI: 10.1016/j.brainres.2003.08.016] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 3.0] [Reference Citation Analysis]
690 Schmeichel BE, Matzeu A, Koebel P, Vendruscolo LF, Sidhu H, Shahryari R, Kieffer BL, Koob GF, Martin-Fardon R, Contet C. Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats. Neuropsychopharmacology 2018;43:2373-82. [PMID: 29703996 DOI: 10.1038/s41386-018-0054-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
691 Kawano H, Honma S, Honma A, Horie M, Kawano Y, Hayashi S. Melanin-concentrating hormone neuron system: the Wide Web that controls the feeding. Anat Sci Int 2002;77:149-60. [PMID: 12422407 DOI: 10.1046/j.0022-7722.2002.00027.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
692 Thorpe AJ, Cleary JP, Levine AS, Kotz CM. Centrally administered orexin A increases motivation for sweet pellets in rats. Psychopharmacology (Berl) 2005;182:75-83. [PMID: 16075284 DOI: 10.1007/s00213-005-0040-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 3.9] [Reference Citation Analysis]
693 Suzuki H, Takemoto Y, Yamamoto T. Differential distribution of orexin-A-like and orexin receptor 1 (OX1R)-like immunoreactivities in the Xenopus pituitary. Tissue Cell 2007;39:423-30. [PMID: 17897692 DOI: 10.1016/j.tice.2007.08.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
694 Duva MA, Tomkins EM, Moranda L, Kaplan R, Sukhaseum A, Jimenez A, Stanley B. Reverse microdialysis of N-methyl-d-aspartic acid into the lateral hypothalamus of rats: effects on feeding and other behaviors. Brain Research 2001;921:122-32. [DOI: 10.1016/s0006-8993(01)03108-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
695 Smolinska N, Kiezun M, Dobrzyn K, Szeszko K, Maleszka A, Kaminski T. Adiponectin, orexin A and orexin B concentrations in the serum and uterine luminal fluid during early pregnancy of pigs. Anim Reprod Sci 2017;178:1-8. [PMID: 28089263 DOI: 10.1016/j.anireprosci.2017.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [